# EDGAR Filing Document

**Accession Number:** 0001997350
**File Stem:** 0001997350-25-000012
**Filing Date:** 2025-11
**Character Count:** 349618
**Document Hash:** 63719b2d140e30dbc72ef928c252f43c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001997350-25-000012.hdr.sgml**: 20251112

**ACCESSION NUMBER**: 0001997350-25-000012

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 104

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251112

**DATE AS OF CHANGE**: 20251112

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Accelerant Holdings
- **CENTRAL INDEX KEY:** 0001997350
- **STANDARD INDUSTRIAL CLASSIFICATION:** INSURANCE AGENTS BROKERS & SERVICES [6411]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 981753044
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42765
- **FILM NUMBER:** 251473476

**BUSINESS ADDRESS:**
- **STREET 1:** P.O. BOX 309 UGLAND HOUSE
- **CITY:** GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-1044
- **BUSINESS PHONE:** (302) 658-7581

**MAIL ADDRESS:**
- **STREET 1:** 1209 ORANGE STREET
- **STREET 2:** C/O THE CORPORATION TRUST COMPANY
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19801

?xml version='1.0' encoding='ASCII'? arx-20250930

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549**

**FORM 10-Q**<br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

**For the quarterly period ended September 30, 2025**

or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from**_________________**to**_________________**

![AccelerantLogo.jpg](arx-20250930_g1.jpg)

**ACCELERANT HOLDINGS**

**(Exact Name of Registrant as Specified in Its Charter)**

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **001-42765** | **98-1753044** |
| (State or Other Jurisdiction of <br>Incorporation or Organization) | (Commission File Number) | &nbsp;&nbsp;&nbsp;&nbsp;(I.R.S. Employer<br> Identification Number) |

---

**Accelerant Holdings**<br>**c/o Accelerant Re (Cayman) Ltd.**<br>**Unit 106, Windward 3, Regatta Office Park,**<br>**West Bay Road, Grand Cayman, KY1-1108**<br>**1 (345) 743-4611**<br>(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Executive Offices) <br>

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Title of Each Class** | &nbsp;&nbsp;&nbsp;&nbsp;**Trading Symbol** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Name of Each Exchange on** <br>**Which Registered** |
| Class A common shares, <br>$0.0000011951862 par value per share | ARX | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

------

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company  | ☐ |
| | | Emerging growth company | ☒ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes ☒ No

As of November 10, 2025, there were 221,820,044 of the registrant's common shares outstanding, comprised of 114,578,616 Class A common shares, $0.0000011951862 par value per share and 107,241,428 Class B common shares, $0.0000011951862 par value per share.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | |
|:---|:---|:---|
| **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** |
| **Quarterly Report on Form 10-Q** | **Quarterly Report on Form 10-Q** | **Quarterly Report on Form 10-Q** |
| **For the Period Ended September 30, 2025** | **For the Period Ended September 30, 2025** | |
| **Index** | **Index** | **Index** |
| | | **Page** |
| **<u>[Part I - Financial Information](#ib1a6822efc494886a9b5551020e883af_16)</u>** | **<u>[Part I - Financial Information](#ib1a6822efc494886a9b5551020e883af_16)</u>** | |
| **Item 1.** | **<u>[Financial Statements](#ib1a6822efc494886a9b5551020e883af_19)</u>** | **[5](#ib1a6822efc494886a9b5551020e883af_19)** |
| **Item 2.** | **<u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#ib1a6822efc494886a9b5551020e883af_139)</u>** | **[45](#ib1a6822efc494886a9b5551020e883af_139)** |
| **Item 3.** | **<u>[Quantitative and Qualitative Disclosures about Market Risk](#ib1a6822efc494886a9b5551020e883af_262)</u>** | **[82](#ib1a6822efc494886a9b5551020e883af_262)** |
| **Item 4.** | **<u>[Controls and Procedures](#ib1a6822efc494886a9b5551020e883af_277)</u>** | **[83](#ib1a6822efc494886a9b5551020e883af_277)** |
| **<u>[Part II - Other Information](#ib1a6822efc494886a9b5551020e883af_280)</u>** | **<u>[Part II - Other Information](#ib1a6822efc494886a9b5551020e883af_280)</u>** | **<u>[Part II - Other Information](#ib1a6822efc494886a9b5551020e883af_280)</u>** |
| **Item 1.** | **<u>[Legal Proceedings](#ib1a6822efc494886a9b5551020e883af_283)</u>** | **[84](#ib1a6822efc494886a9b5551020e883af_283)** |
| **Item 1A.** | **<u>[Risk Factors](#ib1a6822efc494886a9b5551020e883af_286)</u>** | **[84](#ib1a6822efc494886a9b5551020e883af_286)** |
| **Item 2.** | **<u>[Unregistered Sales of Equity Securities and Use of Proceeds](#ib1a6822efc494886a9b5551020e883af_289)</u>** | **[84](#ib1a6822efc494886a9b5551020e883af_289)** |
| **Item 3.** | **<u>[Defaults Upon Senior Securities](#ib1a6822efc494886a9b5551020e883af_292)</u>** | **[84](#ib1a6822efc494886a9b5551020e883af_292)** |
| **Item 4.** | **<u>[Mine Safety Disclosures](#ib1a6822efc494886a9b5551020e883af_295)</u>** | **[84](#ib1a6822efc494886a9b5551020e883af_295)** |
| **Item 5.** | **<u>[Other Information](#ib1a6822efc494886a9b5551020e883af_298)</u>** | **[84](#ib1a6822efc494886a9b5551020e883af_298)** |
| **Item 6.** | **<u>[Exhibits](#ib1a6822efc494886a9b5551020e883af_301)</u>** | **[85](#ib1a6822efc494886a9b5551020e883af_301)** |
|  | **<u>[Signatures](#ib1a6822efc494886a9b5551020e883af_304)</u>** | **[85](#ib1a6822efc494886a9b5551020e883af_304)** |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**Cautionary Note Regarding Forward-Looking Statements**

This Quarterly Report on Form 10-Q contains forward-looking statements. You can generally identify forward-looking statements by our use of forward-looking terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "projection," "seek," "should," "will" or "would," or the negative thereof or other variations thereon or comparable terminology. In particular, statements about the markets in which we operate, including growth of our various markets, and our expectations, beliefs, plans, strategies, objectives, prospects, assumptions, or future events or performance contained in this Quarterly Report on Form 10-Q under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations" are forward-looking statements.

We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors, including those discussed in this Quarterly Report on Form 10-Q under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations" may cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements, or could affect our share price. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to, statements about:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our Risk Exchange's prospects, its potential for expansion to new Members, Risk Capital Partners (including third-party insurers and reinsurers) and offerings beyond the specialty insurance market, as well as the future prospects of our overall business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to grow our business profitably;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our financial strength;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the number of Members and Risk Capital Partners that we expect to retain and our membership growth prospects;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to continue enhancing our technology-based solutions and gain internal efficiencies and effective controls that promote the utility of the analytics we provide to Members and Risk Capital Partners;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to leverage our information systems to enhance the benefits available to our Members through our Risk Exchange;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to continue to attract Risk Capital Partners;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the performance of our Members and Risk Capital Partners;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to accurately assess and manage the underwriting risk we retain and the impacts of sliding scale commissions on the underwriting risk we do not retain;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the competitive environment in the specialty insurance industry;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in government laws and regulations, including insurance regulatory laws, and how the enforcement thereof may affect our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our expectations regarding our projected growth;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the increased expenses associated with being a public company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• whether we will be considered a passive foreign investment company for US tax purposes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the additional regulatory, legal and operational risks that may arise in connection with our expansion into new geographies and how such risks might materially affect our business, results of operations, financial condition, and prospects; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• other factors detailed under heading "Risk Factors" in the Prospectus.

Given the risks and uncertainties set forth in this Quarterly Report on Form 10-Q, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements contained in this Quarterly Report on Form 10-Q are not guarantees of future performance and our actual results of operations, financial condition, and liquidity, and the development of the industry in which we operate, may differ materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q. In addition, even if our results of operations, financial condition and liquidity, and events in the industry in which we operate, are consistent with the forward-looking statements contained in this Quarterly Report on Form 10-Q, they may not be predictive of results or developments in future periods.

Any forward-looking statement that we make in this Quarterly Report on Form 10-Q speaks only as of the date of such statement. Except as required by law, we do not undertake any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this Quarterly Report on Form 10-Q.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**Glossary** 

As used in this Quarterly Report on Form 10-Q, unless the context indicates or otherwise requires, the following terms have the following meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Accelerant Direct Written Premium**: Expressed as a percentage of Exchange Written Premium, the GWP written directly by Accelerant Underwriting companies, the majority of which we cede to Risk Capital Partners through our reinsurance arrangements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Accelerant GWP**: The total GWP written by Accelerant Underwriting companies (both written by our insurance company and assumed as a reinsurer), the majority of which we cede to Risk Capital Partners through our reinsurance arrangements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Accelerant Holdings LP Distribution**: The distribution of all of our existing common shares to holders of limited partnership interests of Accelerant Holdings LP in proportion to the economic interests represented by those limited partnership interests that occurred immediately prior to the consummation of our initial public offering in July 2025. The then-existing common shares were subsequently redesignated as 75,988,500 Class A common shares and 90,196,594 Class B common shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Accelerant-Retained Exchange Premium**: Expressed as a percentage, as Accelerant GWP net of ceded written premium for the trailing twelve month period, divided by total Exchange Written Premium for the trailing twelve month period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Accelerant Underwriting**: Accelerant's owned insurance companies and reinsurance companies, and all revenue and expenses associated with them.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **DAC**: Deferred acquisition costs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Exchange Written Premium**: The total gross written premium written through the Risk Exchange, including both gross written premiums of Accelerant Underwriting companies and Risk Exchange Insurers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Exchange Written Premium Growth Rate**: The percentage increase in Exchange Written Premium in the current period compared to Exchange Written Premium from the comparable period in the prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Flywheel Re**: Collectively, Flywheel Re Ltd. SPC and Flywheel Holdings Ltd. SPC, a Cayman Islands holding company that indirectly owns Flywheel Re Ltd. SPC (unconsolidated reinsurance sidecar entities), sponsored by Accelerant and through which institutional investors are offered specialty insurance risk and returns that are relatively uncorrelated with broader financial markets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **GAAP**: Accounting Principles Generally Accepted in the US.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Gross Loss Ratio**: Gross incurred losses and loss adjustment expense divided by gross earned premium (expressed as a percentage). Gross loss ratio excludes the impact of premium and loss and loss adjustment expense ceded to reinsurers. Gross loss ratio represents the percentage of gross premium earned during the period that will be required to pay current and future claims, based on management's best estimates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **GWP**: Gross written premium, representing the total amount of premium contracted for all policies issued in a given period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Independent Members**: Members in which Accelerant does not own an interest.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Independent Premium**: The gross premium written by Independent Members and placed through our Risk Exchange.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **LAE**: Loss adjustment expense.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Members**: Specialized underwriters, including MGAs, MGUs, and program managers (terms we use interchangeably) that underwrite insurance premiums on behalf of Risk Capital Partners through our Risk Exchange.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **MGA**: Managing general agent; a third-party agent that receives delegated underwriting authority from a Primary Insurance Company to write insurance risk on its behalf. The term "MGA" refers generically to agents receiving this delegation of underwriting authority, including MGUs, MGAs, and/or program managers and any Member or other entity in relation to which the term "MGA" is used and may not fall within the regulatory definition of a "managing general agent" in the jurisdictions in which it operates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **MGU**: Managing general underwriter; a third-party agent that receives delegated underwriting authority from a Primary Insurance Company to write insurance risk on its behalf.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Mission Europe**: Mission Holdings Europe Ltd., one of our subsidiaries.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Mission Members**: Specialty underwriters that operate and develop through Mission Underwriters and in which we have an equity ownership interest.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Mission Underwriters**: Mission Underwriters provides specialty underwriters with the working capital, operational support, and balance sheet capacity necessary to operate their own MGAs, in which the specialty underwriters have a majority ownership interest. These MGAs are Members of the Risk Exchange. Mission Underwriters operates in the US, UK and EU through Mission US and Mission Europe.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Mission US**: Mission Underwriting Holdings, LLC.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Net Revenue Retention**: Expressed as a percentage, the current period's Exchange Written Premium of Members that were actively writing Exchange Written Premium in the prior period divided by these same Members' prior-period Exchange Written Premium. This measure demonstrates an aggregate measure of the net growth of Exchange Written Premium from Members.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Owned Members**: Members in which Accelerant either has a minority equity ownership interest or controlling equity interest.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Owned Premium**: The premium produced by Mission Members and Owned Members, who receive commissions for sourcing and underwriting business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Primary Insurance Company**: Licensed carriers who write business and thus are responsible for insurance policy forms, rate filings, etc. Primary Insurance Companies may reinsure a portion of the risk they have written to third-party reinsurers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Reinsurer**: An insurance company that insures risk written by another insurance company. Reinsurers generally are not required to be licensed directly in a given jurisdiction to provide such reinsurance coverage; however, absent any such license, reinsurers are limited only to writing such risk in a secondary reinsurance capacity and not in a primary direct capacity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Risk Capital Partners**: Third-party insurance companies, reinsurers or institutional investors that provide capacity through the Risk Exchange, directly or indirectly.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Risk Exchange**: The Accelerant technology, data ingestion, and agency operations that serve the needs of our Members and Risk Capital Partners.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Risk Exchange Insurer**: Third-party Primary Insurance Company deploying underwriting capacity directly through our Risk Exchange.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Third-Party Direct Written Premium**: GWP written directly with Risk Exchange Insurers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **TPA**: Third-party administrator, providing claims handling and other operational functions related to administration of insurance policies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **US-UK Tax Treaty**: The Convention between the Government of the United States of America and the Government of the United Kingdom of Great Britain and Northern Ireland for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on Income and on Capital Gains, signed July 24, 2001.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**PART I. FINANCIAL INFORMATION**

**Item 1. Financial Statements** 

---

| | |
|:---|:---|
| | **Page** |
| <u>[Condensed Consolidated Financial Statements (unaudited)](#ib1a6822efc494886a9b5551020e883af_22)</u> | [6](#ib1a6822efc494886a9b5551020e883af_22) |
| <u>[Notes to Condensed Consolidated Financial Statements (unaudited)](#ib1a6822efc494886a9b5551020e883af_46)</u> | [15](#ib1a6822efc494886a9b5551020e883af_46) |
| <u>[Note 1.](#ib1a6822efc494886a9b5551020e883af_49)[Nature of business and basis of presentation](#ib1a6822efc494886a9b5551020e883af_49)</u> | [15](#ib1a6822efc494886a9b5551020e883af_49) |
| <u>[Note 2. Summary of significant accounting policies](#ib1a6822efc494886a9b5551020e883af_52)</u> | [16](#ib1a6822efc494886a9b5551020e883af_52) |
| <u>[Note 3. Segment information](#ib1a6822efc494886a9b5551020e883af_55)</u> | [17](#ib1a6822efc494886a9b5551020e883af_55) |
| <u>[Note 4. Investments](#ib1a6822efc494886a9b5551020e883af_76)</u> | [25](#ib1a6822efc494886a9b5551020e883af_76) |
| <u>[Note 5. Fair value measurements](#ib1a6822efc494886a9b5551020e883af_79)</u> | [29](#ib1a6822efc494886a9b5551020e883af_79) |
| <u>[Note 6. Unpaid losses and loss adjustment expenses](#ib1a6822efc494886a9b5551020e883af_85)</u> | [31](#ib1a6822efc494886a9b5551020e883af_85) |
| <u>[Note 7. Reinsurance](#ib1a6822efc494886a9b5551020e883af_91)</u> | [31](#ib1a6822efc494886a9b5551020e883af_91) |
| <u>[Note 8. Deferred acquisition costs and deferred ceding commissions](#ib1a6822efc494886a9b5551020e883af_94)</u> | [33](#ib1a6822efc494886a9b5551020e883af_94) |
| <u>[Note 9. Debt](#ib1a6822efc494886a9b5551020e883af_97)</u> | [35](#ib1a6822efc494886a9b5551020e883af_97) |
| <u>[Note 10. Equity](#ib1a6822efc494886a9b5551020e883af_412)</u> | [35](#ib1a6822efc494886a9b5551020e883af_412) |
| <u>[Note 11. Business acquisition](#ib1a6822efc494886a9b5551020e883af_103)</u> | [37](#ib1a6822efc494886a9b5551020e883af_103) |
| <u>[Note 12. Share-based compensation](#ib1a6822efc494886a9b5551020e883af_109)</u> | [38](#ib1a6822efc494886a9b5551020e883af_109) |
| <u>[Note 13. Earnings per share](#ib1a6822efc494886a9b5551020e883af_112)</u> | [41](#ib1a6822efc494886a9b5551020e883af_112) |
| <u>[Note 14. Income taxes](#ib1a6822efc494886a9b5551020e883af_115)</u> | [41](#ib1a6822efc494886a9b5551020e883af_115) |
| <u>[Note 15. Other assets](#ib1a6822efc494886a9b5551020e883af_124)</u> | [43](#ib1a6822efc494886a9b5551020e883af_124) |
| <u>[Note 16. Accounts payable and other liabilities](#ib1a6822efc494886a9b5551020e883af_127)</u> | [43](#ib1a6822efc494886a9b5551020e883af_127) |
| <u>[Note 17. Related party transactions](#ib1a6822efc494886a9b5551020e883af_130)</u> | [43](#ib1a6822efc494886a9b5551020e883af_130) |
| <u>[Note 18. Commitments and contingencies](#ib1a6822efc494886a9b5551020e883af_133)</u> | [44](#ib1a6822efc494886a9b5551020e883af_133) |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | |
|:---|:---|:---|
| **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** |
| **Condensed Consolidated Balance Sheets (unaudited)** | **Condensed Consolidated Balance Sheets (unaudited)** | **Condensed Consolidated Balance Sheets (unaudited)** |
| | **September 30, 2025** | **December 31, 2024** |
| ***(expressed in millions of US dollars, except share data)*** | | |
| **Assets** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Short-term investments available for sale, at fair value<br>(amortized cost 2025: $64.8 and 2024: $65.0) | $64.8 | $64.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fixed maturity securities available for sale, at fair value<br>(amortized cost 2025: $716.9 and 2024: $485.6) | 721.9 | 479.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity method investments | 9.4 | 18.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other investments | 81.7 | 45.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total investments** | **877.8** | **607.8** |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents and restricted cash  | 1675.9 | 1273.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Premiums receivable (net of allowance 2025: $2.9 and 2024: $2.4) | 922.0 | 791.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ceded unearned premiums | 1868.0 | 1558.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reinsurance recoverables on unpaid losses and LAE | 1552.9 | 1069.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other reinsurance recoverables | 527.1 | 364.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred acquisition costs | 59.0 | 60.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill and other intangible assets, net | 116.5 | 64.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capitalized technology development costs, net | 95.7 | 83.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 164.5 | 221.7 |
| **Total assets** | $**7859.4** | $**6094.9** |
| **Liabilities and shareholders' equity** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Unpaid losses and loss adjustment expenses | $1841.4 | $1294.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unearned premiums | 2167.5 | 1803.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payables to reinsurers | 1219.5 | 1109.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred ceding commissions | 226.0 | 193.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Funds held under reinsurance | 1132.5 | 746.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance balances payable | 173.5 | 148.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt | 121.9 | 121.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other liabilities  | 273.3 | 252.0 |
| **Total liabilities** | **7155.6** | **5667.9** |
| &nbsp;&nbsp;&nbsp;&nbsp;Commitments and contingencies (Note 18) |  |  |
| **Equity** |  |  |
| &nbsp;&nbsp;**Redeemable preference shares** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class C convertible preference shares (issued and outstanding 2024: 5,556,546) | **—** | **104.4** |
| &nbsp;&nbsp;**Shareholders' equity** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Convertible preference shares: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class A (issued and outstanding 2024: 20,955,497) |  | 236.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Class B (issued and outstanding 2024: 12,569,691) |  | 145.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common shares (par value $0.000001 per share, issued and outstanding<br>&nbsp;&nbsp;&nbsp;&nbsp; 2025: Class A - 114,578,616; Class B - 107,241,428 and <br>&nbsp;&nbsp;&nbsp;&nbsp; 2024: 166,185,094) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 2213.9 | 124.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (1.5) | (19.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (1536.3) | (182.8) |
| &nbsp;&nbsp;**Total Accelerant shareholders' equity** | **676.1** | **304.3** |
| &nbsp;&nbsp;**Non-controlling interests** | **27.7** | **18.3** |
| **Total equity** | **703.8** | **427.0** |
| **Total liabilities and equity** | $**7859.4** | $**6094.9** |

---

*See accompanying notes to the unaudited condensed consolidated financial statements.*

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** |
| **Condensed Consolidated Statements of Operations (unaudited)** | **Condensed Consolidated Statements of Operations (unaudited)** | **Condensed Consolidated Statements of Operations (unaudited)** | **Condensed Consolidated Statements of Operations (unaudited)** | **Condensed Consolidated Statements of Operations (unaudited)** |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(expressed in millions of US dollars)*** | **2025** | **2024** | **2025** | **2024** |
| **Revenues** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Ceding commission income | $92.3 | $62.1 | $264.6 | $186.2 |
| &nbsp;&nbsp;&nbsp;Direct commission income | 43.4 | 17.2 | 105.7 | 38.9 |
| &nbsp;&nbsp;&nbsp;Net earned premiums | 82.1 | 59.3 | 215.7 | 155.5 |
| &nbsp;&nbsp;&nbsp;Net investment income | 10.1 | 11.0 | 35.1 | 27.6 |
| &nbsp;&nbsp;&nbsp;Net realized gains on investments | 3.5 | 0.1 | 6.2 | 0.5 |
| &nbsp;&nbsp;&nbsp;Net unrealized gains on investments | 36.0 | 4.0 | 37.2 | 3.2 |
| **Total revenues** | **267.4** | **153.7** | **664.5** | **411.9** |
| **Expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Losses and loss adjustment expenses | 50.8 | 39.7 | 147.3 | 111.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred acquisition costs | 22.8 | 23.1 | 58.1 | 62.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses <sup>(1)</sup> | 115.8 | 67.3 | 280.2 | 178.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expenses | 2.6 | 3.1 | 7.7 | 9.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 10.0 | 5.8 | 25.7 | 16.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Profits interest distribution expenses <sup>(2)</sup> | 1379.7 |  | 1379.7 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net foreign exchange (gains) losses | (2.4) | 5.4 | 14.9 | 3.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expenses | 45.6 | 8.0 | 70.6 | 22.4 |
| **Total expenses** | **1624.9** | **152.4** | **1984.2** | **402.9** |
| **(Loss) income before income taxes** | **(1357.5)** | **1.3** | **(1319.7)** | **9.0** |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax (expense) benefit | (9.5) | 8.1 | (26.4) | (6.7) |
| **Net (loss) income** | **(1367.0)** | **9.4** | **(1346.1)** | **2.3** |
| Adjustment for net (income) loss attributable to non-controlling interests | (1.8) | (1.3) | (7.4) | 3.9 |
| Deemed dividend upon redemption of Class C preference shares | (70.9) |  | (70.9) |  |
| **Net (loss) income attributable to Accelerant common shareholders** | $**(1439.7)** | $**8.1** | $**(1424.4)** | $**6.2** |
| **Net (loss) income attributable to Accelerant per common share:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $(6.99) | $0.05 | $(7.93) | $0.04 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(6.99) | $0.04 | $(7.93) | $0.03 |
| **Weighted-average common shares outstanding:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 206064119 | 166185094 | 179624179 | 165913933 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 206064119 | 199710283 | 179624179 | 199384420 |

---

<sup>(1)</sup> *General and administrative expenses include share-based compensation expenses of $27.0 million and $2.5 million for the three months ended September 30, 2025 and 2024, respectively and $32.4 million and $6.3 million for the nine months ended September 30, 2025 and 2024, respectively.*

<sup>(2)</sup> *Non-cash profits interest distribution expenses related to the settlement of all outstanding profits interest awards through the distribution of 65,270,453 Class A common shares of the Company held by Accelerant Holdings LP to certain officers and employees of the Company that fully vested upon the Company's July 25, 2025 initial public offering (IPO). The ultimate settlement of the profit interest awards was equity neutral because the contribution of the shares to officers and employees was reflected as a capital contribution to the Company by Accelerant Holdings LP, which represented an equal and offsetting amount to the associated non-cash expense. For further information, refer to Note 12.*

*See accompanying notes to the unaudited condensed consolidated financial statements.*

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** |
| **Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)** | **Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)** | **Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)** | **Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)** | **Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)** |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(expressed in millions of US dollars)*** | **2025** | **2024** | **2025** | **2024** |
| Net (loss) income | $(1367.0) | $9.4 | $(1346.1) | $2.3 |
| **Other comprehensive (loss) income, net of tax** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | (2.1) | (5.5) | 8.2 | (2.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrealized (losses) gains on fixed maturity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrealized (losses) gains on fixed maturity securities | (2.1) | 4.9 | 7.3 | 2.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification adjustments for losses recognized in net income | 0.8 | 0.1 | 3.1 | 0.1 |
| **Other comprehensive (loss) income, net of tax** | **(3.4)** | **(0.5)** | **18.6** | **0.8** |
| **Total comprehensive (loss) income** | **(1370.4)** | **8.9** | **(1327.5)** | **3.1** |
| &nbsp;&nbsp;&nbsp;Adjustment for comprehensive (income) loss attributable to non-controlling interests | (1.6) | (1.7) | (8.0) | 3.5 |
| **Comprehensive (loss) income attributable to Accelerant** | $**(1372.0)** | $**7.2** | $**(1335.5)** | $**6.6** |

---

*See accompanying notes to the unaudited condensed consolidated financial statements.*

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** |
| **Condensed Consolidated Statements of Equity (unaudited)** | **Condensed Consolidated Statements of Equity (unaudited)** | **Condensed Consolidated Statements of Equity (unaudited)** | **Condensed Consolidated Statements of Equity (unaudited)** | **Condensed Consolidated Statements of Equity (unaudited)** | **Condensed Consolidated Statements of Equity (unaudited)** | **Condensed Consolidated Statements of Equity (unaudited)** | **Condensed Consolidated Statements of Equity (unaudited)** | **Condensed Consolidated Statements of Equity (unaudited)** | **Condensed Consolidated Statements of Equity (unaudited)** |
| **(expressed in millions of US dollars)** | **Class C convertible preference shares** | **Class A convertible preference shares** | **Class B convertible preference shares** | **Additional paid-in capital** | **Accumulated other comprehensive (loss) income** | **Accumulated deficit** | **Total Accelerant shareholders' equity** | **Non-controlling interests** | **Total equity** |
| **Three Months Ended September 30, 2025** | | | | | | | | | |
| **Balance, July 1, 2025** | $**104.4** | $**236.7** | $**145.1** | $**130.2** | $**1.7** | $**(167.5)** | $**346.2** | $**31.6** | $**482.2** |
| Net (loss) income |  |  |  |  |  | (1368.8) | (1368.8) | 1.8 | (1367.0) |
| Other comprehensive loss |  |  |  |  | (3.2) |  | (3.2) | (0.2) | (3.4) |
| Issuance of Class A common shares, net of issuance costs |  |  |  | 376.0 |  |  | 376.0 |  | 376.0 |
| Deemed dividend for Class C preference shares redemption | 70.9 |  |  | (70.9) |  |  | (70.9) |  |  |
| Redemption of Class C convertible preference shares | (175.3) |  |  |  |  |  |  |  | (175.3) |
| Conversion of Class A and B convertible preference shares |  | (236.7) | (145.1) | 381.8 |  |  |  |  |  |
| Accelerant Holdings LP contribution for profits interest distribution |  |  |  | 1379.7 |  |  | 1379.7 |  | 1379.7 |
| Share-based compensation <sup>(1)</sup> |  |  |  | 17.2 |  |  | 17.2 |  | 17.2 |
| Dividends paid to and other transactions with non-controlling interests |  |  |  | (0.1) |  |  | (0.1) | (5.5) | (5.6) |
| **Balance, September 30, 2025** | $**—** | $**—** | $**—** | $**2213.9** | $**(1.5)** | $**(1536.3)** | $**676.1** | $**27.7** | $**703.8** |

---

<sup>(1)</sup> Amount represents the sub-set of share-based compensation associated with our common shares, representing a portion of the total $27.0 million of share-based compensation recorded through our statement of operations in the period (which includes additional expenses related to subsidiary and MGA share-based incentive plans). For further information, refer to Note 12.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| ***(expressed in millions of US dollars)*** | **Class A convertible preference shares** | **Class B convertible preference shares** | **Additional paid-in capital** | **Accumulated other comprehensive (loss) income** | **Accumulated deficit** | **Total Accelerant shareholders' equity** | **Non-controlling interests** | **Total equity** |
| **Three Months Ended September 30, 2024** | | | | | | | | |
| **Balance, July 1, 2024** | $**236.7** | $**145.1** | $**110.7** | $**(6.2)** | $**(211.9)** | $**274.4** | $**8.3** | $**282.7** |
| Net income |  |  |  |  | 8.1 | 8.1 | 1.3 | 9.4 |
| Other comprehensive (loss) income |  |  |  | (0.9) |  | (0.9) | 0.4 | (0.5) |
| Share-based compensation |  |  | 2.5 |  |  | 2.5 |  | 2.5 |
| Dividends paid to non-controlling interests |  |  |  |  |  |  | (0.7) | (0.7) |
| **Balance, September 30, 2024** | $**236.7** | $**145.1** | $**113.2** | $**(7.1)** | $**(203.8)** | $**284.1** | $**9.3** | $**293.4** |

---

*See accompanying notes to the unaudited condensed consolidated financial statements.*

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| |
|:---|
| **Accelerant Holdings** |
| **Condensed Consolidated Statements of Equity (unaudited) (continued)** |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **(expressed in millions of US dollars)** | **Class C convertible preference shares** | **Class A convertible preference shares** | **Class B convertible preference shares** | **Additional paid-in capital** | **Accumulated other comprehensive (loss) income** | **Accumulated deficit** | **Total Accelerant shareholders' equity** | **Non-controlling interests** | **Total equity** |
| **Nine months ended September 30, 2025** | | | | | | | | | |
| **Balance, January 1, 2025** | $**104.4** | $**236.7** | $**145.1** | $**124.8** | $**(19.5)** | $**(182.8)** | $**304.3** | $**18.3** | $**427.0** |
| Net (loss) income |  |  |  |  |  | (1353.5) | (1353.5) | 7.4 | (1346.1) |
| Other comprehensive income |  |  |  |  | 18.0 |  | 18.0 | 0.6 | 18.6 |
| Issuance of Class A common shares, net of issuance costs |  |  |  | 376.0 |  |  | 376.0 |  | 376.0 |
| Deemed dividend for Class C preference shares redemption | 70.9 |  |  | (70.9) |  |  | (70.9) |  |  |
| Redemption of Class C convertible preference shares | (175.3) |  |  |  |  |  |  |  | (175.3) |
| Conversion of Class A and B convertible preference shares |  | (236.7) | (145.1) | 381.8 |  |  |  |  |  |
| Accelerant Holdings LP contribution for profits interest distribution |  |  |  | 1379.7 |  |  | 1379.7 |  | 1379.7 |
| Share-based compensation <sup>(1)</sup> |  |  |  | 22.6 |  |  | 22.6 |  | 22.6 |
| Dividends paid to and other transactions with non-controlling interests |  |  |  | (0.1) |  |  | (0.1) | 1.4 | 1.3 |
| **Balance, September 30, 2025** | $**—** | $**—** | $**—** | $**2213.9** | $**(1.5)** | $**(1536.3)** | $**676.1** | $**27.7** | $**703.8** |
| <sup>(1)</sup> Amount represents the sub-set of share-based compensation associated with our common shares, representing a portion of the total $32.4 million of share-based compensation recorded through our statement of operations in the period (which includes additional expenses related to subsidiary and MGA share-based incentive plans). For further information, refer to Note 12. | <sup>(1)</sup> Amount represents the sub-set of share-based compensation associated with our common shares, representing a portion of the total $32.4 million of share-based compensation recorded through our statement of operations in the period (which includes additional expenses related to subsidiary and MGA share-based incentive plans). For further information, refer to Note 12. | <sup>(1)</sup> Amount represents the sub-set of share-based compensation associated with our common shares, representing a portion of the total $32.4 million of share-based compensation recorded through our statement of operations in the period (which includes additional expenses related to subsidiary and MGA share-based incentive plans). For further information, refer to Note 12. | <sup>(1)</sup> Amount represents the sub-set of share-based compensation associated with our common shares, representing a portion of the total $32.4 million of share-based compensation recorded through our statement of operations in the period (which includes additional expenses related to subsidiary and MGA share-based incentive plans). For further information, refer to Note 12. | <sup>(1)</sup> Amount represents the sub-set of share-based compensation associated with our common shares, representing a portion of the total $32.4 million of share-based compensation recorded through our statement of operations in the period (which includes additional expenses related to subsidiary and MGA share-based incentive plans). For further information, refer to Note 12. | <sup>(1)</sup> Amount represents the sub-set of share-based compensation associated with our common shares, representing a portion of the total $32.4 million of share-based compensation recorded through our statement of operations in the period (which includes additional expenses related to subsidiary and MGA share-based incentive plans). For further information, refer to Note 12. | <sup>(1)</sup> Amount represents the sub-set of share-based compensation associated with our common shares, representing a portion of the total $32.4 million of share-based compensation recorded through our statement of operations in the period (which includes additional expenses related to subsidiary and MGA share-based incentive plans). For further information, refer to Note 12. | <sup>(1)</sup> Amount represents the sub-set of share-based compensation associated with our common shares, representing a portion of the total $32.4 million of share-based compensation recorded through our statement of operations in the period (which includes additional expenses related to subsidiary and MGA share-based incentive plans). For further information, refer to Note 12. | <sup>(1)</sup> Amount represents the sub-set of share-based compensation associated with our common shares, representing a portion of the total $32.4 million of share-based compensation recorded through our statement of operations in the period (which includes additional expenses related to subsidiary and MGA share-based incentive plans). For further information, refer to Note 12. | <sup>(1)</sup> Amount represents the sub-set of share-based compensation associated with our common shares, representing a portion of the total $32.4 million of share-based compensation recorded through our statement of operations in the period (which includes additional expenses related to subsidiary and MGA share-based incentive plans). For further information, refer to Note 12. |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| ***(expressed in millions of US dollars)*** | **Class A convertible preference shares** | **Class B convertible preference shares** | **Additional paid-in capital** | **Accumulated other comprehensive (loss) income** | **Accumulated deficit** | **Total Accelerant shareholders' equity** | **Non-controlling interests** | **Total equity** |
| **Nine months ended September 30, 2024** | | | | | | | | |
| **Balance, January 1, 2024** | $**236.7** | $**145.1** | $**146.2** | $**(7.5)** | $**(210.0)** | $**310.5** | $**(23.8)** | $**286.7** |
| Net income (loss) |  |  |  |  | 6.2 | 6.2 | (3.9) | 2.3 |
| Other comprehensive income |  |  |  | 0.4 |  | 0.4 | 0.4 | 0.8 |
| Share-based compensation |  |  | 6.3 |  |  | 6.3 |  | 6.3 |
| Dividends paid to and other transactions with non-controlling interests |  |  | (39.3) |  |  | (39.3) | 36.6 | (2.7) |
| **Balance, September 30, 2024** | $**236.7** | $**145.1** | $**113.2** | $**(7.1)** | $**(203.8)** | $**284.1** | $**9.3** | $**293.4** |

---

*See accompanying notes to the unaudited condensed consolidated financial statements.*

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | |
|:---|:---|:---|
| **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** |
| **Condensed Consolidated Statements of Cash Flows (unaudited)** | **Condensed Consolidated Statements of Cash Flows (unaudited)** | **Condensed Consolidated Statements of Cash Flows (unaudited)** |
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(expressed in millions of US dollars)*** | **2025** | **2024** |
| **Cash flows from operating activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (loss) income | $(1346.1) | $2.3 |
| **Adjustments to reconcile net income (loss) to net cash provided by operating activities:** |  |  |
| **Non-cash revenues, expenses, gains and losses included in net income:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Profits interest distribution expenses | 1379.7 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gains on investments | (6.2) | (0.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains on investments | (37.2) | (3.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings from equity method investments | (1.5) | (1.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expenses <sup>(1)</sup> | 22.6 | 6.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 25.7 | 16.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax benefit | (11.8) | (35.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net foreign exchange losses | 14.9 | 3.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net accretion of discount on fixed maturity securities and short-term investments | (5.9) | (3.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | 2.8 | 1.0 |
| **Changes in operating assets and liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Premiums receivable | (102.7) | (212.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;Ceded unearned premiums | (280.6) | (481.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Reinsurance recoverables on unpaid losses and LAE | (460.5) | (314.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other reinsurance recoverables | (152.8) | (39.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred acquisition costs | 1.9 | (10.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Unpaid losses and loss adjustment expenses | 483.6 | 340.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unearned premiums | 292.1 | 489.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payables to reinsurers | 86.3 | 505.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred ceding commissions | 48.7 | 64.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Funds held under reinsurance | 383.1 | 164.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance balances payable | 23.4 | 13.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets, accounts payable and other liabilities | 23.7 | 39.4 |
| **Net cash provided by operating activities** | **383.2** | **543.9** |
| **Cash flows from investing activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity securities |  | 115.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fixed maturity securities | 150.8 | 21.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity method investments | 1.1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other investments | 3.6 | 0.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Maturities of fixed maturity securities | 40.0 | 14.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments for purchases of: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fixed maturity securities | (397.9) | (313.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity method investments | (0.8) | (4.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in short-term investments | 4.9 | (39.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of subsidiaries, net of cash acquired | (9.9) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capitalized technology development expenditures | (29.8) | (25.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | (0.3) | (0.8) |
| **Net cash used in investing activities** | **(238.3)** | **(231.2)** |
| **Cash flows from financing activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Redemption of Class C convertible preference shares | (175.3) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common shares, net of issuance costs <sup>(2)</sup> | 392.0 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit facility borrowings | 5.0 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit facility repayment | (5.0) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of debt, net of issuance costs |  | 49.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payment of debt |  | (50.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid to non-controlling interests | (7.2) | (2.7) |
| **Net cash provided by (used in) financing activities** | **209.5** | **(3.4)** |
| **Net increase in cash, cash equivalents and restricted cash** | **354.4** | **309.3** |
| Effect of foreign currency rate changes on cash, cash equivalents and restricted cash | 48.5 | 0.3 |
| Cash, cash equivalents and restricted cash at beginning of period | 1273.0 | 775.4 |
| **Cash, cash equivalents and restricted cash at end of period** | $**1675.9** | $**1085.0** |

---

<sup>(1)</sup> Share-based compensation expenses related to our Class A common shares. For additional information, refer to Note 12.

<sup>(2)</sup> For additional information regarding the July 2025 IPO of our Class A common shares and related issuance costs, refer to Note 10.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;See accompanying notes to the unaudited condensed consolidated financial statements.*

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | |
|:---|:---|:---|
| **Accelerant Holdings** | **Accelerant Holdings** | **Accelerant Holdings** |
| **Condensed Consolidated Statements of Cash Flows (unaudited) (continued)** | **Condensed Consolidated Statements of Cash Flows (unaudited) (continued)** | **Condensed Consolidated Statements of Cash Flows (unaudited) (continued)** |
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(expressed in millions of US dollars)*** | **2025** | **2024** |
| **Supplemental cash flows information** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest on debt paid | $7.6 | $8.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes paid | 44.1 | 32.2 |
| **Reconciliation to Consolidated Balance Sheets:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 1604.0 | 1064.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash and cash equivalents | 71.9 | 20.2 |
| **Total cash, cash equivalents and restricted cash** | $**1675.9** | $**1085.0** |

---

*See accompanying notes to the unaudited condensed consolidated financial statements.*

***<u>Supplemental non-cash activity information:</u>***

For the nine months ended September 30, 2025, we had the following significant non-cash investing and financing activities:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We recognized non-cash profits interest distribution expenses related to the settlement of all outstanding profits interest awards through the distribution of 65,270,453 Class A common shares of the Company held by Accelerant Holdings LP to certain officers and employees of the Company that fully vested at the time of the IPO. For further information, refer to Note 12.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>•</sup> In connection with the IPO, all outstanding Class A convertible preference shares and Class B convertible preference shares automatically converted into Class A common shares and Class B common shares (as applicable). The carrying values of Class A convertible preference shares and Class B convertible preference shares at the conversion were $236.7 million and $145.1 million, respectively. For further information, refer to Note 10.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We issued 1,833,481 of our Class A common shares in exchange for the remaining 25% equity interests of Agribusiness Risk Underwriters that we did not previously own. For further information, refer to Note 11.

For the nine months ended September 30, 2024, we had non-cash operating activities related to a novation transaction consisting of the recognition of a deposit liability of $43.6 million within "Accounts payable and other liabilities " equal to the amount of premium consideration receivable in anticipation of the transfer of a trust balance in settlement of the deposit liability. Additionally, we recorded $19.8 million of unearned premiums, net of commission, related to the assumption of policies with an unexpired portion of risk coverage period, to be settled in cash. In each case, the amounts receivable are recorded within "Premiums receivable" in our condensed consolidated balance sheets.

For the nine months ended September 30, 2024, we had non-cash financing activities consisting of the issuance of common shares with a fair value of $7.0 million as consideration for the acquisition of all the outstanding common equity ownership interest in Mission, together with the issuance of convertible preference shares as an anti-dilutive measure to existing shareholders for no consideration.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**Accelerant Holdings**

**Notes to Condensed Consolidated Financial Statements (unaudited)**

**1. Nature of business and basis of presentation**

Accelerant Holdings, together with its subsidiary companies ("Accelerant", "we", "us", "our" or the "Company"), connects selected specialty insurance underwriters ("Members") with Risk Capital Partners through its data-driven risk exchange (the "Risk Exchange"). The Company, together with its Risk Capital Partners, provides property and casualty insurance to policyholders via its network of Members, which are typically MGAs. The Company focuses on small-to-medium sized commercial clients primarily in the United States ("US"), Europe ("EU"), Canada and the United Kingdom ("UK").

These unaudited condensed consolidated interim financial statements and related notes have been prepared in accordance with US GAAP for interim financial information. Accordingly, they do not include all of the financial information and note disclosures required by US GAAP for complete consolidated financial statements. The condensed consolidated interim financial statements are presented in US Dollars and all amounts are in millions, except for the number of shares, per share amounts and the number of securities. Certain prior year comparative information has been reclassified to conform to the current presentation.

In our opinion, these unaudited condensed consolidated financial statements reflect all adjustments that are normal and recurring in nature necessary to fairly state our financial position as of September 30, 2025, our results of operations for the three and nine months ended September 30, 2025 and 2024 and cash flows for the nine months ended September 30, 2025 and 2024. The results of operations for any interim period are not necessarily indicative of results for the full year.

These unaudited condensed consolidated financial statements and related notes should be read in conjunction with our audited consolidated financial statements and related notes included in our prospectus filed with the Securities and Exchange Commission (the "SEC") pursuant to Rule 424(b)(4) under the Securities Act of 1933 (the "Prospectus"). The condensed consolidated financial information as of December 31, 2024 was derived from the audited consolidated financial statements in the Prospectus, but does not include all disclosures required by US GAAP.

***Initial Public Offering ("IPO")***

On July 25, 2025, the Company completed its IPO. For additional information regarding the related net proceeds, equity impact, use of proceeds and expenses associated with the Accelerant Holdings LP distribution and our equity award plans, refer to Note 10 and Note 12.

***Common and preference share subdivision***

In connection with preparing for its IPO, the Company's Board of Directors approved amendments to the authorized share capital of the Company, which were subsequently approved by the Company's shareholders and became effective on July 14, 2025. Pursuant to these amendments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an 83.6690-for-1 share subdivision of the Company's common and preference shares was approved; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the authorized number of common shares and preference shares were increased to 252,652,430 and 39,089,474, respectively.

All share and per share amounts in these unaudited condensed consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to such share subdivision.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**2. Summary of significant accounting policies**

There were no material changes to the Company's significant accounting policies from those that were disclosed in our audited consolidated financial statements included in the Prospectus.

***Future application of accounting standards***

*<u>Internal-Use Software</u>*

In September 2025, the FASB issued ASU 2025-06 Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40) — Targeted Improvements to the Accounting for Internal-Use Software, to modernize the accounting guidance for the costs to develop software for internal use. The standard amends the existing standard that refers to various stages of a software development project to align better with current software development methods, such as agile programming. Under the new standard, entities will start capitalizing eligible costs when (1) management has authorized and committed to funding the software project, and (2) it is probable that the project will be completed and the software will be used to perform the function intended. The standard is effective for all entities for annual periods beginning after December 15, 2027. The standard can be applied on a prospective basis, a retrospective basis or a modified basis for in-process projects. We are assessing the impact of this standard.

*<u>Disaggregation of Income Statement Expenses</u>*

In November 2024, the FASB issued ASU 2024-03 Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40) — Disaggregation of Income Statement Expenses, requiring new interim and annual disclosures that provide transparency about the components of expenses included in the income statement and enhance an investor's ability to forecast future performance. The standard requires disclosure of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The amounts of employee compensation, depreciation, intangible asset amortization, and certain other costs included in each relevant expense caption as well as the inclusion of certain amounts already required to be disclosed under existing US GAAP in the same disclosure;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The total amount of selling expenses and, in annual reporting periods, an entity's definition of selling expenses.

The standard is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The standard will be applied on a prospective basis with the option to apply the standard retrospectively. This standard will not have any impact to the amounts recorded within our consolidated financial statements, but will result in expanded disclosures. We are assessing the impact of this standard.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

*<u>Income Tax</u>*

In December 2023, the FASB issued ASU 2023-09 Income Taxes (Topic 740) — Improvements to Income Tax Disclosures, to address improvements to income tax disclosures. The standard requires disaggregated information about a company's effective tax rate reconciliation as well as information on income taxes paid, which includes the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Disclosure, on an annual basis, of specific categories in the rate reconciliation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Disclosure, on an annual basis, of additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Disclosure, on an annual basis, of the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Disclosure, on an annual basis, of the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Disclosure of income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Disclosure of income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Elimination of the requirement to disclose the nature and estimate of the range of the reasonably possible change in the unrecognized tax benefits balance in the next 12 months or make a statement that an estimate of the range cannot be made; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Elimination of the requirement to disclose the cumulative amount of each type of temporary difference when a deferred tax liability is not recognized because of the exceptions to comprehensive recognition of deferred taxes related to subsidiaries and corporate joint ventures.

The standard is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The standard will be applied on a prospective basis with the option to apply the standard retrospectively. This standard will not have any impact to the amounts recorded within our consolidated financial statements, but will result in expanded disclosures in our 2025 annual consolidated financial statements.

**3. Segment information**

We have three reportable segments (Exchange Services, MGA Operations, and Underwriting). Each of our reportable segments serves the specific needs of our customers based on the products and services provided and reflects the way our Chief Operating Decision Maker (CODM) assesses performance of the business and makes decisions on the allocation of resources. Our CODM is our Chief Executive Officer.

***Exchange Services***

Exchange Services, which is the core of Accelerant, captures the revenue and expenses associated with the Risk Exchange. The Risk Exchange is the platform that houses Accelerant technology, data ingestion, and operations that serve the needs of Members and Risk Capital Partners. Insurance companies that join the Risk Exchange pay Accelerant a fixed-percentage volume-based fee for sourcing, managing, and monitoring the business they write. The Risk Exchange pays fees to Members for the distribution services provided to both consolidated affiliates and third parties. We eliminate net fees and other income earned by the Exchange Services segment in consolidation to the extent such income is received from consolidated insurance companies within the Underwriting segment. Only income earned from third-party companies is not eliminated in consolidation.

***MGA Operations***

MGA Operations consists of our Mission Underwriters ("Mission") and Owned Members reporting units. Mission is a licensed insurance agency that functions as an MGA incubator in the US, UK and EU and represents the largest component of the segment. Mission was previously a consolidated variable interest entity ("VIE") until we acquired all the outstanding common equity interests in Mission on May 1, 2024, at which point it became a wholly-owned subsidiary (and a voting interest entity, or "VOE").

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

The Owned Members reporting unit comprises MGAs in which the Company has made non-controlling or controlling equity investments. Our investments in existing Members typically take the form of an initial minority stake and contractual call option for a majority stake over time. We eliminate commission income earned by MGA Operations in consolidation to the extent it is received from consolidated insurance companies within the Underwriting segment. Only commission income earned from third-party companies is not eliminated in consolidation.

***Underwriting***

Underwriting contains all revenue and expenses associated with the underwriting of insurance policies and assumption of reinsurance policies issued or accepted by Accelerant's consolidated insurance companies and Accelerant Re (Cayman) Ltd. ("Accelerant Re"). Our Underwriting segment is a strategic asset that enables access to Accelerant's portfolio for current and prospective Risk Capital Partners. The activities of these (re)insurance companies include property and casualty insurance, policy issuance, reinsurance arrangements and the payment of commission and other acquisition costs to the Exchange Services segment.

Premium revenue is earned in exchange for the property and casualty insurance policies issued and reinsurance coverage provided. For segment presentation purposes, the commission expense paid to the wholly-owned agencies is subject to deferral as DAC for the portion of insurance policies not subject to reinsurance. DAC associated with business ceded is offset by ceding commissions received from reinsurers, which is typically more than the DAC. The DAC associated with business retained, as well as the excess ceding commissions from reinsurers, are both amortized over the related policy term. Accelerant Re also cedes premium and losses to, and receives ceding commissions from, several third-party reinsurers, including Flywheel Re. Similar to the Exchange Services and MGA Operations segments, transaction activity with our consolidated affiliates is subject to elimination (and therefore the amount of DAC, deferred ceding commissions, DAC amortization and amortization of ceding commission income in consolidation will differ from that presented within the segment results). Specifically, only commission payments and other acquisition expenses paid to third parties are subject to deferral and amortization in consolidation.

We consider the segment presentations of Exchange Services, MGA Operations and Underwriting segments prior to elimination to be the best way to evaluate Accelerant's business and how these business components would be presented if they were stand-alone operations. As we generate additional third-party insurance relationships through our Risk Exchange, the standalone segment results will more closely align with the consolidated results (as such third party transactions would not be subject to elimination).

The following includes the financial results of our three reportable segments for the three and nine months ended September 30, 2025 and 2024. Corporate functions and certain other businesses and operations are included in Corporate and Other.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Financial information by segment:***

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total Segments** | **Corporate and Other** <sup>(1)</sup> | **Consolidation and elimination adjustments** | **Total** |
| **Revenues** | | | | | | | |
| Ceding commission income <sup>(2)</sup> | $— | $— | $29 | $29 | $— | $63.3 | $92.3 |
| Direct commission income |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Affiliated entities | 61.1 | 28.5 |  | 89.6 |  | (89.6) |  |
| &nbsp;&nbsp;Unaffiliated entities | 22.8 | 20.6 |  | 43.4 |  |  | 43.4 |
| Net earned premiums |  |  | 82.1 | 82.1 |  |  | 82.1 |
| Net investment income | 1.1 | 1.0 | 6.1 | 8.2 | 1.9 |  | 10.1 |
| Net realized gains on investments |  | 3.1 | 0.4 | 3.5 |  |  | 3.5 |
| Net unrealized gains on investments |  | 27.6 |  | 27.6 | 8.4 |  | 36.0 |
| **Segment revenues** | **85.0** | **80.8** | **117.6** | **283.4** | **10.3** | **(26.3)** | **267.4** |
| Losses and loss adjustment expenses |  |  | 50.8 | 50.8 |  |  | 50.8 |
| Amortization of deferred acquisition costs |  |  | 34.9 | 34.9 |  | (12.1) | 22.8 |
| General and administrative expenses <sup>(3) (4) (5)</sup> | 25.8 | 35.4 | 14.3 | 75.5 | 23.6 | (10.3) | 88.8 |
| **Adjusted EBITDA** | $**59.2** | $**45.4** | $**17.6** | $**122.2** | $**(13.3)** | $**(3.9)** | **105.0** |
| Interest expenses |  |  |  |  |  |  | (2.6) |
| Depreciation and amortization |  |  |  |  |  |  | (10.0) |
| Profits interest distribution expenses | Profits interest distribution expenses |  |  |  |  |  | (1379.7) |
| Share-based compensation expenses <sup>(5)</sup> | Share-based compensation expenses <sup>(5)</sup> |  |  |  |  |  | (27.0) |
| Net foreign exchange gains |  |  |  |  |  |  | 2.4 |
| Other expenses <sup>(6)</sup> |  |  |  |  |  |  | (45.6) |
| **Loss before income taxes** |  |  |  |  |  |  | $**(1357.5)** |

---

<sup>(1)</sup> Corporate and Other includes shared services and other activities, which represent business activities that do not meet the definition of a reportable segment.

<sup>(2)</sup> Ceding commission income of our Underwriting segment includes the effect of sliding scale adjustments based on actual loss experience. For further information on sliding scale commission adjustments, refer to Note 8.

<sup>(3)</sup> General and administrative expenses is comprised of employee compensation and benefits, consulting and professional fees and all other administrative expenses. The composition of such amounts by each reportable segment was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total** |
| Employee compensation and benefits | $18.1 | $22.7 | $6.9 | $47.7 |
| Consulting and professional fees | 4.3 | 3.5 | 2.5 | 10.3 |
| Other administrative expenses | 3.4 | 9.2 | 4.9 | 17.5 |
| **Total general and administrative expenses** | $**25.8** | $**35.4** | $**14.3** | $**75.5** |

---

<sup>(4)</sup> The consolidation and elimination adjustments for general and administrative expenses consist of expenses attributable to Exchange Services and MGA Operations that form components of acquisition costs of insurance policies that would be capitalized in consolidation, which are offset by other consolidation and elimination adjustments.

<sup>(5)</sup> Share-based compensation expenses are included in "General and administrative expenses" within the condensed consolidated statements of operations.

<sup>(6)</sup> Other expenses for the three months ended September 30, 2025 consist of a $25.0 million termination fee for our former management services agreement contract with Altamont Capital, $12.0 million of professional costs related to corporate development and capital raise activities (including $4.3 million specifically related to our IPO that were not eligible for capitalization as issuance costs), $5.2 million of system development non-operating costs, $2.4 million of Mission profits sharing expense and $1.0 million of other individually insignificant costs.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total Segments** | **Corporate and Other** <sup>(1)</sup> | **Consolidation and elimination adjustments** | **Total** |
| **Revenues** | | | | | | | |
| Ceding commission income <sup>(2)</sup> | $— | $— | $15.4 | $15.4 | $— | $46.7 | $62.1 |
| Direct commission income |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Affiliated entities | 55.5 | 32.3 |  | 87.8 |  | (87.8) |  |
| &nbsp;&nbsp;Unaffiliated entities | 7.7 | 9.5 |  | 17.2 |  |  | 17.2 |
| Net earned premiums |  |  | 59.3 | 59.3 |  |  | 59.3 |
| Net investment income | 0.4 | 1.1 | 8.9 | 10.4 | 0.6 |  | 11.0 |
| Net realized gains on investments |  |  | 0.1 | 0.1 |  |  | 0.1 |
| Net unrealized gains on investments |  |  |  |  | 4.0 |  | 4.0 |
| **Segment revenues** | **63.6** | **42.9** | **83.7** | **190.2** | **4.6** | **(41.1)** | **153.7** |
| Losses and loss adjustment expenses |  |  | 39.7 | 39.7 |  |  | 39.7 |
| Amortization of deferred acquisition costs |  |  | 30.1 | 30.1 |  | (7.0) | 23.1 |
| General and administrative expenses <sup>(3) (4) (5)</sup> | 18.0 | 25.2 | 31.5 | 74.7 | 6.7 | (16.6) | 64.8 |
| **Adjusted EBITDA** | $**45.6** | $**17.7** | $**(17.6)** | $**45.7** | $**(2.1)** | $**(17.5)** | $**26.1** |
| Interest expenses |  |  |  |  |  |  | (3.1) |
| Depreciation and amortization |  |  |  |  |  |  | (5.8) |
| Share-based compensation expenses <sup>(5)</sup> | Share-based compensation expenses <sup>(5)</sup> |  |  |  |  |  | (2.5) |
| Net foreign exchange losses |  |  |  |  |  |  | (5.4) |
| Other expenses <sup>(6)</sup> |  |  |  |  |  |  | (8.0) |
| **Income before income taxes** |  |  |  |  |  |  | $**1.3** |

---

<sup>(1)</sup> Corporate and Other includes shared services and other activities, which represent business activities that do not meet the definition of a reportable segment.

<sup>(2)</sup> Ceding commission income of our Underwriting segment includes the effect of sliding scale adjustments based on actual loss experience. For further information on sliding scale commission adjustments, refer to Note 8.

<sup>(3)</sup> General and administrative expenses is comprised of employee compensation and benefits, consulting and professional fees and all other administrative expenses. The composition of such amounts by each reportable segment was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total** |
| Employee compensation and benefits | $12.3 | $18.9 | $11.1 | $42.3 |
| Consulting and professional fees | 3.2 | 1.9 | 3.1 | 8.2 |
| Other administrative expenses | 2.5 | 4.4 | 17.3 | 24.2 |
| **Total general and administrative expenses** | $**18.0** | $**25.2** | $**31.5** | $**74.7** |

---

<sup>(4)</sup> The consolidation and elimination adjustments for general and administrative expenses consist of expenses attributable to Exchange Services and MGA Operations that form components of acquisition costs of insurance policies that would be capitalized in consolidation, which are offset by other consolidation and elimination adjustments.

<sup>(5)</sup> Share-based compensation expenses are included in "General and administrative expenses" within the condensed consolidated statements of operations.

<sup>(6)</sup> Other expenses for the three months ended September 30, 2024 consist of $2.5 million system development non-operating costs, $4.3 million of professional costs related to corporate development and capital raise activities and $1.2 million of other individually insignificant costs.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total Segments** | **Corporate and Other** <sup>(1)</sup> | **Consolidation and elimination adjustments** | **Total** |
| **Revenues** | | | | | | | |
| Ceding commission income <sup>(2)</sup> | $— | $— | $77.8 | $77.8 | $— | $186.8 | $264.6 |
| Direct commission income |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Affiliated entities | 189.1 | 99.0 |  | 288.1 |  | (288.1) |  |
| &nbsp;&nbsp;Unaffiliated entities | 49.6 | 56.1 |  | 105.7 |  |  | 105.7 |
| Net earned premiums |  |  | 215.7 | 215.7 |  |  | 215.7 |
| Net investment income | 2.8 | 2.8 | 25.8 | 31.4 | 3.7 |  | 35.1 |
| Net realized gains on investments |  | 5.2 | 1.0 | 6.2 |  |  | 6.2 |
| Net unrealized gains on investments |  | 27.1 |  | 27.1 | 10.1 |  | 37.2 |
| **Segment revenues** | **241.5** | **190.2** | **320.3** | **752.0** | **13.8** | **(101.3)** | **664.5** |
| Losses and loss adjustment expenses |  |  | 147.3 | 147.3 |  |  | 147.3 |
| Amortization of deferred acquisition costs |  |  | 87.6 | 87.6 |  | (29.5) | 58.1 |
| General and administrative expenses <sup>(3) (4) (5)</sup> | 79.6 | 100.4 | 40.6 | 220.6 | 54.5 | (27.3) | 247.8 |
| **Adjusted EBITDA** | $**161.9** | $**89.8** | $**44.8** | $**296.5** | $**(40.7)** | $**(44.5)** | $**211.3** |
| Interest expenses |  |  |  |  |  |  | (7.7) |
| Depreciation and amortization |  |  |  |  |  |  | (25.7) |
| Profits interest distribution expenses | Profits interest distribution expenses |  |  |  |  |  | (1379.7) |
| Share-based compensation expenses <sup>(5)</sup> | Share-based compensation expenses <sup>(5)</sup> |  |  |  |  |  | (32.4) |
| Net foreign exchange losses |  |  |  |  |  |  | (14.9) |
| Other expenses <sup>(6)</sup> |  |  |  |  |  |  | (70.6) |
| **Loss before income taxes** |  |  |  |  |  |  | $**(1319.7)** |

---

<sup>(1)</sup> Corporate and Other includes shared services and other activities, which represent business activities that do not meet the definition of a reportable segment.

<sup>(2)</sup> Ceding commission income of our Underwriting segment includes the effect of sliding scale adjustments based on actual loss experience. For further information on sliding scale commission adjustments, refer to Note 8.

<sup>(3)</sup> General and administrative expenses is comprised of employee compensation and benefits, consulting and professional fees and all other administrative expenses. The composition of such amounts by each reportable segment was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total** |
| Employee compensation and benefits | $53.6 | $67.9 | $20.0 | $141.5 |
| Consulting and professional fees | 13.4 | 11.9 | 8.2 | 33.5 |
| Other administrative expenses | 12.6 | 20.6 | 12.4 | 45.6 |
| **Total general and administrative expenses** | $**79.6** | $**100.4** | $**40.6** | $**220.6** |

---

<sup>(4)</sup> The consolidation and elimination adjustments for general and administrative expenses consist of expenses attributable to Exchange Services and MGA Operations that form components of acquisition costs of insurance policies that would be capitalized in consolidation, which are offset by other consolidation and elimination adjustments.

<sup>(5)</sup> Share-based compensation expenses are included in "General and administrative expenses" within the condensed consolidated statements of operations.

<sup>(6)</sup> Other expenses for the nine months ended September 30, 2025 consist of a $25.0 million termination fee for our former management services agreement contract with Altamont Capital, $13.4 million of system development non-operating expenses, $21.7 million of professional costs related to corporate development and capital raise activities (including $5.0 million specifically related to our IPO that were not eligible for capitalization as issuance costs), $8.4 million of Mission profits sharing expense and $2.1 million of individually insignificant costs.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total Segments** | **Corporate and Other** <sup>(1)</sup> | **Consolidation and elimination adjustments** | **Total** |
| **Revenues** | | | | | | | |
| Ceding commission income <sup>(2)</sup> | $— | $— | $65.0 | $65.0 | $— | $121.2 | $186.2 |
| Direct commission income |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Affiliated entities | 143.4 | 76.6 |  | 220.0 |  | (220.0) |  |
| &nbsp;&nbsp;Unaffiliated entities | 14.8 | 24.1 |  | 38.9 |  |  | 38.9 |
| Net earned premiums |  |  | 155.5 | 155.5 |  |  | 155.5 |
| Net investment income | 0.7 | 2.9 | 23.3 | 26.9 | 0.7 |  | 27.6 |
| Net realized gains on investments |  |  | 0.5 | 0.5 |  |  | 0.5 |
| Net unrealized (losses) gains on investments |  |  | (0.8) | (0.8) | 4.0 |  | 3.2 |
| **Segment revenues** | **158.9** | **103.6** | **243.5** | **506.0** | **4.7** | **(98.8)** | **411.9** |
| Losses and loss adjustment expenses |  |  | 111.6 | 111.6 |  |  | 111.6 |
| Amortization of deferred acquisition costs |  |  | 77.4 | 77.4 |  | (15.4) | 62.0 |
| General and administrative expenses <sup>(3) (4) (5)</sup> | 45.7 | 76.6 | 70.2 | 192.5 | 20.6 | (41.4) | 171.7 |
| **Adjusted EBITDA** | $**113.2** | $**27.0** | $**(15.7)** | $**124.5** | $**(15.9)** | $**(42.0)** | $**66.6** |
| Interest expenses |  |  |  |  |  |  | (9.1) |
| Depreciation and amortization |  |  |  |  |  |  | (16.2) |
| Share-based compensation expenses <sup>(5)</sup> | Share-based compensation expenses <sup>(5)</sup> |  |  |  |  |  | (6.3) |
| Net foreign exchange losses |  |  |  |  |  |  | (3.6) |
| Other expenses <sup>(6)</sup> |  |  |  |  |  |  | (22.4) |
| **Income before income taxes** |  |  |  |  |  |  | $**9.0** |

---

<sup>(1)</sup> Corporate and Other includes shared services and other activities, which represent business activities that do not meet the definition of a reportable segment.

<sup>(2)</sup> Ceding commission income of our Underwriting segment includes the effect of sliding scale adjustments based on actual loss experience. For further information on sliding scale commission adjustments, refer to Note 8.

<sup>(3)</sup> General and administrative expenses is comprised of employee compensation and benefits, consulting and professional fees and all other administrative expenses. The composition of such amounts by each reportable segment was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total** |
| Employee compensation and benefits | $31.5 | $54.8 | $31.1 | $117.4 |
| Consulting and professional fees | 7.5 | 5.2 | 10.6 | 23.3 |
| Other administrative expenses | 6.7 | 16.6 | 28.5 | 51.8 |
| **Total general and administrative expenses** | $**45.7** | $**76.6** | $**70.2** | $**192.5** |

---

<sup>(4)</sup> The consolidation and elimination adjustments for general and administrative expenses consist of expenses attributable to Exchange Services and MGA Operations that form components of acquisition costs of insurance policies that would be capitalized in consolidation, which are offset by other consolidation and elimination adjustments.

<sup>(5)</sup> Share-based compensation expenses are included in "General and administrative expenses" within the condensed consolidated statements of operations.

<sup>(6)</sup> Other expenses for the nine months ended September 30, 2024 consists of $11.8 million of system development non-operating costs, $8.5 million of professional costs related to corporate development and capital raise activities and $2.1 million of individually insignificant costs.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

The following table presents our total assets by reportable segments:

---

| | | |
|:---|:---|:---|
| ***(in millions)*** | **September 30, 2025** | **December 31, 2024** |
| Exchange Services | $812.9 | $653.8 |
| MGA Operations | 429.0 | 303.0 |
| Underwriting | 7015.9 | 5589.9 |
| Corporate and eliminations | (398.4) | (451.8) |
| **Total** | $**7859.4** | $**6094.9** |

---

As of September 30, 2025, our equity method investments (as further detailed in Note 4) consisted of $5.0 million held by the MGA Operations segment and $4.4 million within Corporate and Other. As of December 31, 2024, our equity method investments consisted of $14.0 million held by the MGA Operations segment and $4.2 million within Corporate and Other. In addition, expenditures for additions to long-lived assets are not material and and are not reported to our CODM.

All our revenues from external customers were attributable to various geographic locations outside of the Cayman Islands, based on where the insurance policies or services were sold. There were no reportable major customers that accounted for 10% or more of our consolidated revenue for the three and nine months ended September 30, 2025 and 2024.

The following table presents our revenues by geography:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| ***(in millions)*** | **North America** | **UK and EU** | **Total** |
| Ceding commission income <sup>(1)</sup> | $62.0 | $30.3 | $92.3 |
| Direct commission income | 27.3 | 16.1 | 43.4 |
| Net earned premiums | 25.9 | 56.2 | 82.1 |
| Net investment income | 6.9 | 3.2 | 10.1 |
| Net realized gains on investments | 2.8 | 0.7 | 3.5 |
| Net unrealized gains on investments | 36.0 |  | 36.0 |
| **Total revenues** | $**160.9** | $**106.5** | $**267.4** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| ***(in millions)*** | **North America** | **UK and EU** | **Total** |
| Ceding commission income <sup>(1)</sup> | $35.6 | $26.5 | $62.1 |
| Direct commission income | 10.2 | 7.0 | 17.2 |
| Net earned premiums | 34.6 | 24.7 | 59.3 |
| Net investment income | 6.2 | 4.8 | 11.0 |
| Net unrealized gains (losses) on investments | 4.1 | (0.1) | 4.0 |
| **Total revenues** | $**90.6** | $**63.1** | $**153.7** |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| ***(in millions)*** | **North America** | **UK and EU** | **Total** |
| Ceding commission income <sup>(1)</sup> | $188.7 | $75.9 | $264.6 |
| Direct commission income | 59.6 | 46.1 | 105.7 |
| Net earned premiums | 67.8 | 147.9 | 215.7 |
| Net investment income | 22.1 | 13.0 | 35.1 |
| Net realized gains on investments | 3.2 | 3.0 | 6.2 |
| Net unrealized gains on investments | 37.2 |  | 37.2 |
| **Total revenues** | $**378.6** | $**285.9** | $**664.5** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| ***(in millions)*** | **North America** | **UK and EU** | **Total** |
| Ceding commission income <sup>(1)</sup> | $100.0 | $86.2 | $186.2 |
| Direct commission income | 22.0 | 16.9 | 38.9 |
| Net earned premiums | 100.4 | 55.1 | 155.5 |
| Net investment income | 14.6 | 13.0 | 27.6 |
| Net realized (losses) gains on investments | (0.1) | 0.6 | 0.5 |
| Net unrealized gains (losses) on investments | 4.0 | (0.8) | 3.2 |
| **Total revenues** | $**240.9** | $**171.0** | $**411.9** |

---

<sup>(1)</sup> For further information on the impacts of sliding scale commission adjustments on our ceding commission income for the three and nine months ended September 30, 2025 and 2024 resulting from the loss experience of covered insurance contracts, refer to Note 8.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**4. Investments**

***Unrealized gains and losses on available for sale fixed maturity and short-term investments, at fair value***

The amortized cost, gross unrealized gains, gross unrealized losses and fair values of fixed maturity and short-term investments, were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| ***(in millions)*** | **Amortized cost** | **Gross unrealized gains** | **Gross unrealized losses** | **Fair value** |
| Corporate | $276.9 | $3.0 | $(0.2) | $279.7 |
| US government and agency | 152.4 | 1.3 | (0.1) | 153.6 |
| Non-US government and agency | 234.0 | 1.3 | (0.9) | 234.4 |
| Residential mortgage-backed | 62.8 | 0.6 | (0.5) | 62.9 |
| Commercial mortgage-backed | 20.1 | 0.3 |  | 20.4 |
| Other asset-backed securities | 35.5 | 0.2 |  | 35.7 |
| **Total fixed maturity and short-term investments** | $**781.7** | $**6.7** | $**(1.7)** | $**786.7** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| ***(in millions)*** | **Amortized cost** | **Gross unrealized gains** | **Gross unrealized losses** | **Fair value** |
| Corporate | $175.5 | $0.8 | $(2.3) | $174.0 |
| US government and agency | 128.9 | 0.1 | (0.8) | 128.2 |
| Non-US government and agency | 161.1 | 0.5 | (3.0) | 158.6 |
| Residential mortgage-backed | 44.4 | 0.1 | (1.5) | 43.0 |
| Commercial mortgage-backed | 18.6 |  | (0.2) | 18.4 |
| Other asset-backed securities | 22.1 | 0.1 | (0.1) | 22.1 |
| **Total fixed maturity and short-term investments** | $**550.6** | $**1.6** | $**(7.9)** | $**544.3** |

---

The following table summarizes, for all our available for sale securities in an unrealized loss position, the fair value and gross unrealized loss by length of time the security has been in a continual unrealized loss position:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Less than 12 months** | **Less than 12 months** | **12 Months or more** | **12 Months or more** | **Total** | **Total** |
| ***(in millions)*** | **Fair<br>value** | **Gross<br>unrealized<br>losses** | **Fair<br>value** | **Gross<br>unrealized<br>losses** | **Fair<br>value** | **Gross<br>unrealized<br>losses** |
| Corporate | $57.6 | $(0.2) | $— | $— | $57.6 | $(0.2) |
| US government and agency |  |  | 4.8 | (0.1) | 4.8 | (0.1) |
| Non-US government and agency | 124.2 | (0.8) | 3.0 | (0.1) | 127.2 | (0.9) |
| Residential mortgage-backed |  |  | 3.4 | (0.5) | 3.4 | (0.5) |
| **Total fixed maturity and short-term investments** | $**181.8** | $**(1.0)** | $**11.2** | $**(0.7)** | $**193.0** | $**(1.7)** |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Less than 12 months** | **Less than 12 months** | **12 Months or more** | **12 Months or more** | **Total** | **Total** |
| ***(in millions)*** | **Fair<br>value** | **Gross<br>unrealized<br>losses** | **Fair<br>value** | **Gross<br>unrealized<br>losses** | **Fair<br>value** | **Gross<br>unrealized<br>losses** |
| Corporate | $85.4 | $(2.2) | $6.5 | $(0.1) | $91.9 | $(2.3) |
| US government and agency | 66.3 | (0.6) | 4.7 | (0.2) | 71.0 | (0.8) |
| Non-US government and agency | 93.5 | (3.0) |  |  | 93.5 | (3.0) |
| Residential mortgage-backed | 29.0 | (0.8) | 5.1 | (0.7) | 34.1 | (1.5) |
| Commercial mortgage-backed | 13.2 | (0.2) | 0.5 |  | 13.7 | (0.2) |
| Other asset-backed securities | 12.1 | (0.1) |  |  | 12.1 | (0.1) |
| **Total fixed maturity and short-term investments** | $**299.5** | $**(6.9)** | $**16.8** | $**(1.0)** | $**316.3** | $**(7.9)** |

---

We did not recognize the unrealized losses in earnings on these fixed maturity and short-term investments as of September 30, 2025 and December 31, 2024 because we determined that such losses were due to non-credit factors that are temporary in nature. Additionally, we neither intend to sell the securities nor do we believe that it is more likely than not that we will be required to sell these securities before recovery of their amortized cost basis.

***Contractual maturity***

The amortized cost and fair values of our fixed maturity and short-term investments by contractual maturity were as follows:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** |
| ***(in millions)*** | **Amortized cost** | **Fair value** |
| Due in one year or less | $127.0 | $127.2 |
| Due after one year through five years | 456.9 | 460.9 |
| Due after five years through ten years | 78.9 | 79.1 |
| Due after ten years | 0.5 | 0.5 |
| Residential mortgage-backed | 62.8 | 62.9 |
| Commercial mortgage-backed | 20.1 | 20.4 |
| Other asset-backed securities | 35.5 | 35.7 |
| **Total** | $**781.7** | $**786.7** |

---

The expected maturities may differ from the contractual maturities because debtors may have the right to call or prepay obligations with or without call or prepayment penalties.

***Equity method and other investments***

We have made investments in private equity funds focused on insurance technology ventures, certain MGAs that form part of our distribution network and a technology-focused TPA that provides services to certain of our Members. Such strategic investments are generally accounted for using the equity method of accounting and are included as equity method investments in the financial statements or, in cases where we have elected the measurement alternative, accounted for at fair value based on observable price changes or impairment within Other investments.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

Details regarding our equity method investments were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| ***(in millions)*** | **Ownership %** | **Carrying value** | **Ownership %** | **Carrying value** |
| MGAs | 19.0% - 20.0% | $1.9 | 19.0% - 20.0% | $11.0 |
| Other | 9.2% - 15.0% | 7.5 | 9.4% - 15.0% | 7.2 |
| **Equity method investments** |  | $**9.4** |  | $**18.2** |

---

In applying the equity method of accounting, we record investments initially at cost and subsequently adjust their carrying value based on our proportionate share of the net income or loss of the investment. As permitted by the applicable accounting guidance, we generally record such investments on a one-to-three-month lag. Our maximum exposure to loss with respect to these investments is limited to the investment carrying amounts reported in our consolidated balance sheet and any unfunded commitments. As of September 30, 2025, we had unfunded commitments of $6.2 million to our equity method investees.

For the nine months ended September 30, 2025 and 2024, we received dividends from equity method investees of $1.6 million and $0.2 million, respectively.

Details regarding the carrying value of our other investments portfolio were as follows:

---

| | | |
|:---|:---|:---|
| ***(in millions)*** | **September 30, 2025** | **December 31, 2024** |
| **Investment type:** | | |
| &nbsp;&nbsp;MGAs and TPAs | $57.6 | $26.2 |
| &nbsp;&nbsp;Venture funds | 24.1 | 19.1 |
| **Other investments** | $**81.7** | $**45.3** |

---

We have elected the measurement alternative to carry private equity investments in venture funds, ordinary stocks, warrants and stock options of MGAs and TPAs that qualify for the equity method basis of accounting and that do not have a readily determinable fair value, at cost, less any impairment. If observable prices in identical or similar investments from the same issuer are observed, we measure the equity investment at fair value as of the date that such observable transaction occurs.

For the three months ended September 30, 2025, we recognized $36.0 million of income as a component of unrealized gains following observable prices related to our other investments. For the nine months ended September 30, 2025, we recognized a $0.5 million impairment charge, and we recognized $37.7 million of income as a component of unrealized gains following observable prices related to our other investments. For the three and nine months ended September 30, 2024, we recognized $4.0 million as a component of unrealized gains following observable prices related to these investments.

We have recognized cumulative income as a component of unrealized gains of $72.5 million, net of cumulative impairments of $0.7 million associated with investments accounted for under the measurement alternative from inception of the related investments.

As of September 30, 2025, we had unfunded commitments of $2.1 million to venture funds.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Net investment income***

Investment income and expenses were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** | **2025** | **2024** |
| &nbsp;&nbsp;Interest on cash and cash equivalents | $14.5 | $9.7 | $38.3 | $24.4 |
| &nbsp;&nbsp;Interest on fixed maturity investments | 7.0 | 4.1 | 18.5 | 10.5 |
| &nbsp;&nbsp;Income from equity method investments | 0.3 | 0.8 | 1.5 | 1.7 |
| **Gross investment income** | **21.8** | **14.6** | **58.3** | **36.6** |
| &nbsp;&nbsp;Interest on funds held under reinsurance | (11.2) | (3.5) | (22.0) | (8.5) |
| &nbsp;&nbsp;Investment expenses | (0.5) | (0.1) | (1.2) | (0.5) |
| **Net investment income** | $**10.1** | $**11.0** | $**35.1** | $**27.6** |

---

***Net realized and unrealized gains on investments***

The following table presents net realized and unrealized gains (losses) on our investments:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** | **2025** | **2024** |
| **Net realized gains on investments:** |  |  |  |  |
| &nbsp;&nbsp;Net realized gains on fixed maturity and short-term investments | $0.4 | $0.1 | $1.0 | $— |
| &nbsp;&nbsp;Net realized gains on equity securities |  |  |  | 0.5 |
| &nbsp;&nbsp;Net realized gains on equity method investments | 0.4 |  | 2.5 |  |
| &nbsp;&nbsp;Net realized gains on other investments | 2.7 |  | 2.7 |  |
| **Net realized gains on investments** | **3.5** | **0.1** | **6.2** | **0.5** |
| **Net unrealized gains on investments:** |  |  |  |  |
| &nbsp;&nbsp;Net unrealized losses on equity securities held at the reporting date |  |  |  | (0.8) |
| &nbsp;&nbsp;Other investments <sup>(1)</sup>: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Venture funds | 4.9 | 4.0 | 4.9 | 4.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;MGAs and TPAs | 31.1 |  | 32.3 |  |
| **Net unrealized gains on other investments** | **36.0** | **4.0** | **37.2** | **4.0** |
| **Net unrealized gains on investments** | **36.0** | **4.0** | **37.2** | **3.2** |
| **Net realized and unrealized gains on investments** | $**39.5** | $**4.1** | $**43.4** | $**3.7** |

---

<sup>(1)</sup> Amounts correspond to income arising from our equity investments accounted for under the measurement alternative (as described above).

***Regulated deposits and restricted assets***

Certain subsidiaries of the Company are required to maintain assets on deposit with various regulatory authorities to support our insurance and reinsurance operations. Securities on deposit for regulatory and other purposes were $5.0 million and $4.9 million as of September 30, 2025 and December 31, 2024, respectively, which are included in the "Fixed maturity securities available for sale, at fair value" in our condensed consolidated balance sheets.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

The following table represents the restricted assets we have pledged in favor of certain ceding companies to collateralized obligations:

---

| | | |
|:---|:---|:---|
| ***(in millions)*** | **September 30, 2025** | **December 31, 2024** |
| Short-term investments | $8.0 | $17.2 |
| Fixed maturity securities | 25.6 | 33.0 |
| Cash and cash equivalents | 71.9 | 47.3 |
| **Total** | $**105.5** | $**97.5** |

---

**5. Fair value measurements**

Assets recorded at fair value in our condensed consolidated balance sheets are measured and classified in accordance with a fair value hierarchy consisting of three "levels" based on the observability of valuation inputs:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1: Financial assets and liabilities for which inputs are observable and are obtained from reliable quoted prices in active markets for identical assets and liabilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2: Financial assets and liabilities for which values are based on quoted prices in markets that are not active or for which values are based on similar assets and liabilities that are actively traded. This also includes pricing models for which the inputs are corroborated by market data; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3: Financial assets and liabilities for which values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. The valuation of Level 3 assets and liabilities requires the greatest degree of judgment. These measurements may be made when there is little, if any, market activity for the asset or liability. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment. In making the assessment, we consider factors specific to the asset. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement is classified is determined based on the lowest level input that is significant to the fair value measurement in its entirety.

There were no material changes to valuation methodologies of assets measured at fair value from those that were disclosed in our audited consolidated financial statements included in the Prospectus.

***Fair value measurements on a recurring basis***

Our financial assets and liabilities measured at fair value on a recurring basis by level were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| ***(in millions)*** | **Quoted prices in active markets for identical assets<br>Level 1** | **Significant other observable <br>Level 2** | **Significant unobservable inputs<br>Level 3** | **Estimated fair value** |
| **Fixed maturity and short-term investments measured at fair value:** | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate | $— | $279.7 | $— | $279.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;US government and agency |  | 153.6 |  | 153.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-US government and agency |  | 234.4 |  | 234.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Residential mortgage-backed |  | 62.9 |  | 62.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commercial mortgage-backed |  | 20.4 |  | 20.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other asset-backed securities |  | 35.7 |  | 35.7 |
| **Total fixed maturity and short-term investments** | $**—** | $**786.7** | $**—** | $**786.7** |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| ***(in millions)*** | **Quoted prices in active markets for identical assets<br>Level 1** | **Significant other observable <br>Level 2** | **Significant unobservable inputs<br>Level 3** | **Estimated fair value** |
| **Fixed maturity and short-term investments measured at fair value:** | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate | $— | $174.0 | $— | $174.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;US government and agency |  | 128.2 |  | 128.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-US government and agency |  | 158.6 |  | 158.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Residential mortgage-backed |  | 43.0 |  | 43.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commercial mortgage-backed |  | 18.4 |  | 18.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other asset-backed securities |  | 22.1 |  | 22.1 |
| **Total fixed maturity and short-term investments** | $**—** | $**544.3** | $**—** | $**544.3** |

---

There were no transfers between Level 1, Level 2, or Level 3 for the nine months ended September 30, 2025 and for the year ended December 31, 2024.

***Fair value measurements on a non-recurring basis***

We measure the fair value of certain assets on a non-recurring basis, or when events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. These assets include our investments in limited partnerships reported in "Other investments" in our condensed consolidated balance sheets.

The following table presents assets measured at fair value on a non-recurring basis:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| ***(in millions)*** | **Quoted prices in active markets for identical assets<br>Level 1** | **Significant other observable <br>Level 2** | **Significant unobservable inputs<br>Level 3** | **Estimated fair value** |
| **Assets measured at fair value:** | | | | |
| Other investments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;MGAs and TPAs | $— | $— | $57.6 | $57.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Venture funds |  |  | 24.1 | 24.1 |
| **Total** | $**—** | $**—** | $**81.7** | $**81.7** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| **(in millions)** | **Quoted prices in active markets for identical assets<br>Level 1** | **Significant other observable <br>Level 2** | **Significant unobservable inputs<br>Level 3** | **Estimated fair value** |
| **Assets measured at fair value:** | | | | |
| Other investments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;MGAs | $— | $— | $26.2 | $26.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Venture funds |  |  | 19.1 | 19.1 |
| **Total** | $**—** | $**—** | $**45.3** | $**45.3** |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Fair value information about financial instruments not measured at fair value***

Our estimation of fair value for financial instruments not carried at fair value (excluding insurance contracts) is discussed below:

*<u>Debt</u>:* As further described in Note 9, given the frequency with which the variable interest rates on our senior unsecured debt reset, the carrying value of our debt measured at amortized cost approximates its fair value as of September 30, 2025 and December 31, 2024. The debt is classified as Level 2.

*<u>Remaining financial assets and liabilities</u>:* Our remaining financial assets and liabilities were generally carried at cost or amortized cost, which due to their short-term nature, approximates their fair value as of September 30, 2025 and December 31, 2024.

**6. Unpaid losses and loss adjustment expenses**

Activity in unpaid losses and LAE reserve is summarized as follows:

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** |
| Gross reserve for unpaid losses and LAE, beginning of year | $1294.4 | $772.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Reinsurance recoverables, beginning of year | 1069.5 | 605.5 |
| **Net reserve for unpaid losses and LAE, beginning of year** | **224.9** | **167.0** |
| Incurred losses and LAE related to: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current accident year | 147.9 | 100.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior accident years | (0.6) | 11.1 |
| **Total incurred losses and LAE** | **147.3** | **111.6** |
| Paid losses and LAE: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current accident year | (31.1) | (15.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior accident years | (65.6) | (59.1) |
| **Total paid losses and LAE** | **(96.7)** | **(74.6)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange adjustments | 13.0 | 6.1 |
| **Net reserve for unpaid losses and LAE, end of period** | **288.5** | **210.1** |
| &nbsp;&nbsp;&nbsp;&nbsp;Reinsurance recoverables on unpaid losses and LAE, end of period | 1552.9 | 929.8 |
| **Gross reserve for unpaid losses and LAE, end of period** | $**1841.4** | $**1139.9** |

---

Reserves for losses and LAE represent our estimated indemnity cost and related adjustment expenses necessary to administer and settle claims. Our estimates are based upon individual case estimates for reported claims set by our claims specialists, adjusted with actuarial estimates for any further expected development on reported claims and for losses that have been incurred, but not yet reported.

The increase in incurred losses and LAE attributable to prior accident years of $11.1 million for the nine months ended September 30, 2024 primarily related to the EU and UK general liability and property portfolio for members that have either been discontinued or subject to significant responsive underwriting actions.

**7. Reinsurance**

We enter into reinsurance agreements to limit our exposure to large losses and to enable us to underwrite policies with sufficient limits to meet policyholder needs. In a reinsurance transaction, an insurance company transfers, or cedes, part or all of its exposure to the reinsurer in exchange for all or a portion of the premiums.

We use extensive reinsurance arrangements, including quota share and excess of loss contracts, to manage our exposure under issued insurance contracts. Such reinsurance provides loss coverage subject to certain limits and may include sliding scale ceding commissions, premium caps, loss ratio limits and other features, which align our interests with those of our reinsurers. We consider these features when evaluating risk transfer and whether such contracts qualify as reinsurance or must be treated as deposits.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

Flywheel Re is an unconsolidated reinsurance sidecar that provides multi-year collateralized quota share capacity backed by institutional investors. We formed Flywheel Re to facilitate the participation of institutional investors in the Risk Exchange portfolio. During the second quarter of 2025, Flywheel Re completed a capital raise from new and existing institutional investors to extend and upsize its capacity to support business assumed.

The impacts of reinsurance on earned premiums and loss and loss adjustment expenses were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** | **2025** | **2024** |
| **Written premiums:** |  |  |  |  |
| &nbsp;&nbsp; Direct | $706.9 | $700.1 | $2288.9 | $1909.0 |
| &nbsp;&nbsp; Assumed | 85.0 | 95.4 | 288.3 | 164.6 |
| &nbsp;&nbsp; Ceded | (654.0) | (710.7) | (2348.1) | (1888.3) |
| **Net written premiums** | $**137.9** | $**84.8** | $**229.1** | $**185.3** |
| **Earned premiums:** |  |  |  |  |
| &nbsp;&nbsp; Direct | $703.7 | $567.1 | $2047.0 | $1494.9 |
| &nbsp;&nbsp; Assumed | 79.0 | 32.4 | 237.8 | 69.4 |
| &nbsp;&nbsp; Ceded | (700.6) | (540.2) | (2069.1) | (1408.8) |
| **Net earned premiums** | $**82.1** | $**59.3** | $**215.7** | $**155.5** |
| **Loss and LAE:** |  |  |  |  |
| &nbsp;&nbsp; Direct | $353.0 | $294.1 | $1084.8 | $792.6 |
| &nbsp;&nbsp; Assumed | 39.2 | 16.5 | 85.6 | 33.9 |
| &nbsp;&nbsp; Ceded | (341.4) | (270.9) | (1023.1) | (714.9) |
| **Net loss and LAE** | $**50.8** | $**39.7** | $**147.3** | $**111.6** |

---

***Reinsurance recoverables***

Amounts recoverable from reinsurers on paid and unpaid losses and LAE are recognized in a manner consistent with the unpaid losses and LAE associated with the reinsurance and presented as reinsurance recoverables. The balances were as follows:

---

| | | |
|:---|:---|:---|
| ***(in millions)*** | **September 30, 2025** | **December 31, 2024** |
| Reinsurance recoverables on unpaid losses and LAE | $1552.9 | $1069.5 |
| Other reinsurance recoverables: |  |  |
| &nbsp;&nbsp;Reinsurance recoverables on paid losses and LAE | 452.6 | 281.4 |
| &nbsp;&nbsp;Deposit assets | 74.5 | 82.9 |
| **Total other reinsurance recoverables** | **527.1** | **364.3** |
| **Reinsurance recoverables** | $**2080.0** | $**1433.8** |

---

For the nine months ended September 30, 2025, we reduced the deposit assets by $9.2 million attributed to actual recoveries. The deposit assets reported as of September 30, 2025, are comprised of expected recoveries, net of accretion, calculated using the interest method.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

Credit risk exists with reinsurance ceded to the extent that any reinsurer is unable to meet the obligation assumed under the reinsurance agreements. An allowance is established for amounts deemed uncollectible. We evaluate the financial condition of our reinsurers and monitor concentration of credit risk arising from our exposure to individual reinsurers. To further reduce credit exposure to reinsurance recoverables balances, we have received letters of credit from certain reinsurers that are not authorized as reinsurers under US state insurance regulations.

Of the total reinsurance recoverables on paid and unpaid losses and LAE outstanding as of September 30, 2025, 55% were with reinsurers having an A.M. Best rating of "A-" (excellent) or better, and we require reinsurance recoverables with reinsurers that have an A.M. Best rating below "A-" or are not rated by A.M. Best to be subject to collateral arrangements through a combination of letters of credit, funds withheld arrangements or trust agreements. We consider such collateral arrangements, credit ratings assigned to reinsurers by A.M. Best and other historical default rate information in estimating the credit valuation allowance for reinsurance recoverables. The credit valuation allowance was $0.6 million and $0.4 million as of September 30, 2025 and December 31, 2024, respectively.

**8. Deferred acquisition costs and deferred ceding commissions**

The following table presents the amounts of policy acquisition costs deferred and amortized for insurance business retained by Accelerant:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** |
| Balance as of July 1, | $51.2 | $60.7 |
| Direct commissions and other acquisition costs on retained business | 30.6 | 25.1 |
| Amortization of deferred acquisition costs | (22.8) | (23.1) |
| Foreign currency translation |  | 1.5 |
| **Balance as of September 30,** | $**59.0** | $**64.2** |

---

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** |
| Balance as of January 1, | $60.7 | $53 |
| Direct commissions and other acquisition costs on retained business | 56.1 | 72.2 |
| Amortization of deferred acquisition costs | (58.1) | (62.0) |
| Foreign currency translation | 0.3 | 1.0 |
| **Balance as of September 30,** | $**59.0** | $**64.2** |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

The following table presents the amounts of ceding commissions deferred and amortized:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** |
| Balance as of July 1, | $235.0 | $155.6 |
| Deferral of excess ceding commission income over deferred acquisition costs | 85.2 | 94.6 |
| Amortization of deferred excess ceding commission to income | (92.3) | (62.1) |
| Foreign currency translation | (1.9) | (10.6) |
| **Balance as of September 30,** | $**226.0** | $**177.5** |

---

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** |
| Balance as of January 1, | $193.0 | $120.4 |
| Deferral of excess ceding commission income over deferred acquisition costs | 300.9 | 250.6 |
| Amortization of deferred excess ceding commission to income | (264.6) | (186.2) |
| Foreign currency translation | (3.3) | (7.3) |
| **Balance as of September 30,** | $**226.0** | $**177.5** |

---

We cede a significant portion of our premiums written to reinsurance companies. The ceding commissions are offset against DAC related to the insurance contracts that are subject to such reinsurance. Any excess ceding commissions over the related DAC are subject to deferral over the insurance premiums earning period.

Our contractual acquisition costs are expressed as a percentage of the underlying premiums by type of insurance policy. Certain agreements with our Members include sliding scale adjustments to acquisition cost based on the actual loss experience of the insurance contracts they write, such that our ultimate acquisition cost inversely changes relative to the loss ratio (i.e., adverse experience in the loss ratio will result in a reduction in the related acquisition cost and, conversely, any favorable experience in the loss ratio will result in an increase in the acquisition cost).

Certain of our reinsurance arrangements are subject to sliding scale adjustments pursuant to the agreements with various reinsurers based on the actual loss experience of covered insurance contracts. The contractual ceding commission amounts are expressed as a percentage of the underlying premiums by type of insurance policy. Further, the amount of ceding commissions will vary based on the volume of ceded premium and may be adjusted for changes in the loss ratio. As that loss ratio changes from the original expected contractual amount, the amount of ceding commission inversely changes (such that adverse experience in the subject loss ratio will result in a reduction in ceding commissions and, conversely, any favorable experience in the subject loss ratio will result in an increase in ceding commissions). Such changes in ceding commission will result in a change to the deferred ceding commissions liability to the extent that the underlying premiums are unearned and, conversely, will result in a direct change to income to the extent that the underlying premium has been earned. As such, the sliding scale commissions act as our substantive participation in the underlying loss experience of the underlying insurance contracts.

Ceding commission income recognized for the three and nine months ended September 30, 2025 included net increases of $7.7 million and $20.2 million, respectively, due to sliding scale commission adjustments resulting from the favorable loss experience of covered insurance contracts. For the three and nine months ended September 30, 2024, ceding commission income recognized included net reductions of $0.6 million and $7.9 million, respectively, due to sliding scale commission adjustments resulting from the loss experience of covered insurance contracts.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**9. Debt**

We had the following debt outstanding as of September 30, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
| ***(in millions)*** | **September 30, 2025** | **December 31, 2024** |
| Senior unsecured debt | $125.0 | $125.0 |
| Less: unamortized debt issuance costs | (3.1) | (3.6) |
| **Senior unsecured debt** | **121.9** | **121.4** |

---

We have a senior unsecured syndicated US dollar denominated loan facility with a September 2029 maturity date with an aggregate outstanding principal balance of $125 million. The credit agreement includes a $50 million revolving credit facility (all of which was unutilized and available as of September 30, 2025). Each borrowing under the revolving credit facility may have a maturity of one, three or six months, at the Company's election, but may not extend beyond the credit agreement's maturity date. Such borrowings may be repaid early.

The senior notes are senior unsecured obligations and include a delayed draw term loan ("DDTL") feature that allows us to withdraw predefined amounts. Incremental facilities up to an additional $75 million are available to draw upon request, subject to the agreement of the lenders.

Partial quarterly repayments of the aggregate principal amount are required until the maturity date. Interest payments on the senior notes are due at the end of each period, being a certain month or quarter during which the applicable interest rate has been reset. The interest rate is subject to a sliding scale based on our consolidated senior debt to capitalization ratio and varies between a 3.4% and 4.0% spread in addition to the Secured Overnight Financing Rate ("SOFR"). Interest is calculated based on a 360-day year of twelve 30-day months. Interest expense for the three months ended September 30, 2025 and 2024 was $2.6 million and $3.1 million, respectively. Interest expense for the nine months ended September 30, 2025 and 2024 was $7.7 million and $9.1 million, respectively.

Subject to conditions of optional prepayment, we may voluntarily prepay the senior notes at any time and from time to time, prior to the maturity date without penalty. Any prepayment, in whole or in part, shall include any accrued and unpaid interest thereon to, but excluding, the prepayment date. Any amounts we prepay may not be reborrowed.

The senior notes contain certain restrictive and maintenance covenants customary for facilities of this type, including restrictions on minimum consolidated net worth, maximum leverage levels and a minimum interest coverage ratio. As of September 30, 2025, we were in compliance with all such covenants.

**10. Equity**

***Initial Public Offering***

On July 25, 2025, the Company completed its IPO and issued and sold 20,276,280 Class A common shares at a public offering price of $21.00 per share, resulting in net cash proceeds of $392.0 million after deducting the underwriting discounts and commissions and offering costs . Certain of the Company's pre-existing investors participated in the offering as selling shareholders and sold 19,354,044 Class A common shares at the IPO price for which the Company received no proceeds.

The Company used a portion of the net proceeds from the IPO to fund the redemption of the Class C convertible preference shares for $175.3 million in cash (as all holders of the Class C convertible preference shares elected to redeem their shares at the date of its IPO) and to pay a $25.0 million termination fee to an affiliate of Altamont Capital Partners related to a then-existing management services agreement.

As of the closing of the IPO:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• All of our outstanding Class A convertible preference shares and Class B convertible preference shares automatically converted into Class A common shares and Class B common shares (as applicable), with voting attributes described further below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Investment funds controlled by Altamont Capital Partners, our equity sponsor, own 90,916,841 Class B common shares, representing 76.7% of the combined voting power of our common shares outstanding (given that each Class B common share is entitled to 10 votes per share as compared to one vote per share for each Class A common share).

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

Prior to the IPO, deferred offering costs, which consisted of accounting, legal and other fees directly related to the IPO, were capitalized within Other assets on the condensed consolidated balance sheets. In connection with the IPO, $18.9 million of deferred offering costs were reduced and reflected as a reduction of the net proceeds received from the IPO within additional paid in capital such that, in total, the increase in additional paid in capital from the IPO was $376.0 million (which compares to net cash proceeds presented within the consolidated statement of cash flows of $392.0 million, as $16.0 million of offering costs were incurred prior to January 1, 2025).

***Common shares:***

The Company has two classes of authorized common shares with a par value of $0.0000011951862 per share.

The Company's common shares confer upon its holders the following rights:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The holders of our Class A common shares are entitled to one vote per share, and the holders of our Class B common shares are entitled to ten votes per share on all matters subject to a vote at the Company's general meetings.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the right to share in the distribution of dividends, the distribution of assets or any other distribution pro-rata to the par value of the shares held by them; and the right to share in the distribution of any assets for distribution to shareholders upon our liquidation, dissolution or winding up pro-rata to the par value of the shares held by them.

Class A common shares are not convertible to Class B common shares. Class B common shares are convertible to Class A commons shares, on a share-to-share basis, in the following manner:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• at the option of the holder at any time after issuance;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• automatically upon transfer of Class B common shares, other than to a "Permitted Transferee" (defined as the holder, an affiliate, or a trust for their benefit);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• upon enforcement of security interests that result in a third party obtaining legal title;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• on the third anniversary of the IPO, all remaining Class B common shares automatically convert to Class A common shares.

As of September 30, 2025, common shares authorized, issued and outstanding consisted of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 500,000,000 Class A shares authorized, 114,578,616 issued and outstanding

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 140,000,000 Class B shares authorized, 107,241,428 issued and outstanding

As of December 31, 2024, there were 252,652,430 common shares authorized with a par value of $0.0001 per share, and 166,185,094 shares issued and outstanding. Prior to the consummation of the IPO, Accelerant Holdings LP distributed 1,986,221 of our then existing pre-split common shares to holders of existing limited partnership interests of Accelerant Holdings LP in proportion to the economic interests represented by those limited partnership interests. These were subsequently redesignated as 75,988,500 Class A common shares and 90,196,594 Class B common shares on a post-split basis.

***Preference shares:***

Prior to the IPO, the Company had issued and outstanding Class A, Class B and Class C preference shares. In connection with the IPO, all outstanding Class A convertible preference shares and Class B convertible preference shares automatically converted into Class A common shares and Class B common shares (as applicable). At the date of the IPO, all holders of the Class C convertible preference shares elected to redeem their shares for the stated redemption value of $175.3 million in cash. The $70.9 million difference in redemption value from carrying value was reflected as a deemed dividend and a reduction to additional paid in capital and earnings per share.

As of September 30, 2025, there were 100,000,000 preference shares authorized and no preference shares issued and outstanding. The Board of Directors is authorized, without any action by our shareholders, to designate and issue preference shares in one or more classes and to designate the powers, preferences and rights of each class, which may be greater than the rights of our common shares.

As of December 31, 2024, convertible preference shares authorized, issued and outstanding consist of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 20,955,646 Class A shares authorized, 20,955,497 issued and outstanding

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 12,569,841 Class B shares authorized, 12,569,691 issued and outstanding

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 5,563,987 Class C shares authorized, 5,556,546 issued and outstanding

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**11. Business acquisition**

***Step acquisition of Agribusiness Risk Underwriters***

In July 2025, we executed an agreement to purchase the remaining 25% equity interests of Agribusiness Risk Underwriters ("ARU") that we did not previously own for consideration of 1,833,481 of our Class A common shares. The transaction closed in August 2025 and was reflected as an equity transaction using the basis of the previously outstanding non-controlling interests of $2.4 million, as we previously consolidated ARU as a controlled subsidiary. This amount was offset by a capital transaction of $2.5 million with the non-controlling interests owner.

***Acquisition of Corniche Underwriting Ltd. ("Corniche")***

In January 2025, our consolidated subsidiary Corniche Acquisition Co. Ltd. acquired an additional 61% of the outstanding share capital of Corniche, a UK based MGA that specializes in the insurance of risks related to the recycling industry, in exchange for $56.2 million of consideration consisting of i) $17.1 million of cash paid at acquisition, $8.6 million paid in July and an additional $8.5 million of cash to be paid in January 2026 that is reflected as a payable within "Accounts payable and other liabilities" in our condensed consolidated balance sheets as of September 30, 2025); ii) our previously held equity interest of $11.0 million; and iii) the non-controlling interests of $11.0 million. The acquisition of the additional 61% interest increased our ownership in Corniche from 19.5% to 80.5%. Previously, we accounted for the investment in Corniche as an equity method investment. Following the completion of the step acquisition, we remeasured our previously held equity interest to fair value at the step acquisition date. Accordingly, we recorded a revaluation gain of $2.0 million within "Net realized gains on investments" in our condensed consolidated statements of operations.

The fair value of the assets acquired and liabilities assumed and non-controlling interest was estimated using an income approach. Key assumptions included market-observable inputs and management's estimates of nominal cash flows. The purchase consideration was allocated to the estimated fair value of the tangible and identifiable intangible assets acquired less liabilities assumed at the date of the acquisition. Our purchase price allocation related to the acquisition is provisional and could change in subsequent periods to reflect new information obtained about the facts and circumstances that existed as of the acquisition date, which if known, would have affected the measurement of the amounts recognized as of the acquisition date. We may recognize measurement period adjustments to the provisional amounts in future periods, but no later than one year from the closing date (referred to as the "measurement period"). We recorded goodwill from this acquisition, primarily attributable to expected growth and profitability, none of which is expected to be deductible for income tax purposes.

Our consolidated financial statements include the results of our acquisitions after their respective closing dates. Revenue, net income, as well as pro forma information is not presented for the Corniche acquisition as such results of operations would not be materially different to the actual results of operations of the Company. Acquisition-related costs pertaining to Corniche incurred during the nine months ended September 30, 2025 were $0.7 million.

The following table provides our preliminary purchase accounting financial information for the Corniche acquisition:

---

| | |
|:---|:---|
| ***(in millions)*** | **2025** |
| **Assets acquired:** |  |
| Cash and cash equivalents | $16.2 |
| Other identifiable intangible assets | 21.6 |
| Premiums receivable | 7.0 |
| Other assets | 0.4 |
| **Total assets acquired** | **45.2** |
| **Liabilities assumed:** |  |
| Accounts payable and other liabilities | 16.7 |
| **Total liabilities assumed** | **16.7** |
| **Total identifiable net assets acquired** <sup>(1)</sup> | **28.5** |
| Goodwill | 27.7 |
| **Total acquisition consideration** | $**56.2** |

---

<sup>(1)</sup> Total net cash paid to date for the interest in Corniche was $9.5 million, net of cash acquired (consisting of the $25.7 million cash payments to date net of the $16.2 million cash acquired). As noted above, this does not include the final cash payment of $8.5 million that will be due in January 2026.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

A roll forward of goodwill and other intangible assets, net, including Corniche and an additional immaterial acquisition as of and for the nine months ended September 30, 2025 is as follows:

---

| | |
|:---|:---|
| ***(in millions)*** | **Goodwill and other intangible assets, net** |
| Balance as of January 1, 2025 | $64.0 |
| Goodwill from acquisition of business | 28.2 |
| Other intangible assets from acquisition of business | 21.6 |
| Amortization of other intangible assets | (4.0) |
| Foreign currency translation | 6.7 |
| **Balance as of September 30, 2025** | $**116.5** |

---

**12. Share-based compensation**

During the nine months ended September 30, 2025, the Company granted share-based compensation prior to, in conjunction with, and subsequent to the IPO, as described below.

***Accelerant Holdings LP distribution***

As discussed in Note 20 to our audited consolidated financial statements, the Company previously issued profits interest awards to certain officers and employees in the form of Accelerant Holdings LP partnership shares and incentive units (the "profit interest awards"). The profit interest awards required achievement of certain return thresholds and continuous service for the officers and employees to receive distributions (such as a significant increase in the valuation of the Company as realized through a market event, like an IPO). Compensation cost associated with these profit interest awards could only be recorded to the extent payment was reasonably estimable and probable, as well as giving consideration to service requirements. Prior to the IPO, no related compensation cost was recognized because, for accounting purposes, an IPO cannot be assessed as probable until it occurs. However, at the time of the IPO, the Company recognized $1.38 billion of non-cash stock-based compensation expenses related to the settlement of all outstanding profits interest awards through the distribution of 65,270,453 Class A common shares of the Company held by Accelerant Holdings LP to certain officers and employees of the Company that fully vested upon the IPO. The ultimate settlement of the profit interest awards was equity neutral as the contribution of the shares to officers and employees was reflected as a capital contribution to the Company by Accelerant Holdings LP in an equal and offsetting amount to the associated non-cash compensation expense.

***Share options granted to employees***

In connection with the IPO, to align the long-term interests of certain officers and employees with those of the Company, as well as to settle a pre-existing bonus program (as discussed in Note 20 to the annual consolidated financial statements of the Company), 26,205,555 Class A common share options were also granted to certain officers and employees. The options are backed by Class A common shares issuable upon the exercise of common share option awards in connection with the consummation of the IPO under our Share Incentive Plan, based on the IPO price of $21.00 per share and consisting of (i) common share options with respect to 9,236,398 Class A common shares with an exercise price equal to $22.49; and (ii) common share options with respect to 16,969,157 Class A common shares with an exercise price equal to the IPO price, in each case, vesting with respect to 25% of the Class A common shares subject to the awards on the one-year anniversary of the grant date and in 6.25% quarterly installments through the four-year anniversary of the grant date. The total value of compensation for the option grants was $242.6 million (based upon a Black-Scholes model valuation) to be recognized ratably over the four-year vesting period of the options.

During the second quarter, we granted 3,368,577 options to certain of our employees under our employee Share Incentive Plan. The contractual term of the option awards is ten years from the grant date. The vesting terms of the option awards varied based on the date of the respective employee's date of service commencement such that a portion of the awards was, in certain instances, vested as of the grant date. The vesting periods per each of the awards varied from two to four years (with either quarterly or annual partial vesting periods over those two to four year full vesting periods).

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

The fair value of each share option award granted during the nine months ended September 30, 2025 and 2024 was estimated on the date of grant using the following option pricing model assumptions:

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
| Weighted average expected term (years) - Options granted prior to the IPO | 3.0 - 10.0 | 1.2 - 10.0 |
| Weighted average expected term (years) - Options granted at IPO | 6.1 | N/A |
| Risk-free interest rate | 3.83% - 4.36% | 3.82% - 4.87% |
| Expected volatility | 39% | 31% - 38% |
| Expected dividend yield | 0% | 0% |

---

For options granted prior to the IPO, we estimated the expected term based on application of the Hull-White valuation method (widely used in the determination of option fair value), assuming that employees exercise their options, on average, when the stock price over strike price reaches a threshold of 2.2. For options granted in conjunction with the IPO we calculated fair value using the Black-Scholes model and utilized the simplified method to estimate the time to expiration for options because, as a newly public company, the Company did not have sufficient exercise data on which to base its own estimate nor historical exercise data for employee stock options, and such data from comparable companies was not easily obtainable.

The risk-free interest rate is based on observed interest rates appropriate for the term of our stock options. Expected volatility is based on companies at a comparable stage, as well as companies in the same or similar industry. The dividend yield assumption is based on the Company's historical and expected future dividend payouts and may be subject to change in the future.

The following table summarizes the activity related to share option awards for the nine months ended September 30, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Number of Options** | **Weighted-Average Exercise Price** | **Weighted-Average Remaining Contractual Term (Years)** | **Aggregate Intrinsic Value** | **Weighted- Average Fair Value** |
| Outstanding as of January 1, 2025 | 15016536 | $19.31 | 9.1 | $— | $2.84 |
| &nbsp;&nbsp;Granted | 29574132 | 22.38 | 9.8 |  | 9.01 |
| &nbsp;&nbsp;Exercised |  |  |  |  |  |
| &nbsp;&nbsp;Canceled | (1573813) | 19.80 |  |  |  |
| &nbsp;&nbsp;Forfeited | (733802) | 19.31 |  |  |  |
| **Outstanding as of September 30, 2025** | **42283053** | $**21.43** | **9.3** | $**—** | $**7.13** |
| Options exercisable as of September 30, 2025 | 7032616 | $19.44 | 8.2 | $— | $2.41 |
| Options unvested as of September 30, 2025 | 35250437 | $21.83 | 9.6 | $— | $8.07 |

---

The weighted average grant-date fair value of share options granted during the nine months ended September 30, 2025 and 2024 was $9.01 and $3.38 per option, respectively.

For the three months ended September 30, 2025 and 2024, share-based compensation expense from share option awards granted was $15.3 million and $2.5 million, respectively, which is included in "General and administrative expenses" in our condensed consolidated statements of operations. For the nine months ended September 30, 2025 and 2024, share-based compensation expense from share option awards granted was $20.7 million and $6.3 million, respectively,

The unrecognized compensation cost related to unvested share option awards as of September 30, 2025 and December 31, 2024 was $269.7 million and $29.6 million, respectively. The weighted average remaining requisite service period as of September 30, 2025 is 2.0 years, over which period the total cost will be amortized as compensation expense within the financial statements.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Restricted Stock Units ("RSUs")***

In connection with the IPO, to align the long-term interests of certain officers and employees with those of the Company, 2,381,858 RSUs were granted (538,295 RSUs were fully vested at issuance) which were valued at the IPO price of $21.00 per share and backed by Class A common shares. The 1,843,563 unvested RSUs vest in 6.25% quarterly installments through the four-year anniversary of the grant date.

In August 2025, we granted an additional 77,707 RSUs which were valued at $28.80 per share as of the grant date. These RSUs are also backed by Class A common shares and subject to the same vesting conditions as the RSUs granted in conjunction with the IPO.

The following table summarizes the activity related to RSUs for the nine months ended September 30, 2025:

---

| | | |
|:---|:---|:---|
| | **Number of Restricted Stock Units** | **Weighted-Average Grant-Date Fair Value** |
| **Unvested as of January 1, 2025** |  | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 2459565 | 21.25 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vested | (538295) | 21.00 |
| &nbsp;&nbsp;&nbsp;&nbsp;Forfeited |  |  |
| **Unvested as of September 30, 2025** | **1921270** | $**21.32** |

---

For the three and nine months ended September 30, 2025, share-based compensation expense from RSUs granted was $1.9 million, which is included in "General and administrative expenses" in our condensed consolidated statements of operations.

The total value of compensation for the RSU grants was $52.3 million, with $39.0 million associated with the unvested portion to be recognized as expense ratably over the four-year vesting period. The weighted average remaining requisite service period is 2.0 years, over which period the total cost will be amortized as shared-based compensation expense within the financial statements.

***Liability Classified Awards***

The Company has issued share-based compensation awards to certain of its employees that are classified as liabilities because they can be settled in either cash or common shares of the Company at its discretion. These awards are subject to both service and performance vesting conditions which were initially met during the third quarter 2025. The fair value of these awards was determined using an earnings multiple approach. For the three and nine months ended September 30, 2025, the share-based compensation expense from the liability classified awards was $9.8 million, which is included in "General and administrative expenses" in our condensed consolidated statements of operations.

The following table summarizes the share-based compensation expense the Company recognized by award type for the three and nine months ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| ***(in millions)*** | **2025** | **2024** | **2025** | **2024** |
| Share options | $15.3 | $2.5 | $20.7 | $6.3 |
| RSUs | 1.9 |  | 1.9 |  |
| Liability-classified awards | 9.8 |  | 9.8 |  |
| **Total share-based compensation expenses** | $**27.0** | $**2.5** | $**32.4** | $**6.3** |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***2025 Employee Stock Purchase Plan***

Our Board of Directors adopted, and our shareholders approved, the 2025 Employee Stock Purchase Plan ("ESPP") that become effective upon completion of the IPO. Generally, all of our employees are eligible to participate in the ESPP. Subject to any limitations contained therein, the ESPP allows eligible employees to contribute (in the form of payroll deductions or otherwise) to purchase Class A common shares at a discounted price per share. There are currently 1,000,000 of our Class A common shares reserved for issuance under the ESPP, which will automatically increase on the first trading day in January of each calendar year, commencing in 2026 and continuing until (and including) 2035, by an amount equal to the lesser of (i) 1% of the Class A common shares issued and outstanding on December 31 of the immediately preceding calendar year; (ii) 1,000,000 Class A common shares; or (iii) such lesser amount as is determined by our Board of Directors.

**13. Earnings per share**

The following table sets forth the computation of basic and diluted net earnings per common share:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions, except share data)*** | **2025** | **2024** | **2025** | **2024** |
| **Numerator:** |  |  |  |  |
| Net (loss) income attributable to Accelerant | $(1368.8) | $8.1 | $(1353.5) | $6.2 |
| Less: Deemed dividend for Class C preference shares redemption <sup>(1)</sup> | (70.9) |  | (70.9) |  |
| Net (loss) income attributable to Accelerant common shareholders | $(1439.7) | $8.1 | $(1424.4) | $6.2 |
| **Denominator:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted-average common shares outstanding - basic | 206064119 | 166185094 | 179624179 | 165913933 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of dilutive securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dilutive common shares <sup>(2)</sup> |  | 33525189 |  | 33470487 |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted-average common shares outstanding - diluted | 206064119 | 199710283 | 179624179 | 199384420 |
| **Net (loss) income attributable to Accelerant per common share:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $(6.99) | $0.05 | $(7.93) | $0.04 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(6.99) | $0.04 | $(7.93) | $0.03 |

---

<sup>(1)</sup> The difference in redemption value from carrying value is reflected as a deemed dividend and an increase of the Class C preference shares, as well as a corresponding reduction to additional paid in capital and earnings per share.

<sup>(2)</sup> Potential dilutive common shares consist of all of our convertible preference shares and certain of our share-based compensation options and RSUs described in Note 12. During a period of loss, the basic weighted average ordinary shares outstanding is used in the denominator of the diluted loss per ordinary share computation as the effect of including potentially dilutive securities would be anti-dilutive. The potential common shares excluded from the calculation of potential diluted shares outstanding were 2,963,669 and 2,243,862 shares for the three and nine months ended September 30, 2025, respectively, because the effect of including those common shares in the calculation would have been anti-dilutive. The potential common shares excluded from the calculation of potential diluted shares outstanding were 12,970,866 shares for the three and nine months ended September 30, 2024, respectively. Such potential common shares solely related to share options granted and outstanding described in Note 12.

**14. Income taxes**

For the three months ended September 30, 2025 and 2024, our effective tax rates were (0.7)% and (623.1)%, respectively. For the nine months ended September 30, 2025 and 2024, our effective tax rates were (2.0)% and 74.4%, respectively. We use the estimated annual effective tax rate method for calculating our tax provision in interim periods, which reflects our best estimate of the effective tax rate expected for the full year. The effective tax rates in both periods were impacted by taxable income subject to tax in certain jurisdictions, losses incurred in zero tax rate jurisdictions and valuation allowances offsetting available carry-forward losses in certain jurisdictions.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

In March 2025, the Board of Directors of Accelerant Holdings and certain intermediary holding companies (together, the "Holding Companies") approved a change in the Holding Companies' tax residency from the Cayman Islands to the UK. Upon becoming UK tax residents, the Holding Companies began to benefit from operational efficiencies including, but not limited to, lower withholding tax rates applicable to dividend distributions from certain US subsidiaries under the US-UK tax treaty. In addition, the aggregate income (loss) of the Holding Companies became subject to UK income tax effective as of the March 2025 date of change to UK tax residency. To the extent that the Holding Companies have incremental income it will generate additional UK tax expense and, conversely, to the extent that there are any incremental losses, income tax benefits will be generated to the extent that there is current or projected taxable income available in our UK operations. Over the remainder of 2025, we expect incremental benefits to emerge due to the Holding Companies' projected expense base and, therefore, our effective tax rate for the year ended December 31, 2025 is expected to fall below those reported in previous years when such expenses were incurred in the Cayman Islands (a zero tax rate jurisdiction).

The relationship of our income tax expense to pre-tax income (loss) is atypical because our taxable income has predominately been generated in the US, UK, Ireland, and Puerto Rico resulting in income tax expense in those jurisdictions (entities in such jurisdictions are referred to as "tax-paying entities").

Meanwhile, we have incurred operating losses in zero tax rate jurisdictions (such as in our corporate and reinsurance entities in the Cayman Islands) resulting in no income tax benefit. We have also incurred pre-tax operating losses in Belgium and other jurisdictions where we have generated cumulative operating losses; however, in each of those cases, a valuation allowance has been recorded against the corresponding deferred tax assets (entities in these two types of jurisdictions are referred to as "non-tax paying entities").

Taxable losses in one jurisdiction generally cannot be applied to offset earnings in another. In certain other jurisdictions, losses in one entity may not be used to offset taxable income generated by another entity in that same jurisdiction.

The composition of our effective tax rates among our tax-paying and non-tax paying entities, which demonstrates the non-tax paying entities' effect on the total effective tax rate, were as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30, 2025** | **Three Months Ended<br>September 30, 2025** | **Three Months Ended<br>September 30, 2025** | **Three Months Ended<br>September 30, 2025** | **Three Months Ended<br>September 30, 2024** | **Three Months Ended<br>September 30, 2024** | **Three Months Ended<br>September 30, 2024** |
| ***(in millions)*** | **Tax-paying entities** | **Profits interests and termination fee expenses** | **Non-tax paying entities** | **Total** | **Tax-paying entities** | **Non-tax paying entities** | **Total** |
| (Loss) income before income taxes | $44.7 | $(1404.7) | $2.5 | $(1357.5) | $33.1 | $(31.8) | $1.3 |
| Income tax (expense) benefit | (9.5) |  |  | (9.5) | 8.1 |  | 8.1 |
| **Effective tax rate** | **21.3%** | **—** | **—** | **(0.7)%** | **(24.5)%** | **—** | **(623.1)%** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended<br>September 30, 2025** | **Nine Months Ended<br>September 30, 2025** | **Nine Months Ended<br>September 30, 2025** | **Nine Months Ended<br>September 30, 2025** | **Nine Months Ended<br>September 30, 2024** | **Nine Months Ended<br>September 30, 2024** | **Nine Months Ended<br>September 30, 2024** |
| ***(in millions)*** | **Tax-paying entities** | **Profits interests and termination fee expenses** | **Non-tax paying entities** | **Total** | **Tax-paying entities** | **Non-tax paying entities** | **Total** |
| (Loss) income before income taxes | $141.7 | $(1404.7) | $(56.7) | $(1319.7) | $104.4 | $(95.4) | $9.0 |
| Income tax (expense) benefit | (26.4) |  |  | (26.4) | (6.7) |  | (6.7) |
| **Effective tax rate** | **18.6%** | **—** | **—** | **(2.0)%** | **6.4%** | **—** | **74.4%** |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

The effective tax rate for the three and nine months ended September 30, 2025 included the effects of non-deductible profits interests and termination fee expenses pertaining to the IPO, which impacted the aggregate rate and therefore are presented separately in the tables above. The effective tax rates for the three and nine months ended September 30, 2025 excluding these items would have been 20.1% and 31.1%, respectively.

**15. Other assets** 

Other assets consisted of the following:

---

| | | |
|:---|:---|:---|
| ***(in millions)*** | **September 30, 2025** | **December 31, 2024** |
| Net deferred tax assets | $57.5 | $51.6 |
| Commission income receivable | 42.7 | 28.3 |
| Funds withheld by reinsurers | 18.6 | 18.2 |
| Deferred offering costs <sup>(1)</sup> |  | 16.0 |
| Prepaid expenses | 14.1 | 11.8 |
| Related party receivables (refer to Note 17) |  | 7.6 |
| Prepaid retrocession premium | 4.7 | 5.3 |
| Other | 26.9 | 82.9 |
| **Total** | $**164.5** | $**221.7** |

---

<sup>(1)</sup> These costs were deferred pending the completion of the Company's IPO. For further information on the IPO, refer to Note 10.

**16. Accounts payable and other liabilities**

Accounts payable and other liabilities consisted of the following:

---

| | | |
|:---|:---|:---|
| ***(in millions)*** | **September 30, 2025** | **December 31, 2024** |
| Premium tax payables | $48.9 | $53.7 |
| Commission refund liabilities | 43.9 | 38.8 |
| Deposit liabilities | 24.6 | 43.9 |
| Trade payables | 17.6 | 13.8 |
| Corporation tax payable | 2.1 | 4.4 |
| Accrued expenses and other | 136.2 | 97.4 |
| **Total** | $**273.3** | $**252.0** |

---

**17. Related party transactions**

For the three and nine months ended September 30, 2025, the Company incurred $0.1 million and $0.8 million, respectively of advisory fees and expenses with Altamont Capital Management LLC, an affiliate. There were no net Altamont Capital Management LLC advisory fees and expenses for the three and nine months ended September 30, 2024.

As referenced in Note 10, the Company agreed to terminate the existing management services agreement between Accelerant Holdings LP and Altamont Capital Management, LLC, dated February 19, 2019 (the "MSA"), which previously set out terms on which, among other things, the Company had compensated Altamont Capital Management, LLC for its services. During July 2025, the Company agreed to pay Altamont Capital a termination fee of $25 million upon the successful consummation of its IPO, at which point the MSA was terminated. Such fee and related expense was reflected within "Other expenses" in our condensed consolidated financial statements.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

As discussed in more detail in Note 12, we recognized non-cash profits interest distribution expenses related to the settlement of all outstanding profits interest awards and other liabilities of Accelerant Holdings LP through the distribution of 65,270,453 Class A common shares of the Company held by Accelerant Holdings LP. Following the consummation of the IPO and related profits interests distribution, the Company's board of directors deemed all residual receivable and payable balances between Accelerant Holdings LP and the Company to be settled as a precursor to the dissolution of Accelerant Holdings LP. As of December 31, 2024, we had a net accounts receivable balance with Accelerant Holdings LP of $6.7 million.

**18. Commitments and contingencies**

***Litigation***

We are occasionally a party to routine contractual disputes impacting receivables, claims (re)insurance contracts or litigation incidental to our business. We do not believe that we are a party to any pending legal proceeding that is likely to have a material adverse effect on our business, financial condition, or results of operations.&nbsp;&nbsp;&nbsp;&nbsp;

Contingencies arise in the normal conduct of our operations and are not expected to have a material effect on our financial condition or results of operations. However, adverse outcomes are possible and could negatively affect our financial condition and results of operations.

***Unfunded investment commitments***

As of September 30, 2025, we had unfunded commitments of $8.3 million in respect of our limited partnership investments. Refer to Note 4 for additional information.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

*The following discussion and analysis of our financial condition and our results of operations should be read in conjunction with our interim unaudited condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q and our audited consolidated financial statements included in our prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended (the "Prospectus"). This management's discussion and analysis contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from such forward-looking statements. Factors that could cause or contribute to those differences include, but are not limited to, those identified below and those discussed in the sections titled "Cautionary Note Regarding Forward-Looking Statements" in this Quarterly Report on Form 10-Q and "Risk Factors" in the Prospectus. Additionally, our historical results are not necessarily indicative of the results that may be expected for any period in the future.*

**Overview**

Accelerant Holdings, together with its subsidiary companies, connects Members with Risk Capital Partners through its Risk Exchange. The Company, together with its Risk Capital Partners, provides property and casualty insurance to policyholders via its network of Members, which are typically MGAs. The Company focuses on small-to-medium sized commercial clients primarily in the US, EU, Canada and the UK.

***Initial Public Offering ("IPO")***

On July 25, 2025, the Company completed its IPO. For additional information regarding the related net proceeds, equity impact, use of proceeds and expenses associated with the Accelerant Holdings LP distribution and our equity award plans, refer to Note 10 and Note 12 to our interim condensed consolidated financial statements.

**Overview of Accelerant**

We operate a data-driven risk exchange that connects selected specialty insurance underwriters (the "supply side" of our platform) with Risk Capital Partners (the "demand side" on our platform). Our Risk Exchange reduces information asymmetries and operational barriers present in the traditional insurance value chain by leveraging proprietary technology to share actionable high-fidelity data and insights with platform participants.

The Accelerant Risk Exchange simplifies the traditional insurance value chain which is fragmented, costly, and inflexible. Legacy technology, excessive intermediation, and misaligned incentives cause data leakage, high costs, and wasted resources for participants. Our technology-powered platform addresses these issues by connecting our Members, and Risk Capital Partners, including insurers, reinsurers, and institutional investors. On the supply side of our Risk Exchange, we deliver a full service offering to our Members that includes insights and analytics, distribution management, operational resources, and the commitment of stable underwriting capacity. Our offerings free our Members to focus on growing their businesses through their core expertise of profitable underwriting. On the demand side of our Risk Exchange, we offer Risk Capital Partners an attractive, validated, and diversified portfolio of specialty insurance premium that may otherwise be difficult to access elsewhere. Risk Capital Partners who provide capacity through our Risk Exchange pay us fees to source, manage, and monitor risks on their behalf that recur when the underlying policies renew.

By harnessing our proprietary technology, access to data, and industry experience, we believe we have created the future marketplace of the specialty insurance industry. As of September 30, 2025, we had 265 Members (an increase of 17 Members since June 30, 2025) and 92 Risk Capital Partners on our platform and we have grown Exchange Written Premium at a 196% compounded annual growth rate since inception. As we mature and continue to scale our business, we expect our annual growth rate to moderate.

***Our Members ("Supply Side" of the Risk Exchange)***

The vast majority of our Members are independent third parties in which Accelerant has no ownership stake. We refer to these Members as "Independent Members." Each Independent Member enters into a long-term contract with Accelerant where it agrees to underwrite certain types of policies through the Risk Exchange. Generally, these contracts are five years in duration and subject to annual renewal, with Accelerant retaining a right to terminate early for performance reasons. For a large majority of the gross written premium produced by Independent Members, Accelerant has an exclusive arrangement to write such policy types with the Independent Member. Additionally, Accelerant has the right of first refusal to offer on the Risk Exchange any new products an Independent Member may launch.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

The remaining Members consist of "Mission Members" and "Owned Members." Mission Members are Members started within Mission Underwriters, our MGA incubation platform. With Mission Underwriters, we support entrepreneurial specialty underwriters with start-up capital and operational tools and resources to form their own MGAs that are then jointly owned by Mission Underwriters and the specialty underwriters. Our primary means of identifying such underwriters is our reliance on the Accelerant management team's knowledge of the specialty insurance markets, which includes reliance on certain historical metrics (such as loss ratios) from their underwriting track records at reputable incumbent institutions and, generally, prospective underwriters' reputations among the industry, leveraging our experience and tenure in the space. Such knowledge includes an awareness of high-quality underwriters in these markets. Mission Underwriters attracts specialty underwriters with its independence, turnkey back office, and equity incentivization combined with the overall Accelerant value proposition. We supplement this market awareness with arrangements with a number of specialist recruiters that seek out underwriters that match our desired profile. While our ongoing recruitment efforts will continue to be important as we grow, we do not currently expect any associated recruitment costs to increase materially over time. Mission Underwriters owns the majority of the MGAs that it helped to create, with meaningful equity shared with management teams based on the performance of their MGA. Owned Members are Members in which we either have a minority ownership interest or controlling equity interest. Typically, our investments in Owned Members take the form of an initial minority ownership interest and a contractual call option for a controlling equity ownership interest over time.

The gross premium written by Independent Members and placed through the Risk Exchange is referred to as "Independent Premium." The gross premium written by Mission Members and Owned Members and placed through the Risk Exchange is referred to as "Owned Premium." Historically, Independent Premium has comprised the large majority of Exchange Written Premium and we expect this trend to continue over time.

**Members and Exchange Written Premium Detail**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| | **2025** | **2025** | **2024** | **2024** |
| ***($ in millions)*** | **# of Members** | **Exchange Written Premium** | **# of Members** | **Exchange Written Premium** |
| Independent Members | 220 | $715.8 | 158 | $632.6 |
| Mission Members | 30 | 196.2 | 29 | 142.1 |
| Owned Members | 15 | 130.9 | 17 | 113.7 |
| **Total** | **265** | $**1042.9** | **204** | $**888.4** |
| Exchange Premium Growth Rate |  | 17% |  | 94% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2025** | **2024** | **2024** |
| ***($ in millions)*** | **# of Members** | **Exchange Written Premium** | **# of Members** | **Exchange Written Premium** |
| Independent Members | 220 | $2189.0 | 158 | $1574.0 |
| Mission Members | 30 | 569.7 | 29 | 360.8 |
| Owned Members | 15 | 341.7 | 17 | 294.2 |
| **Total** | **265** | $**3100.4** | **204** | $**2229.0** |
| Exchange Premium Growth Rate |  | 39% |  | 84% |

---

***Our Risk Capital Partners ("Demand Side" of the Risk Exchange)***

Currently, our Risk Capital Partners include third-party insurance companies, reinsurance companies, and institutional investors. As of September 30, 2025, 15 Risk Exchange Insurers (an increase of 1 Risk Exchange Insurer since June 30, 2025) accessed gross premium written directly from the Risk Exchange (on a primary insurance basis) rather than via reinsurance from Accelerant Underwriting, accounting for 26% of the premium written on the Risk Exchange for the nine months ended September 30, 2025, as compared to 14% for the nine months ended September 30, 2024 by 11 Risk Exchange Insurers.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

We refer to gross written premium written directly on behalf of Risk Exchange Insurers as "Third-Party Direct Written Premium." All premiums written by Accelerant Underwriting, including that which is ultimately reinsured to institutional investors and third-party reinsurers, is referred to as "Accelerant GWP." We expect the premium placed with Risk Exchange Insurers will increase in coming years, and as a result, the contribution from Third-Party Direct Written Premium will continue to increase. This is expected to lead to less overall revenue growth in our Underwriting segment, but more direct commission income within our Exchange Services segment.

For Accelerant Underwriting, we have historically targeted reinsuring approximately 90% of our gross premium written to institutional investors and third-party reinsurers, with Accelerant retaining approximately 10% of the risk associated with these gross premiums written, which we believe demonstrates alignment with our Risk Capital Partners. For the trailing twelve months ended September 30, 2025, Accelerant-Retained Exchange Premium represented 7% of Exchange Written Premium.

***Our Business Model***

We operate our business across three reportable segments – Exchange Services, which is the core offering of Accelerant, as well as MGA Operations and Underwriting. Exchange Services and MGA Operations are both fee-based businesses. Underwriting captures the net ceding commission income from reinsurers and Flywheel Re and net underwriting profit from retained business that is written or assumed by Accelerant Underwriting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Exchange Services:** The Exchange Services segment includes the revenue and expenses associated with our Risk Exchange. The Risk Exchange is our operating platform that incorporates all of our technology, data ingestion, and agency operations that serve the needs of our Members and Risk Capital Partners. Risk Capital Partners writing premiums directly through the Risk Exchange pay us a fixed-percentage, volume-based fee for sourcing, managing and monitoring the business they write, which is netted by the amount the Risk Exchange pays in performance-based commissions to Members.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **MGA Operations:** This segment reports all revenue and expenses from Mission Members and Owned Members in which we have majority ownership positions. Equity method accounting is used for Owned Members in which we have a minority equity ownership interest. The largest component of the segment is our investment in the 30 Mission Members as of September 30, 2025. There are 15 Owned Members as of September 30, 2025, of which, nine are majority-owned and controlled by us and therefore consolidated in our financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Underwriting:** Our Underwriting segment includes all revenue and expenses associated with our Accelerant Underwriting companies (each of which solely operates through the Risk Exchange) and reinsurance companies. We view the Underwriting segment as a strategic capability and source of operational flexibility and alignment with current and prospective Risk Capital Partners. Accelerant Underwriting earns premiums and pays losses from business sourced and retained through the Risk Exchange. Accelerant Underwriting pays commissions to the Risk Exchange as consideration to access this business on market-consistent terms with Risk Exchange Insurers. This is offset by the ceding commission we receive from several third-party reinsurers including Flywheel Re, a reinsurance sidecar, for ceding premium and losses to them. The performance of our Underwriting segment will vary with the performance of the portfolio reinsured to Risk Capital Partners. We expect the portion of Risk Exchange premium underwritten by Accelerant Underwriting to decrease over time, relative to other segments, as Risk Exchange Insurers increase in number and grow their premium written through our Risk Exchange.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

A high-level view of our business model is included below (based on activity for the trailing twelve months ended September 30, 2025)<sup>(4)</sup>:

![TTMPPTJPGv5.jpg](arx-20250930_g2.jpg)

**<u>Notes</u>**:

<sup>(1)</sup> Calculated as Exchange Services direct commission income divided by Exchange Written Premium (rounded from 7.6%).

<sup>(2)</sup> Calculated as $198.6 million of MGA Operations direct commission income, $4.1 million of net investment income, $6.5 million of net realized gains on investments, and $3.2 million of net unrealized losses on investments (after excluding unrealized gains of $30.3 million attributable to investments accounted for under the measurement alternative) divided by Exchange Written Premium attributable to Mission Members and Owned Members (rounded from 17.4%).

<sup>(3)</sup> Calculated as net earned premium and the amortization of deferred excess ceding commission income, reduced by net losses and the amortization of DAC, plus net investment income and net realized gains and net unrealized gains (losses) on investments expressed as a percentage of total Underwriting gross earned premium, excluding operating expenses (rounded from 3.4%).

<sup>(4)</sup> The table above references amounts for the trailing twelve months ended September 30, 2025 herein. The GAAP to non-GAAP reconciliation for this period can be derived using amounts presented above for the year ended December 31, 2024 less amounts reported for the nine months ended September 30, 2024 to arrive at the three months ended December 31, 2024, which can be added to the results for the nine months ended September 30, 2025 to arrive at amounts for the trailing twelve months ended September 30, 2025.

**Key Factors that Could Affect Our Performance**

***Ability to Maintain and Grow Our Member Base***

We believe there is a significant opportunity to attract new Members to the Risk Exchange and grow our existing Members. This is impacted by our ability to continue to deliver a holistic and compelling value proposition. We believe that existing and prospective Members will continue to be drawn to the Risk Exchange, and the growth of Members facilitated by our strong Member-centric service model, high value-add data and analytics capabilities, and ability to provide stable multi-year capacity.

***Access to Third-Party Capital Providers to Support Members***

Our future revenue growth also depends, in part, on our ability to expand our relationships with new and existing third-party capital providers to meet the growth of gross premiums sourced by our Members. We believe that the low-hazard, low-limit specialty business that we source from our Members will continue to attract these Risk Capital Partners. Since 2019, we have grown our Risk Capital Partners from two to 92 as of September 30, 2025. As of September 30, 2025, we had 15 Risk Exchange Insurers.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Sourcing a Portfolio with Sustainable Loss Ratios***

Our ability to maintain the support of Risk Capital Partners depends, in part, on maintaining an attractive ratio of gross premiums to gross losses and gross commissions that Risk Capital Partners pay to the Risk Exchange. We believe the historic quality of the portfolio written by our Members is reflected by the gross loss ratios of 51.2% and 52.8% for the nine months ended September 30, 2025 and 2024, respectively. We intend to leverage our data and analytics capability and our team of expert underwriters to continue to produce a portfolio with increasing diversification and attractive risk/return characteristics for our Risk Capital Partners.

***Investing in Technology Platform Capabilities***

We continue to invest in our Risk Exchange to add capabilities and enhance the overall user experience of Risk Exchange participants and deepen our analytical and underwriting insights. Our ability to successfully attract high-quality specialty underwriters and risk capital depends on our ability to continue to develop value from our technology platform. We may choose to increase our level of investment in technology from past levels to enhance the platform capabilities and our competitive position. We believe that our ability to deliver platform capabilities that our Risk Exchange participants perceive as unique will continue in the future.

***Costs of Being a Public Company***

As we operate as a public company, we will be required to continue to implement changes in certain aspects of our business and develop, manage, and train employees to comply with ongoing public company requirements. We will also incur new expenses, including public reporting obligations, proxy statements, shareholder meetings, stock exchange fees, transfer agent fees, SEC and Financial Industry Regulatory Authority ("FINRA") filing fees.

**Key Components of Our Results of Operations**

**Revenue**

***Ceding commission income***

We cede a significant portion of the premiums written on behalf of Accelerant Underwriting to third-party reinsurance companies or institutional investors through Flywheel Re. This generates positive ceding commissions which are recorded as a reimbursement for (and reduction of) the acquisition costs related to the reinsurance portion of the ceded insurance business. Ceding commissions that are in excess of the proportionate share of the DAC of the business ceded are deferred and amortized over the same period in which the related premium is earned. The amortization of this excess ceding commission income is recorded as "Ceding commission income" in the consolidated statements of operations within revenue. Certain ceding commissions are subject to sliding scale adjustments based on the actual loss experience of covered insurance contracts, which can result in the need for us to refund previous commissions received, resulting in a reduction of income in the determined period, or conversely, result in incremental commissions and related income. These adjustments often occur well after the ceding commissions are earned based on the development of insurance liabilities. In such instances, commission adjustments are not subject to deferral and are instead recorded directly as income or loss when determined. Accordingly, in all cases, we adjust ceding commissions as of the reporting date for our best estimate of loss experience for reinsured insurance policies.

***Direct commission income***

Accounting treatment of direct commissions received in the Exchange Services and the MGA Operations segments depend on whether the direct commission is being paid on an intercompany basis or by a third party.

Direct commissions paid by one Accelerant entity to another (referred to as "intercompany basis") are required to be eliminated in consolidation pursuant to generally accepted accounting principles. These include fees paid by Accelerant Underwriting to the Risk Exchange, commissions paid by the Risk Exchange to Mission Members and/or to Owned Members, and fees paid by third party Risk Exchange Insurers to the Risk Exchange on premiums which are assumed by Accelerant Underwriting. These intercompany direct commissions are recognized under "Direct commission income" in our consolidated statements of operations under the segment to which they relate and are fully recognized by the segment when the services and related performance obligations are completed.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

While these intercompany basis commissions are all eliminated on a consolidated basis, we nevertheless derive a significant economic benefit from these commissions. Unlike third parties, which bear the costs of the services performed by the Risk Exchange in the form of cash payments, we do not bear the cost of such services once fully eliminated, resulting in less commission amortization expense over the insurance policy term. This has the practical effect of increasing consolidated earnings as the corresponding premiums are earned. Direct commission income paid by third parties in the Exchange Services or MGA Operations segments on premiums that are otherwise not assumed by Accelerant Underwriting are fully recognized in the current period under "Direct commission income" in the statement of operations, to the extent that the underlying services and performance obligations to which they relate have been performed. As more business is written by Risk Exchange Insurers, we expect a higher proportion of direct commission income to be recognized on a consolidated basis (instead of being subject to elimination on an intercompany business basis, as discussed above).

***Net earned premiums***

Net earned premiums represent the earned portion of GWP placed with Accelerant Underwriting companies, less the portion of our GWP that is ceded to third-party reinsurers under our quota share and excess of loss reinsurance agreements. Premiums are earned in proportion to the amount of insurance protection provided over the term of the insurance contract. Unearned premiums represent the portion of premiums written applicable to the unexpired term of the related policy.

***Net investment income***

Net investment income represents interest earned from fixed maturity securities, short-term securities and other investments. Dividends from equity securities and other investments are also included in net investment income. Interest, dividend income and amortization of fixed maturity market premiums and discounts related to these securities are recorded in net investment income, net of investment management and custody fees. The principal factors that influence net investment income are the size of our investment portfolio and the yield on that portfolio.

We have certain unconsolidated investments within our MGA Operations segment and we account for these investments under the equity method, whereby we record our proportionate share of income or loss from such investments within net investment income (or the measurement alternative accounted for at fair value based on observable price changes or impairment whereby such amount is included in net unrealized gains or losses on investments). Any decline in value of equity method investments considered by management to be other than temporary is charged to income in the period in which it is determined.

***Net realized and unrealized gains (losses) on investments***

Our equity securities primarily consist of interests in investment funds that primarily invest in debt securities. The equity securities are measured at fair value with changes in fair value recognized in net realized and unrealized gains (losses) on investments. Realized gains and losses on disposition of investments are based on specific identification of investments sold.

We hold other investments such as limited partnership and private equity investments in operating entities whereby we elected the measurement alternative to carry such investments at cost, less any impairment and to mark to fair value when observable prices in identical or similar investments from the same issuer occur with changes in fair value recognized in net unrealized gains on investments.

**Expenses**

***Losses and LAE***

The reserves for losses and LAE include estimates for unpaid claims and claim expenses on reported losses as well as estimates of losses incurred but not reported ("IBNR"), net of reinsurance. These reserves represent our best estimates of the unpaid portion of ultimate costs of all reported and unreported losses incurred through the balance sheet date, and these estimates are based upon the assumption that past developments are an appropriate indicator of future events, among other factors. The reserves are based on individual claims, case reserves and other estimates reported, as well as actuarial estimates of ultimate losses.

Inherent in the estimates of ultimate losses are expected trends in claim severity and frequency and other factors which could vary significantly as claims are settled. Ultimate losses are estimates and may vary materially from the amounts provided in the consolidated financial statements. These estimates are reviewed regularly. As experience develops and new information becomes known, the reserves are adjusted as necessary. Such adjustments, if any, are reflected in our consolidated statements of operations in the period in which they become known and are accounted for as changes in estimates. The unpaid losses and LAE are presented on an undiscounted basis.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Amortization of deferred acquisition costs***

Policy acquisition costs represent the costs directly related to the successful acquisition of new and renewal insurance contracts. The costs are deferred and amortized over the same period in which the related premiums are earned. These costs principally consist of commissions, fees, brokerage, premium tax expenses, and direct agency costs. The amounts presented within the consolidated balance sheets pertain to the DAC associated with the retained portion of insurance policies we issue, as the acquisition costs associated with the ceded portion of the insurance policies are offset by ceding commissions received from our reinsurance providers. Deferred policy acquisition costs are reviewed to determine if they are recoverable from future income, including investment income. Unrecoverable deferred policy acquisition costs, if any, are expensed in the period identified.

***General and administrative expenses***

General and administrative expenses primarily consist of salaries, employee benefits and other general operating expenses that are expensed as incurred, and share-based compensation expenses. Generally, we expect our distribution, underwriting, and claims operating expenses to be most closely tied to growth of our membership and Risk Exchange premium volume. However, these and other functions within the Risk Exchange (including costs of supporting the development of the Risk Exchange), and our other segments have large, fixed-cost components that we believe will increase operating leverage as gross premiums continue to grow. Share-based compensation expenses represent amortization of the grant date fair value of equity awards granted to employees and directors, including restricted stock units, stock options, and other awards that can settle in cash or the common shares, over the requisite service period using the straight-line method. Forfeitures are recognized as they occur. The portion of the awards that settle in our common shares are non-cash in nature. We expect share-based compensation expenses to fluctuate over time in connection with new equity grants, changes in our workforce, and the overall structure of our long-term incentive programs.

***Interest expenses***

Interest expenses primarily relate to amounts paid on our debt financing obligations, including amortized debt issuance costs.

***Depreciation and amortization***

Depreciation and amortization expenses primarily relate to amortization of capitalized technology development costs, as well as amortization of intangible assets associated with acquisitions of businesses (including our investments in Owned Members).

***Profits interest distribution expenses***

Projects interest distribution expenses consist of non-cash profits interest distribution expenses related to the settlement of all outstanding profits interest awards through the distribution of 65,270,453 Class A common shares of the Company held by Accelerant Holdings LP to certain officers and employees of the Company that fully vested upon the July 25, 2025 initial public offering (IPO). The ultimate settlement of the profit interest awards was equity neutral as the contribution of the shares to officers and employees was reflected as a capital contribution to the Company by Accelerant Holdings LP in an equal and offsetting amount to the associated non-cash expense.

***Other expenses***

Other expenses represent costs related to our non-core business operations, primarily related to our global enterprise resource planning system and integrated financial reporting systems, and legal and advisory costs in connection with corporate development activities including mergers and acquisitions, capital raising activities and entity formations that support our growing business. For the three and nine months ended September 30, 2025, other expenses included a termination fee payable to Altamont Capital of $25.0 million related to the then-existing management services agreement.

***Income tax expense***

The provision for income tax consists of current and deferred tax expense. The calculation of current and deferred tax expense is based on tax rates and tax laws which have been enacted in the reporting period. Deferred tax assets and liabilities, result from temporary differences between the amounts recorded in the consolidated financial statements and the tax basis of assets and liabilities used in the various jurisdictional tax returns.

As of September 30, 2025, we had net deferred tax assets of $57.5 million and also apply full valuation allowances to certain of our deferred tax assets of unutilized net operating losses ("NOLs") and outside basis differences in partnership investments. The NOLs and outside basis differences predominantly arose from start-up losses on certain operating locations that drove significant taxable losses in the early stages of operations.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**Key Operating and Financial Metrics**

We regularly review key operating and financial metrics to evaluate our business, measure our performance, identify trends in our business, prepare financial projections and make strategic decisions. Our key operating and financial metrics include operational, GAAP and non-GAAP financial measures which are useful in evaluating our performance and our GAAP financial results discussed below.

As further discussed in "Segment Information — Consolidation and Elimination Adjustments" our consolidated results are subject to consolidation and elimination adjustments with respect to transactions among the businesses within our segments, notably between the Risk Exchange and Accelerant-owned insurance companies. We view the Adjusted EBITDA generated by our segments as representative of the economics that each would generate if they were independent companies and if the intersegment transactions were with third parties.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions, unless indicated)*** | **2025** | **2024** | **2025** | **2024** |
| Number of members | 265 | 204 | 265 | 204 |
| Net revenue retention | 135% | 146% | 135% | 146% |
| Exchange written premium<sup>(2)</sup> | $1042.9 | $888.4 | $3100.4 | $2229.0 |
| Accelerant direct written premium<sup>(2)</sup> | 68% | 79% | 74% | 86% |
| Third-party direct written premium<sup>(2)</sup> | 32% | 21% | 26% | 14% |
| Accelerant-retained exchange premium<sup>(2)</sup> | 7% | 10% | 7% | 10% |
| Exchange written premium growth rate<sup>(2)</sup> | 17% | 94% | 39% | 84% |
| Total revenues | $267.4 | $153.7 | $664.5 | $411.9 |
| Gross loss ratio | 50.1% | 51.8% | 51.2% | 52.8% |
| (Loss) income before income taxes | $(1357.5) | $1.3 | $(1319.7) | $9.0 |
| Net (loss) income | $(1367.0) | $9.4 | $(1346.1) | $2.3 |
| Non-GAAP financial measures<sup>(1)</sup> |  |  |  |  |
| &nbsp;&nbsp;Adjusted net income<sup>(1)</sup> | $79.8 | $19.0 | $127.5 | $27.3 |
| &nbsp;&nbsp;Adjusted EBITDA<sup>(1)</sup> | $105.0 | $26.1 | $211.3 | $66.6 |
| &nbsp;&nbsp;Adjusted EBITDA margin<sup>(1)</sup> | 39% | 17% | 32% | 16% |

---

<sup>(1)</sup> Refer to "—Reconciliation of Non-GAAP financial measures" section for details on how non-GAAP measures are defined and reconciled to GAAP measures.

<sup>(2)</sup> See the definitions of Exchange Written Premium, Accelerant Direct Written Premium, Third-Party Direct Written Premium, Accelerant-Retained Exchange Premium, and Exchange Written Premium Growth Rate below for explanation of calculations and metrics.

***Number of Members***

We define the number of Members as those under contract with our Risk Exchange as of the period end date. We view the number of Members as an important metric to assess our financial performance because Member growth drives our revenue from fees, commissions, and net retained premiums; expands brand awareness and our market penetration; and generates additional data to continue to attract more risk capital and accelerate the compounding momentum of our platform.

As of September 30, 2025, we had 265 Members. Our Members wrote $3.10 billion of Exchange Written Premium for the nine months ended September 30, 2025. This compares to Exchange Written Premium of $2.23 billion for the nine months ended September 30, 2024, representing a 39% increase. Of our 265 Members, 30 are Mission Members, 15 are Owned Members, and 220 are Independent Members. Of the $3.10 billion in Exchange Written Premium for the nine months ended September 30, 2025, 74% was written by Accelerant Underwriting as Accelerant Direct Written Premium and 26% was written by our 15 Risk Exchange Insurers as Third-Party Direct Written Premium.

***Number of MGA Operations Members***

We define the number of MGA Operations members as the number of Mission Members and Owned Members under contract with the Risk Exchange as of the period end date.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Net Revenue Retention***

We define Net Revenue Retention, expressed as a percentage, as the current period's Exchange Written Premium for Members that were actively writing Exchange Written Premium in the comparable period divided by these same Members' prior-period Exchange Written Premium. This measure demonstrates an aggregate measure of the net growth of Exchange Written Premium from previously onboarded Members.

***Exchange Written Premium***

We define Exchange Written Premium as the total GWP written through the Accelerant Risk Exchange, including both gross premiums written on behalf of Accelerant Underwriting and written directly on behalf of Risk Exchange Insurers.

***Accelerant Direct Written Premium***

We define Accelerant Direct Written Premium, expressed as a percentage of Exchange Written Premium, as the GWP written directly by Accelerant Underwriting, the majority of which we cede directly to Risk Capital Partners through our reinsurance arrangements.

***Third-Party Direct Written Premium***

We define Third-Party Direct Written Premium, expressed as a percentage of Exchange Written Premium, as the GWP written directly with our Risk Exchange Insurers.

***Accelerant-Retained Exchange Premium***

We define Accelerant-Retained Exchange Premium, expressed as a percentage, as Accelerant GWP net of ceded written premium for the trailing twelve month period, divided by total Exchange Written Premium for the trailing twelve month period. This represents the percentage of total Exchange Written Premium that Accelerant-owned insurance companies retain relative to total written premiums. We expect this retained portion of Exchange Written Premium in the aggregate to decrease over time as Exchange Written Premium is increasingly written with existing and new Risk Exchange Insurers.

For the nine months ended September 30, 2025, Accelerant Underwriting reinsured 91% of Accelerant GWP to third-party reinsurers. Of this amount, 33% of our Accelerant GWP was ceded to Flywheel Re during the nine months ended September 30, 2025.

***Exchange Written Premium Growth Rate***

We define Exchange Written Premium Growth Rate, expressed as a percentage, as the increase in Exchange Written Premium in the current period compared to Exchange Written Premium from the comparable period in the prior year period. It is calculated as the difference between the current period's Exchange Written Premium and the comparable prior period's Exchange Written Premium, divided by the Exchange Written Premium of the prior period. This metric provides insight into the growth trajectory of our premium volumes generated through our Risk Exchange and serves as a key indicator of business expansion, Member acquisition, and existing Member growth.

***Total Revenues***

Total revenues consist of the following items: Ceding commission income; Direct commission income; Net earned premiums; Net investment income; Net realized gains on investments and Net unrealized (losses) gains on investments.

***Gross Loss Ratio***

Gross loss ratio is calculated as gross incurred losses and loss adjustment expense divided by gross earned premium, expressed as a percentage. Gross loss ratio excludes the impact of premium and loss and loss adjustment expense ceded to reinsurers. Gross loss ratio represents the percentage of gross premium earned during the period that will be required to pay current and future claims, based on management's best estimates.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**Reconciliation of Non-GAAP financial measures**

***Adjusted EBITDA and Adjusted Net Income (Loss)***

Adjusted EBITDA and Adjusted Net Income (Loss) are non-GAAP measures, which we believe should be used to evaluate our financial performance by excluding certain items that are related to our non-core business operations and therefore are not considered to be directly attributable to our underlying operating performance. Adjusted EBITDA and Adjusted Net Income (Loss) are internal performance measures used in the management of our operations. We believe that disclosing Adjusted EBITDA and Adjusted Net Income (Loss) enables investors, analysts, rating agencies and other users of our financial information to more easily analyze our underlying business performance. Adjusted EBITDA and Adjusted Net Income (Loss) should not be used as substitutes for net income (loss), and other companies may define Adjusted EBITDA and Adjusted Net Income (Loss) differently than we do.

We define Adjusted EBITDA as GAAP net income (loss) less the impact of depreciation and amortization, interest expenses, income tax expenses and the following items:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *<u>Other expenses</u>:* Represents costs related to our non-core business operations, primarily related to our global enterprise resource planning system and integrated financial reporting systems, and legal and advisory costs in connection with corporate development activities including mergers and acquisitions, capital raising activities and entity formations that support our growing business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *<u>Non-recurring profits interest distribution expenses resulting from the IPO</u>*: Represents non-cash profits interest distribution expenses related to the settlement of all outstanding profits interest awards through the distribution of 65,270,453 Class A common shares of the Company held by Accelerant Holdings LP to certain officers and employees of the Company that fully vested upon the IPO. These expenses were entirely offset by a corresponding capital contribution for that distribution of shares. These expenses only occurred at one point in time and will not recur.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *<u>Share-based compensation expenses included within general and administrative expenses</u>*: Represents non-cash expense related to the fair value of share-based awards granted to employees and directors, including restricted stock units and stock options and other awards that can settle in cash, recognized over the requisite service period for the awards.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *<u>Net foreign currency exchange gains (losses)</u>:* The functional currency for each of our operating subsidiaries is generally the currency of the local operating environment. Transactions in currencies other than the local operation's functional currency are remeasured into the functional currency, and the resulting foreign exchange gains or losses are reflected in net foreign currency exchange gains (losses). Such gains and losses are generally offset by the translation of our subsidiaries who have the corresponding reinsurance-related balances within their own functional currencies, whereby such effects are translated to other comprehensive income, yielding a much lower net impact on total comprehensive income and equity (such measure differs from Adjusted EBITDA as it includes the effect of interest, taxes, depreciation and amortization, as well as foreign currency exchange gains (losses)).

We define Adjusted Net Income (Loss) as GAAP net income (loss) less the impact of other expenses, non-recurring profits interest distribution expenses, share-based compensation expenses, and the tax effect of the adjustments for other expenses.

***Adjusted EBITDA Margin***

We define Adjusted EBITDA Margin, a non-GAAP financial measure, as Adjusted EBITDA divided by total revenue. Adjusted EBITDA margin is an internal performance measure used in the management of our operations.

Adjusted EBITDA and Adjusted EBITDA margin should not be considered substitutes for the reported results prepared in accordance with GAAP and should not be considered in isolation or as alternatives to GAAP net income or net (loss) as indicators of our financial performance. Although we use Adjusted EBITDA and Adjusted EBITDA margin as financial measures to assess the performance of our business, such use is limited because it does not include certain material costs necessary to operate our business. Our presentation of Adjusted EBITDA and Adjusted EBITDA margin should not be construed as indications that our future results will be unaffected by unusual or non-recurring items. These non-GAAP financial measures, as determined and presented by us, may not be comparable to related or similarly titled measures reported by other companies. Set forth below are reconciliations of our most directly comparable financial measures calculated in accordance with GAAP to these non-GAAP financial measures on a consolidated basis.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

The following table provides a reconciliation of net income (loss) to Adjusted Net Income, Adjusted EBITDA and Adjusted EBITDA Margin for the three and nine months ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** | **2025** | **2024** |
| Net income (loss) | $(1367.0) | $9.4 | $(1346.1) | $2.3 |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Profits interest distribution expenses | 1379.7 |  | 1379.7 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expenses <sup>(1)</sup> | 27.0 | 2.5 | 32.4 | 6.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expenses <sup>(2)</sup> | 45.6 | 8.0 | 70.6 | 22.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax effect of adjustments to net income (loss) <sup>(3)</sup> | (5.5) | (0.9) | (9.1) | (3.7) |
| **Adjusted net income** | **79.8** | **19.0** | **127.5** | **27.3** |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Add back tax effect of adjustments to net income (loss) | 5.5 | 0.9 | 9.1 | 3.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense (benefit) | 9.5 | (8.1) | 26.4 | 6.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expenses | 2.6 | 3.1 | 7.7 | 9.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 10.0 | 5.8 | 25.7 | 16.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net foreign exchange (gains) losses | (2.4) | 5.4 | 14.9 | 3.6 |
| **Adjusted EBITDA** | $**105.0** | $**26.1** | $**211.3** | $**66.6** |
| Total revenues | 267.4 | 153.7 | 664.5 | 411.9 |
| **Adjusted EBITDA margin** | **39%** | **17%** | **32%** | **16%** |

---

<sup>(1)</sup> Share-based compensation expenses are included in "General and administrative" expenses in our interim condensed consolidated Statement of Operations.

<sup>(2)</sup> Other expenses for the three and nine months ended September 30, 2025 and 2024 consisted of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** | **2025** | **2024** |
| System development non-operating costs | $5.2 | $2.5 | $13.4 | $11.8 |
| Professional costs related to corporate development and capital raise activities | 12.0 | 4.3 | 21.7 | 8.5 |
| Mission profit interests expense | 2.4 |  | 8.4 |  |
| Managed services agreement termination fee payable to Altamont | 25.0 |  | 25.0 |  |
| Individually insignificant costs | 1.0 | 1.2 | 2.1 | 2.1 |
| **Total other expenses** | $**45.6** | $**8.0** | $**70.6** | $**22.4** |

---

<sup>(3)</sup> The tax effect of other expenses adjustments to net income (loss) for each period presented were calculated using the statutory tax rates for each of our legal entities where the expenses were incurred, including certain non-taxing jurisdictions. The statutory tax rates used in the calculations were adjusted in instances where our legal entities have applied full valuation allowances to their respective deferred tax assets of unutilized NOLs. As such, the tax effect for the respective years varies based on the jurisdictional mix of where the expenses were incurred in each year.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**Condensed Consolidated Results of Operations**

The following tables reflect our consolidated results of operations for the three and nine months ended September 30, 2025 and 2024 in the format that we use to analyze our financial performance. This information is derived from our interim condensed consolidated financial statements prepared in accordance with GAAP and included elsewhere in this Form 10-Q.

**Comparison of the Three and Nine Months Ended September 30, 2025 and 2024**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Accelerant Holdings** | | | | |
| **Condensed Consolidated Statements of Operations Summary** | **Condensed Consolidated Statements of Operations Summary** | **Condensed Consolidated Statements of Operations Summary** | **Condensed Consolidated Statements of Operations Summary** | **Condensed Consolidated Statements of Operations Summary** |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** | **2025** | **2024** |
| **Revenues** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ceding commission income | $92.3 | $62.1 | $264.6 | $186.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Direct commission income | 43.4 | 17.2 | 105.7 | 38.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net earned premiums | 82.1 | 59.3 | 215.7 | 155.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 10.1 | 11.0 | 35.1 | 27.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized gains on investments | 3.5 | 0.1 | 6.2 | 0.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains on investments | 36.0 | 4.0 | 37.2 | 3.2 |
| **Total revenues** | **267.4** | **153.7** | **664.5** | **411.9** |
| **Expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Losses and loss adjustment expenses | 50.8 | 39.7 | 147.3 | 111.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred acquisition costs | 22.8 | 23.1 | 58.1 | 62.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses <sup>(1)</sup> | 115.8 | 67.3 | 280.2 | 178.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expenses | 2.6 | 3.1 | 7.7 | 9.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 10.0 | 5.8 | 25.7 | 16.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Profits interest distribution expenses <sup>(2)</sup> | 1379.7 |  | 1379.7 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net foreign exchange (gains) losses | (2.4) | 5.4 | 14.9 | 3.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expenses | 45.6 | 8.0 | 70.6 | 22.4 |
| **Total expenses** | **1624.9** | **152.4** | **1984.2** | **402.9** |
| **(Loss) income before income taxes** | **(1357.5)** | **1.3** | **(1319.7)** | **9.0** |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | (9.5) | 8.1 | (26.4) | (6.7) |
| **Net (loss) income** | **(1367.0)** | **9.4** | **(1346.1)** | **2.3** |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for net (income) loss attributable to non-controlling interests | (1.8) | (1.3) | (7.4) | 3.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deemed dividend upon redemption of Class C preference shares | (70.9) |  | (70.9) |  |
| **Net (loss) income attributable to Accelerant common shareholders** | $**(1439.7)** | $**8.1** | $**(1424.4)** | $**6.2** |

---

<sup>(1)</sup> G*eneral and administrative expenses include share-based compensation expenses of* $27.0 million and $2.5 million for the three months ended September 30, 2025 and 2024, respectively and $32.4 million and 6.3 million for the nine months ended September 30, 2025 and 2024, respectively.

<sup>(2)</sup> *Non-cash profits interest distribution expenses related to the settlement of all outstanding profits interest awards through the distribution of 65,270,453 Class A common shares of the Company held by Accelerant Holdings LP to certain officers and employees of the Company that fully vested upon the Company's July 25, 2025 initial public offering (IPO). The ultimate settlement of the profit interest awards was equity neutral because the contribution of the shares to officers and employees was reflected as a capital contribution to the Company by Accelerant Holdings LP, which represented an equal and offsetting amount to the associated non-cash expense. For further information, refer to Note 12* in our interim condensed consolidated financial

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

statements *.*

**Comparison of the Three and Nine Months Ended September 30, 2025 and 2024**

***Ceding Commission Income***

Ceding commission income of $92.3 million for the three months ended September 30, 2025 increased $30.2 million from the three months ended September 30, 2024 amount of $62.1 million as we continued to grow our gross earned premium base and the amount ceded to reinsurers. Ceding commission income for the three months ended September 30, 2025 and 2024 included an increase of $7.7 million and a reduction of $0.6 million, respectively, due to net sliding scale commission adjustments resulting from the loss experience of covered insurance contracts in the US.

Ceding commission income of $264.6 million for the nine months ended September 30, 2025 increased $78.4 million from the nine months ended September 30, 2024 amount of $186.2 million due to the continued growth in our gross earned premium base and the amount ceded to reinsurers. Ceding commission income for the nine months ended September 30, 2025 and 2024 included an increase of $20.2 million and a reduction of $7.9 million, respectively, due to net sliding scale commission adjustments resulting from the loss experience of covered insurance contracts in the US.

The following table presents the amounts of ceding commissions deferred and amortized for the three months ended September 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** |
| Balance as of July 1, | $235.0 | $155.6 |
| Deferral of excess ceding commission income over deferred acquisition costs | 85.2 | 94.6 |
| Amortization of deferred excess ceding commissions to income | (92.3) | (62.1) |
| Foreign currency translation | (1.9) | (10.6) |
| **Balance as of September 30,** | $**226.0** | $**177.5** |

---

The following table presents the amounts of ceding commissions deferred and amortized for the nine months ended September 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** |
| Balance as of January 1, | $193.0 | $120.4 |
| Deferral of excess ceding commission income over deferred acquisition costs | 300.9 | 250.6 |
| Amortization of deferred excess ceding commissions to income | (264.6) | (186.2) |
| Foreign currency translation | (3.3) | (7.3) |
| **Balance as of September 30,** | $**226.0** | $**177.5** |

---

The amortization of the excess deferred ceding commissions is recorded as "Ceding commission income" in our consolidated statements of operations.

***Direct Commission Income***

Direct commission income was $43.4 million and $105.7 million for the three and nine months ended September 30, 2025, respectively, representing increases of $26.2 million and $66.8 million compared to the same periods in 2024 of $17.2 million and $38.9 million, respectively. These increases were, in each period, primarily driven by commissions from third-party insurers and increased volume in our Exchange Services and MGA Operations segments on business written with unaffiliated entities.

Additionally, the amount of our business between Accelerant-affiliated entities (including from Underwriting to Exchange Services and Exchange Services to MGA Operations) increased year-over-year. However, all transactions between affiliated entities are fully eliminated in our consolidated results of operations. A discussion of the impact of consolidation and elimination adjustments is further discussed below under "— Segment Information — Consolidation and Elimination Adjustments."

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Net Earned Premium***

GWP was $791.9 million and $2.58 billion for the three and nine months ended September 30, 2025, respectively, representing a decrease of $3.6 million (or (0.5)%) and an increase of $503.6 million (or 24.3%) compared to the same periods in 2024 of $795.5 million and $2.07 billion, respectively. The quarter-over-quarter decrease in GWP was driven by the growth in our third-party business on the Risk Exchange and the related increase in premiums written with third-party Risk Exchange Insurers instead of by Accelerant Underwriting. The year-over-year increase was primarily driven by new and existing Member growth. Since September 30, 2024, we have added 61 new Members, bringing the total number of Members to 265 as of September 30, 2025. This Member growth was driven by our continued expansion across all of our markets.

Net written premium was $137.9 million for the three months ended September 30, 2025, representing an increase of $53.1 million compared to the same period in 2024 of $84.8 million. The increase, despite the aforementioned decrease in GWP, is related our increased net retention (17.4% for the three months ended September 30, 2025 compared to 10.7% for the same period in 2024). The increased retention was primarily due to the UK retention rate increasing, as expected, related to regulatory requirements, as well as the timing of excess of loss reinsurance purchases. Our Accelerant-Retained Exchange Premium was 7% for the trailing twelve months ended September 30, 2025, and we expect our retained portion of Exchange Written Premium to trend towards our historical average of around 10% over future quarters.

Net written premium was $229.1 million for the nine months ended September 30, 2025, representing an increase of $43.8 million compared to the same period in 2024 of $185.3 million. The increase was driven by our GWP growth.

Net earned premium was $82.1 million and $215.7 million for the three and nine months ended September 30, 2025, respectively, representing increases of $22.8 million (or 38.4%) and $60.2 million (or 38.7%) compared to the same periods in 2024 of $59.3 million and $155.5 million, respectively. These increases were driven by the earn through of increased net written premiums from preceding periods.

The table below shows the amount of premium written on a gross and net basis, as well as net earned premium for the three and nine months ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** | **2025** | **2024** |
| Gross written premiums | $791.9 | $795.5 | $2577.2 | $2073.6 |
| Ceded written premiums | (654.0) | (710.7) | (2348.1) | (1888.3) |
| **Net written premiums** | $**137.9** | $**84.8** | $**229.1** | $**185.3** |
| **Net earned premiums** | $**82.1** | $**59.3** | $**215.7** | $**155.5** |

---

***Net Investment Income***

Net investment income was $10.1 million and $35.1 million for the three and nine months ended September 30, 2025, respectively, representing a decrease of $0.9 million and an increase of $7.5 million compared to the same periods in 2024 of $11.0 million and $27.6 million, respectively. The decrease for the three months ended September 30, 2025 as compared to the same period in 2024 was primarily driven by an increase in investment income applied to funds withheld liabilities of $7.7 million, which was almost fully offset by higher investment returns. The year-over-year increase of $7.5 million was primarily driven by the increase in total average investments year-over-year, partially offset by the aforementioned increases in interest expenses. Refer to Note 4 to our interim condensed consolidated financial statements for additional information.

***Net Realized Gains On Investments***

Net realized gains on investments were $3.5 million and $6.2 million for the three and nine months ended September 30, 2025, respectively, representing increases of $3.4 million and $5.7 million compared to the same periods in 2024 of $0.1 million and $0.5 million. The three months ended September 30, 2025 includes a gain of $2.7 million related to selling a portion of our interest in one of our owned MGA investments. Refer to Note 4 to our interim condensed consolidated financial statements for additional information.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Net Unrealized Gains On Investments***

Net unrealized gains on investments were $36.0 million and $37.2 million for the three and nine months ended September 30, 2025, respectively, representing increases of $32.0 million and $34.0 million compared to the same periods in 2024 of $4.0 million and $3.2 million. These increases were driven by a gain of $27.6 million related to an observable price increase on one of our owned MGA investments accounted for under the measurement alternative and a gain of $8.4 million relating to an investment in a TPA. Refer to Note 4 to our interim condensed consolidated financial statements for additional information.

***Loss and Loss Adjustment Expenses***

Net losses and LAE were $50.8 million and $147.3 million for the three and nine months ended September 30, 2025, respectively, representing increases of $11.1 million and $35.7 million compared to the same periods in 2024 of $39.7 million and $111.6 million, respectively. These increases were, in each period, primarily driven by growth in our net earned premium base.

Gross incurred losses and LAE of $392.2 million and $1.17 billion for the three and nine months ended September 30, 2025 increased by $81.6 million or 26% and $343.9 million or 42%, respectively, compared to the same periods in 2024 of $310.6 million and $826.5 million, respectively, while ceded losses and LAE of $341.4 million and $1.02 billion for the three and nine months ended September 30, 2025 increased $70.5 million or 26% and $308.2 million or 43%, respectively, compared to the same periods in 2024 of $270.9 million and $714.9 million, respectively, under our external reinsurance program.

Our net loss ratio differs from the gross loss ratio (50.1% and 51.2% for the three and nine months ended September 30, 2025, respectively, and 51.8% and 52.8% for the three and nine months ended September 30, 2024, respectively) primarily due to decisions that we make regarding the amount of excess of loss reinsurance secured (since this will reduce the amount of retained premiums we have). The decision to engage such reinsurance, which, in most cases, inures to the benefit of our Risk Capital Partners, supports our management of downside risk to large losses.

See "Segment Information—Comparison of the three and nine months ended September 30, 2025 and 2024—Underwriting" below for further information regarding our loss and loss adjustment expenses.

The table below reflects our net loss ratio for the three and nine months ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** | **2025** | **2024** |
| Gross incurred loss and LAE | $392.2 | $310.6 | $1170.4 | $826.5 |
| Ceded incurred loss and LAE | (341.4) | (270.9) | (1023.1) | (714.9) |
| **Net incurred loss and LAE** | $**50.8** | $**39.7** | $**147.3** | $**111.6** |
| **Net loss ratio** | **61.9%** | **66.9%** | **68.3%** | **71.8%** |

---

***Amortization of Deferred Acquisition Costs***

Amortization of DAC of $22.8 million and $58.1 million for the three and nine months ended September 30, 2025 decreased by $0.3 million and $3.9 million, respectively, compared to the same periods in 2024 of $23.1 million and $62.0 million due to a decrease in our retention rate of net earned premium, partially offset by growth in our business.

The following table presents the amounts of acquisition costs deferred and amortized for insurance business retained by us for the three months ended September 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** |
| Balance as of July 1, | $51.2 | $60.7 |
| Direct commissions and other acquisition costs on retained business | 30.6 | 25.1 |
| Amortization of deferred acquisition costs | (22.8) | (23.1) |
| Foreign currency translation |  | 1.5 |
| **Balance as of September 30,** | $**59.0** | $**64.2** |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

The following table presents the amounts of acquisition costs deferred and amortized for insurance business retained by us for the nine months ended September 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** |
| Balance as of January 1, | $60.7 | $53 |
| Direct commissions and other acquisition costs on retained business | 56.1 | 72.2 |
| Amortization of deferred acquisition costs | (58.1) | (62.0) |
| Foreign currency translation losses | 0.3 | 1.0 |
| **Balance as of September 30,** | $**59.0** | $**64.2** |

---

***General and Administrative Expenses***

General and administrative expenses were $115.8 million and $280.2 million for the three and nine months ended September 30, 2025, respectively, representing increases of $48.5 million and $102.2 million compared to the same periods in 2024 of $67.3 million and $178.0 million, respectively.

For the three and nine months ended September 30, 2025, the increase in general and administrative expenses was primarily attributable to increases in share-based compensation expenses, consisting of equity grants awarded prior to, in conjunction with, and subsequent to the IPO, employee compensation and benefits, driven by growth in headcount to support our growth across all markets, consulting and professional fees, and other administrative expenses.

The following table presents the components of general and administrative expenses for the three and nine months ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** | **2025** | **2024** |
| Employee compensation and benefits | $57.2 | $46.0 | $167.8 | $126.7 |
| Consulting and professional fees | 15.3 | 11.0 | 47.5 | 31.2 |
| Share-based compensation expenses | 27.0 | 2.5 | 32.4 | 6.3 |
| Other administrative expenses, net | 16.3 | 7.8 | 32.5 | 13.8 |
| **Total general and administrative expenses** | $**115.8** | $**67.3** | $**280.2** | $**178.0** |

---

***Interest Expenses***

Interest expenses were $2.6 million and $7.7 million for the three and nine months ended September 30, 2025, respectively, representing decreases, in each period, of $0.5 million and $1.4 million compared to the same periods in 2024 of $3.1 million and $9.1 million, respectively. The declines were primarily driven by lower interest rates year-over-year.

***Depreciation & Amortization***

Depreciation and amortization expenses were $10.0 million and $25.7 million for the three and nine months ended September 30, 2025, respectively, representing increases of $4.2 million and $9.5 million compared to the same periods in 2024 of $5.8 million and $16.2 million, respectively. These increases, in each period, were driven primarily by increased amortization of a larger balance of capitalized information technology development costs.

***Profits Interest Distribution Expenses***

Profits interest distribution expenses consisted of non-cash profits interest distribution expenses related to the settlement of all outstanding profits interest awards through the distribution of 65,270,453 Class A common shares of the Company held by Accelerant Holdings LP to certain officers and employees of the Company that fully vested upon the IPO. The ultimate settlement of the profits interest awards was equity neutral as the contribution of the shares to officers and employees was reflected as a capital contribution to the Company by Accelerant Holdings LP in an equal and offsetting amount to the associated non-cash expense. For further information, refer to Note 12.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Net Foreign Exchange (Gains) Losses***

Net foreign exchange gains were $2.4 million for the three months ended September 30, 2025 compared to net foreign exchange losses of $5.4 million for the same period in 2024. For the nine months ended September 30, 2025 and 2024, we recognized net foreign exchange losses of $14.9 million and $3.6 million. As noted above, transactions in currencies other than the local operation's functional currency are remeasured into the functional currency, and the resulting foreign exchange gains or losses are reflected in net foreign currency exchange gains (losses). Such gains and losses are generally offset by the translation of our subsidiaries who have the corresponding reinsurance-related balances within their own functional currencies, whereby such effects are translated to other comprehensive income, yielding a much lower net impact on total comprehensive income and equity.

For the three months ended September 30, 2025 and 2024, offsetting foreign exchange losses of $2.1 million and $5.5 million were recognized in other comprehensive income related to foreign currency translation adjustments. For the nine months ended September 30, 2025, offsetting foreign exchange gains of $8.2 million were recognized in other comprehensive income related to foreign currency translation adjustments, compared to foreign exchange losses of $2.1 million for the same period in 2024. Also included were $1.5 million of losses for the three months ended September 30, 2025 and $4.2 million of gains for the nine months ended September 30, 2025 related to foreign exchange impacts related to unrealized gains (losses) on fixed maturity securities.

See "Foreign Exchange Currency Risk" below for further information regarding how we mitigate risks resulting from foreign exchange currency fluctuations.

***Other Expenses***

Other expenses were $45.6 million and $70.6 million for the three and nine months ended September 30, 2025, respectively, representing increases of $37.6 million and $48.2 million compared to the same periods in 2024 of $8.0 million and $22.4 million, respectively. The year-over-year increases were driven primarily by a $25 million termination fee payable to Altamont related to a then-existing management services agreement, Mission profit interests expense, and increases in professional costs related to corporate development activities which includes expenses specifically related to our recently completed IPO, which were $4.3 million and $5.0 million for the three and nine months ended September 30, 2025, respectively.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** | **2025** | **2024** |
| System development non-operating costs | $5.2 | $2.5 | $13.4 | $11.8 |
| Professional costs related to corporate development and capital raise activities | 12.0 | 4.3 | 21.7 | 8.5 |
| Mission profit interests expense | 2.4 |  | 8.4 |  |
| Managed services agreement termination fee payable to Altamont | 25.0 |  | 25.0 |  |
| Individually insignificant costs | 1.0 | 1.2 | 2.1 | 2.1 |
| **Total other expenses** | $**45.6** | $**8.0** | $**70.6** | $**22.4** |

---

***Income Tax Expense***

Income tax expense was $9.5 million and $26.4 million for the three and nine months ended September 30, 2025 and 2024, respectively, representing increases of $17.6 million and $19.7 million compared to the same periods in 2024. Our consolidated effective tax rates ("ETRs") were (0.7)% and (623.1)%, respectively, for the three months ended September 30, 2025 and 2024, compared to (2.0)% and 74.4%, respectively for the nine months ended September 30, 2025 and 2024. However, the comparability of our tax expense and effective tax rates is often challenged due to the mix of taxable income subject to tax in certain jurisdictions, losses incurred in zero tax rate jurisdictions and valuation allowances offsetting available carry-forward losses in certain jurisdictions. Furthermore, the effective tax rate in the current period is impacted by certain discrete items related to non-deductible profits interest distribution expense and termination fee costs incurred in connection with our recent IPO and gains from the our revaluation of other investments under the measurement alternative.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

In March 2025, the Board of Directors of Accelerant Holdings and certain intermediary holding companies (together, the "Holding Companies") approved a change in the Holding Companies' tax residency from the Cayman Islands to the UK. Upon becoming UK tax residents, the Holding Companies began to benefit from operational efficiencies including, but not limited to, lower withholding tax rates applicable to dividend distributions from certain US subsidiaries under the US-UK tax treaty. In addition, the aggregate income (loss) of the Holding Companies became subject to UK income tax effective as of the March 2025 date of change to UK tax residency. To the extent that the Holding Companies have incremental income it will generate additional UK tax expense and, conversely, to the extent that there are any incremental losses, income tax benefits will be generated to the extent that there is current or projected taxable income available in our UK operations. Over the remainder of 2025, we expect incremental benefits to emerge due to the Holding Companies' projected expense base and, therefore, our effective tax rate ("ETR") for the year ended December 31, 2025 is expected to fall below those reported in previous years when such expenses were incurred in the Cayman Islands (a zero tax rate jurisdiction).

The relationship of our income tax expense to pre-tax income (loss) is atypical because our taxable income has predominately been generated in the US, UK, Ireland, and Puerto Rico resulting in income tax expense in those jurisdictions (entities in such jurisdictions are referred to as "tax-paying entities").

Meanwhile, we have incurred operating losses in zero tax rate jurisdictions (such as in our corporate and reinsurance entities in the Cayman Islands) resulting in no income tax benefit. We have also incurred pre-tax operating losses in Belgium and other jurisdictions where we have generated cumulative operating losses; however, in each of those cases, a valuation allowance has been recorded against the corresponding deferred tax assets (entities in these two types of jurisdictions are referred to as "non-tax paying entities").

Taxable losses in one jurisdiction generally cannot be applied to offset earnings in another. In certain other jurisdictions, losses in one entity may not be used to offset taxable income generated by another entity in that same jurisdiction.

The composition of our ETRs among our tax-paying and non-tax paying entities, which demonstrates the non-tax paying entities' effect on the total ETR, for the three months ended September 30, 2025 and 2024 were as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30, 2025** | **Three Months Ended<br>September 30, 2025** | **Three Months Ended<br>September 30, 2025** | **Three Months Ended<br>September 30, 2025** | **Three Months Ended<br>September 30, 2024** | **Three Months Ended<br>September 30, 2024** | **Three Months Ended<br>September 30, 2024** |
| ***(in millions)*** | **Tax-paying entities** | **Profits interests and termination fee expenses** | **Non-tax paying entities** | **Total** | **Tax-paying entities** | **Non-tax paying entities** | **Total** |
| (Loss) income before income taxes | $44.7 | $(1404.7) | $2.5 | $(1357.5) | $33.1 | $(31.8) | $1.3 |
| Income tax (expense) benefit | (9.5) |  |  | (9.5) | 8.1 |  | 8.1 |
| **Effective tax rate** | **21.3%** | **—** | **—** | **(0.7)%** | **(24.5)%** | **—** | **(623.1)%** |

---

The composition of our ETRs among our tax-paying and non-tax paying entities, which demonstrates the non-tax paying entities' effect on the total ETR, for the nine months ended September 30, 2025 and 2024 were as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended<br>September 30, 2025** | **Nine Months Ended<br>September 30, 2025** | **Nine Months Ended<br>September 30, 2025** | **Nine Months Ended<br>September 30, 2025** | **Nine Months Ended<br>September 30, 2024** | **Nine Months Ended<br>September 30, 2024** | **Nine Months Ended<br>September 30, 2024** |
| ***(in millions)*** | **Tax-paying entities** | **Profits interests and termination fee expenses** | **Non-tax paying entities** | **Total** | **Tax-paying entities** | **Non-tax paying entities** | **Total** |
| (Loss) income before income taxes | $141.7 | $(1404.7) | $(56.7) | $(1319.7) | $104.4 | $(95.4) | $9.0 |
| Income tax (expense) benefit | (26.4) |  |  | (26.4) | (6.7) |  | (6.7) |
| **Effective tax rate** | **18.6%** | **—** | **—** | **(2.0)%** | **6.4%** | **—** | **74.4%** |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

The effective tax rates for the three and nine months ended September 30, 2025 calculated excluding the nondeductible profits interest and termination fee expenses would have been 20.1% and 31.1%, respectively.

***Enactment of new US tax legislation***

On July 4, 2025, the US enacted the budget reconciliation package H.R.1, commonly referred to as the One Big Beautiful Bill Act ("OBBBA"), which includes a number of income tax provisions, among others. The Company is still analyzing any potential impact of the tax provisions in the OBBBA, but does not expect these provisions to have a material impact on the Company's results from operations.

**Segment Information**

We have three reportable segments, which align to the nature of the services we offer:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Exchange Services*** – Our Exchange Services segment includes the fees paid by Risk Exchange Insurers and Accelerant Underwriting for sourcing, managing and monitoring the portfolio of business written by Members reduced by the expenses associated with providing these services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***MGA Operations*** – Our MGA Operations segment includes the fees earned by Mission Members and Owned Members, predominantly for originating and underwriting a portfolio of insurance policies, reduced by the expenses associated with providing those services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Underwriting*** – Our Underwriting segment includes the revenue from net earned premium, investment income and the ceding commission paid to us by our third-party reinsurers and institutional investors, reduced by net incurred losses, the amortization of DAC and the general and administrative costs of operating our insurance and reinsurance companies.

Corporate functions, including holding company expenses, are included in Corporate and Other and our consolidation and eliminations adjustments for intersegment activity are shown separately from our reportable segments.

We consider the segment presentations of our Exchange Services, MGA Operations and Underwriting segments prior to elimination to be the best way to evaluate our business and how these business components would be presented if they were standalone operations. Such presentation is also representative of the results that would be generated from third parties as we build additional third-party insurance relationships through our Risk Exchange.

The following includes the financial results of our three reportable segments for the three months ended September 30, 2025 and 2024. Corporate functions and certain other businesses and operations are included in Corporate and Other.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total Segments** | **Corporate and Other** <sup>(1)</sup> | **Consolidation and elimination adjustments** | **Total** |
| **Revenues** | | | | | | | |
| Ceding commission income <sup>(2)</sup> | $— | $— | $29 | $29 | $— | $63.3 | $92.3 |
| Direct commission income |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Affiliated entities | 61.1 | 28.5 |  | 89.6 |  | (89.6) |  |
| &nbsp;&nbsp;Unaffiliated entities | 22.8 | 20.6 |  | 43.4 |  |  | 43.4 |
| Net earned premiums | *—* |  | 82.1 | 82.1 |  |  | 82.1 |
| Net investment income | 1.1 | 1.0 | 6.1 | 8.2 | 1.9 |  | 10.1 |
| Net realized gains on investments |  | 3.1 | 0.4 | 3.5 |  |  | 3.5 |
| Net unrealized gains on investments |  | 27.6 |  | 27.6 | 8.4 |  | 36.0 |
| **Segment revenues** | **85.0** | **80.8** | **117.6** | **283.4** | **10.3** | **(26.3)** | **267.4** |
| Losses and loss adjustment expenses |  |  | 50.8 | 50.8 |  |  | 50.8 |
| Amortization of deferred acquisition costs |  |  | 34.9 | 34.9 |  | (12.1) | 22.8 |
| General and administrative expenses <sup>(3) (4) (5)</sup> | 25.8 | 35.4 | 14.3 | 75.5 | 23.6 | (10.3) | 88.8 |
| **Adjusted EBITDA** | $**59.2** | $**45.4** | $**17.6** | $**122.2** | $**(13.3)** | $**(3.9)** | $**105.0** |
| Interest expenses |  |  |  |  |  |  | (2.6) |
| Depreciation and amortization |  |  |  |  |  |  | (10.0) |
| Profits interest distribution expenses |  |  |  |  |  |  | (1379.7) |
| Share-based compensation expenses <sup>(5)</sup> |  |  |  |  |  |  | (27.0) |
| Net foreign exchange gains |  |  |  |  |  |  | 2.4 |
| Other expenses <sup>(6)</sup> |  |  |  |  |  |  | (45.6) |
| **Loss before income taxes** |  |  |  |  |  |  | $**(1357.5)** |

---

<sup>(1)</sup> Corporate and Other includes shared services and other activities, which represent business activities that do not meet the definition of a reportable segment.

<sup>(2)</sup> Ceding commission income of our Underwriting segment includes the effect of sliding scale adjustments based on actual loss experience. For further information on sliding scale commission adjustments, refer to Note 8 to our condensed consolidated financial statements included herein.

<sup>(3)</sup> General and administrative expenses is comprised of employee compensation and benefits, consulting and professional fees and all other administrative expenses. The composition of such amounts by each reportable segment was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total** |
| Employee compensation and benefits | $18.1 | $22.7 | $6.9 | $47.7 |
| Consulting and professional fees | 4.3 | 3.5 | 2.5 | 10.3 |
| Other administrative expenses | 3.4 | 9.2 | 4.9 | 17.5 |
| **Total general and administrative expenses** | $**25.8** | $**35.4** | $**14.3** | $**75.5** |

---

<sup>(4)</sup> Share-based compensation expenses are included in "General and administrative expenses" within the condensed consolidated statements of operations.

<sup>(5)</sup> The consolidation and elimination adjustments for general and administrative expenses consist of expenses attributable to Exchange Services and MGA Operations that form components of acquisition costs of insurance policies that would be capitalized in consolidation, which are offset by adjustments as components of the other consolidation and elimination adjustments.

<sup>(6)</sup> Other expenses for the three months ended September 30, 2025 consist of $25.0 million termination fee for our former management services agreement contract with Altamont Capital, $12.0 million of professional costs related to corporate development and capital raise activities (including $4.3 million specifically related to our IPO that were not eligible for capitalization as issuance costs), $5.2 million of system development non-operating costs, $2.4 million of Mission profits sharing expense and $1.0 million of other individually insignificant costs.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total Segments** | **Corporate and Other** <sup>(1)</sup> | **Consolidation and elimination adjustments** | **Total** |
| **Revenues** | | | | | | | |
| Ceding commission income <sup>(2)</sup> | $— | $— | $15.4 | $15.4 | $— | $46.7 | $62.1 |
| Direct commission income |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Affiliated entities | 55.5 | 32.3 |  | 87.8 |  | (87.8) |  |
| &nbsp;&nbsp;Unaffiliated entities | 7.7 | 9.5 |  | 17.2 |  |  | 17.2 |
| Net earned premiums | *—* |  | 59.3 | 59.3 |  |  | 59.3 |
| Net investment income | 0.4 | 1.1 | 8.9 | 10.4 | 0.6 |  | 11.0 |
| Net realized gains on investments |  |  | 0.1 | 0.1 |  |  | 0.1 |
| Net unrealized gains on investments |  |  |  |  | 4.0 |  | 4.0 |
| **Segment revenues** | **63.6** | **42.9** | **83.7** | **190.2** | **4.6** | **(41.1)** | **153.7** |
| Losses and loss adjustment expenses |  |  | 39.7 | 39.7 |  |  | 39.7 |
| Amortization of deferred acquisition costs |  |  | 30.1 | 30.1 |  | (7.0) | 23.1 |
| General and administrative expenses <sup>(3) (4)</sup> | 18.0 | 25.2 | 31.5 | 74.7 | 6.7 | (16.6) | 64.8 |
| **Adjusted EBITDA** | $**45.6** | $**17.7** | $**(17.6)** | $**45.7** | $**(2.1)** | $**(17.5)** | $**26.1** |
| Interest expenses |  |  |  |  |  |  | (3.1) |
| Depreciation and amortization |  |  |  |  |  |  | (5.8) |
| Share-based compensation expenses <sup>(5)</sup> | Share-based compensation expenses <sup>(5)</sup> |  |  |  |  |  | (2.5) |
| Net foreign exchange losses |  |  |  |  |  |  | (5.4) |
| Other expenses <sup>(6)</sup> |  |  |  |  |  |  | (8.0) |
| **Income before income taxes** |  |  |  |  |  |  | $**1.3** |

---

<sup>(1)</sup> Corporate and Other includes shared services and other activities, which represent business activities that do not meet the definition of a reportable segment.

<sup>(2)</sup> Ceding commission income of our Underwriting segment includes the effect of sliding scale adjustments based on actual loss experience. For further information on sliding scale commission adjustments, refer to Note 8 to our condensed consolidated financial statements included herein.

<sup>(3)</sup> General and administrative expenses is comprised of employee compensation and benefits, consulting and professional fees and all other administrative expenses. The composition of such amounts by each reportable segment was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total** |
| Employee compensation and benefits | $12.3 | $18.9 | $11.1 | $42.3 |
| Consulting and professional fees | 3.2 | 1.9 | 3.1 | 8.2 |
| Other administrative expenses | 2.5 | 4.4 | 17.3 | 24.2 |
| **Total general and administrative expenses** | $**18.0** | $**25.2** | $**31.5** | $**74.7** |

---

<sup>(4)</sup> The consolidation and elimination adjustments for general and administrative expenses consist of expenses attributable to Exchange Services and MGA Operations that form components of acquisition costs of insurance policies that would be capitalized in consolidation, which are offset by adjustments as components of the other consolidation and elimination adjustments.

<sup>(5)</sup> Share-based compensation expenses are included in "General and administrative expenses" within the condensed consolidated statements of operations.

<sup>(6)</sup> Other expenses for the three months ended September 30, 2024 consist of $2.5 million of system development non-operating costs, $4.3 million of professional costs related to corporate development and capital raise activities and $1.2 million of other individually insignificant costs.

The following includes the financial results of our three reportable segments for the nine months ended September 30, 2025 and 2024. Corporate functions and certain other businesses and operations are included in Corporate and Other.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total Segments** | **Corporate and Other** <sup>(1)</sup> | **Consolidation and elimination adjustments** | **Total** |
| **Revenues** | | | | | | | |
| Ceding commission income <sup>(2)</sup> | $— | $— | $77.8 | $77.8 | $— | $186.8 | $264.6 |
| Direct commission income |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Affiliated entities | 189.1 | 99.0 |  | 288.1 |  | (288.1) |  |
| &nbsp;&nbsp;Unaffiliated entities | 49.6 | 56.1 |  | 105.7 |  |  | 105.7 |
| Net earned premiums | *—* |  | 215.7 | 215.7 |  |  | 215.7 |
| Net investment income | 2.8 | 2.8 | 25.8 | 31.4 | 3.7 |  | 35.1 |
| Net realized gains on investments |  | 5.2 | 1.0 | 6.2 |  |  | 6.2 |
| Net unrealized gains on investments |  | 27.1 |  | 27.1 | 10.1 |  | 37.2 |
| **Segment revenues** | **241.5** | **190.2** | **320.3** | **752.0** | **13.8** | **(101.3)** | **664.5** |
| Losses and loss adjustment expenses |  |  | 147.3 | 147.3 |  |  | 147.3 |
| Amortization of deferred acquisition costs |  |  | 87.6 | 87.6 |  | (29.5) | 58.1 |
| General and administrative expenses <sup>(3) (4) (5)</sup> | 79.6 | 100.4 | 40.6 | 220.6 | 54.5 | (27.3) | 247.8 |
| **Adjusted EBITDA** | $**161.9** | $**89.8** | $**44.8** | $**296.5** | $**(40.7)** | $**(44.5)** | $**211.3** |
| Interest expenses |  |  |  |  |  |  | (7.7) |
| Depreciation and amortization |  |  |  |  |  |  | (25.7) |
| Profits interest distribution expenses |  |  |  |  |  |  | (1379.7) |
| Share-based compensation expenses <sup>(5)</sup> |  |  |  |  |  |  | (32.4) |
| Net foreign exchange losses |  |  |  |  |  |  | (14.9) |
| Other expenses <sup>(6)</sup> |  |  |  |  |  |  | (70.6) |
| **Loss before income taxes** |  |  |  |  |  |  | $**(1319.7)** |

---

<sup>(1)</sup> Corporate and Other includes shared services and other activities, which represent business activities that do not meet the definition of a reportable segment.

<sup>(2)</sup> Ceding commission income of our Underwriting segment includes the effect of sliding scale adjustments based on actual loss experience. For further information on sliding scale commission adjustments, refer to Note 8 to our condensed consolidated financial statements included herein.

<sup>(3)</sup> General and administrative expenses is comprised of employee compensation and benefits, consulting and professional fees and all other administrative expenses. The composition of such amounts by each reportable segment was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total** |
| Employee compensation and benefits | $53.6 | $67.9 | $20.0 | $141.5 |
| Consulting and professional fees | 13.4 | 11.9 | 8.2 | 33.5 |
| Other administrative expenses | 12.6 | 20.6 | 12.4 | 45.6 |
| **Total general and administrative expenses** | $**79.6** | $**100.4** | $**40.6** | $**220.6** |

---

<sup>(4)</sup> The consolidation and elimination adjustments for general and administrative expenses consist of expenses attributable to Exchange Services and MGA Operations that form components of acquisition costs of insurance policies that would be capitalized in consolidation, which are offset by adjustments as components of the other consolidation and elimination adjustments.

<sup>(5)</sup> Share-based compensation expenses are included in "General and administrative expenses" within the condensed consolidated statements of operations.

<sup>(6)</sup> Other expenses for the nine months ended September 30, 2025 consist of a $25.0 million termination fee for our former management services agreement contract with Altamont Capital, $13.4 million of system development non-operating expenses, $21.7 million of professional costs related to corporate development and capital raise activities (including $5.0 million specifically related to our IPO that were not eligible for capitalization as issuance costs), $8.4 million of Mission profits sharing expense and $2.1 million of individually insignificant costs.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total Segments** | **Corporate and Other** <sup>(1)</sup> | **Consolidation and elimination adjustments** | **Total** |
| **Revenues** | | | | | | | |
| Ceding commission income <sup>(2)</sup> | $— | $— | $65.0 | $65.0 | $— | $121.2 | $186.2 |
| Direct commission income |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Affiliated entities | 143.4 | 76.6 |  | 220.0 |  | (220.0) |  |
| &nbsp;&nbsp;Unaffiliated entities | 14.8 | 24.1 |  | 38.9 |  |  | 38.9 |
| Net earned premiums | *—* |  | 155.5 | 155.5 |  |  | 155.5 |
| Net investment income | 0.7 | 2.9 | 23.3 | 26.9 | 0.7 |  | 27.6 |
| Net realized gains on investments |  |  | 0.5 | 0.5 |  |  | 0.5 |
| Net unrealized (losses) gains on investments |  |  | (0.8) | (0.8) | 4.0 |  | 3.2 |
| **Segment revenues** | **158.9** | **103.6** | **243.5** | **506.0** | **4.7** | **(98.8)** | **411.9** |
| Losses and loss adjustment expenses |  |  | 111.6 | 111.6 |  |  | 111.6 |
| Amortization of deferred acquisition costs |  |  | 77.4 | 77.4 |  | (15.4) | 62.0 |
| General and administrative expenses <sup>(3) (4) (5)</sup> | 45.7 | 76.6 | 70.2 | 192.5 | 20.6 | (41.4) | 171.7 |
| **Adjusted EBITDA** | $**113.2** | $**27.0** | $**(15.7)** | $**124.5** | $**(15.9)** | $**(42.0)** | $**66.6** |
| Interest expenses |  |  |  |  |  |  | (9.1) |
| Depreciation and amortization |  |  |  |  |  |  | (16.2) |
| Share-based compensation expenses <sup>(5)</sup> |  |  |  |  |  |  | (6.3) |
| Net foreign exchange losses |  |  |  |  |  |  | (3.6) |
| Other expenses <sup>(6)</sup> |  |  |  |  |  |  | (22.4) |
| **Income before income taxes** |  |  |  |  |  |  | $**9.0** |

---

<sup>(1)</sup> Corporate and Other includes shared services and other activities, which represent business activities that do not meet the definition of a reportable segment.

<sup>(2)</sup> Ceding commission income of our Underwriting segment includes the effect of sliding scale adjustments based on actual loss experience. For further information on sliding scale commission adjustments, refer to Note 8 to our condensed consolidated financial statements included herein.

<sup>(3)</sup> General and administrative expenses is comprised of employee compensation and benefits, consulting and professional fees and all other administrative expenses. The composition of such amounts by each reportable segment was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **Exchange Services** | **MGA Operations** | **Underwriting** | **Total** |
| Employee compensation and benefits | $31.5 | $54.8 | $31.1 | $117.4 |
| Consulting and professional fees | 7.5 | 5.2 | 10.6 | 23.3 |
| Other administrative expenses | 6.7 | 16.6 | 28.5 | 51.8 |
| **Total general and administrative expenses** | $**45.7** | $**76.6** | $**70.2** | $**192.5** |

---

<sup>(4)</sup> The consolidation and elimination adjustments for general and administrative expenses consist of expenses attributable to Exchange Services and MGA Operations that form components of acquisition costs of insurance policies that would be capitalized in consolidation, which are offset by adjustments as components of the other consolidation and elimination adjustments.

<sup>(5)</sup> Share-based compensation expenses are included in "General and administrative expenses" within the condensed consolidated statements of operations.

<sup>(6)</sup> Other expenses for the nine months ended September 30, 2024 consists of $11.8 million of system development non-operating costs, $8.5 million of professional costs related to corporate development and capital raise activities and $2.1 million of individually insignificant costs.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**<u>Comparison of the Three and Nine Months Ended September 30, 2025 and 2024</u>**

***Exchange Services***

As noted above, our segment results are presented prior to elimination and, as such, a portion of Exchange Services direct commission income revenue was generated from transactions with Accelerant Underwriting, which is eliminated upon consolidation. Additionally, a portion of Exchange Services revenue is generated by activity with MGA Operations that is also eliminated upon consolidation, as further described below.

Exchange Services direct commission income from Accelerant-affiliated entities accounted for 73% and 79% of the segment's direct commission income for the three and nine months ended September 30, 2025, respectively, compared to 88% and 91% for the three and nine months ended September 30, 2024. The decrease year-over-year represents growth in direct commission income from unaffiliated entities.

Exchange Services revenue grew by $21.4 million (or 34%) to $85.0 million for the three months ended September 30, 2025 and by $82.6 million (or 52%) to $241.5 million for the nine months ended September 30, 2025, as compared to the same periods in 2024. This growth is primarily driven by increases in direct commission income, supported by an increase in Members from 204 at September 30, 2024 to 265 at September 30, 2025 and Net Revenue Retention of 135% among continuing Members. As a result, Exchange Written Premium increased to $1.04 billion for the three months ended September 30, 2025 (from $888.4 million in the comparative period in prior year) and to $3.10 billion for the nine months ended September 30, 2025 (from $2.23 billion in the comparative period in prior year).

Third-Party Direct Written Premium from our 15 Risk Exchange Insurers comprised 32% of the total Exchange Written Premium for the three months ended September 30, 2025 and 26% for the nine months ended September 30, 2025, an increase from 21% and 14% from the same periods in 2024, respectively. The year-over-year acceleration in Third-Party Direct Written Premium was driven primarily by the ramping of Risk Exchange Insurers onboarded during 2024. Revenues are recognized in accordance with written premium when the performance obligations underlying the services have been satisfied. The increase in direct commission income from affiliated entities accounted for $5.6 million and $45.7 million of the year-over-year growth in revenue, for three and nine months ended September 30, 2025, respectively, compared to the same periods in 2024.

Hadron, one of our Risk Exchange Insurers which is sponsored by Altamont Capital Partners, insured $179.8 million and $472.5 million of Exchange Written Premium during the three and nine months ended September 30, 2025, respectively. As other third-party insurers increase their participation on the Risk Exchange, Hadron's share of Third-Party Direct Written Premium has declined throughout 2025 from 67% at March 31, 2025, to 58% at June 30, 2025, and 54% at September 30, 2025. For the three and nine months ended September 30, 2024, Hadron insured $75.8 million and $102.7 million of Exchange Written Premium, respectively.

General and administrative expenses for the segment increased to $25.8 million and $79.6 million for the three and nine months ended September 30, 2025, respectively, over the respective comparative periods in the prior year of $18.0 million and $45.7 million. These increases were largely driven by the expansion and scaling to support the growth of the Risk Exchange.

We added to the talent and headcount of our data science, product and technology teams to expand our platform offering. We expect the expenses associated with these areas will not vary directly with the size of the Exchange Written Premium once we have built the desired capabilities. We also added to our distribution, underwriting and claims teams, which are expected to grow more in line with the overall number of Members or size of the portfolio.

Adjusted EBITDA was $59.2 million and $161.9 million for three and nine months ended September 30, 2025, respectively, representing increases of $13.6 million and $48.7 million compared to the same periods in 2024. This growth was driven by increased Exchange Written Premium volumes of $154.5 million (or 17%) and $871.4 million (or 39%) for the three and nine months ended September 30, 2025, respectively, driven by stable underlying margins and the aforementioned ramping of Risk Exchange Insurers onboarded during 2024, partially offset by higher year-over-year Member profit commission accruals, along with the increase in expenses noted above.

The year-over-year growth rates for the three- and nine-month periods reflect the impact of certain Member movements that adversely impacted the comparison of the Q3 2025 Exchange Written Premium Growth Rate of 17% to the preceding periods. Specifically, at the end of the second quarter of 2025, we put into runoff a Member with below-average unit economics that had historically written $50 million to $55 million of premium per quarter on the Risk Exchange. In the third quarter of 2024, we onboarded a new Member with significant written built-up premium in its first quarter with us (approximating double its usual per quarter average), whereas that Member has since averaged approximately $30 million of premium per quarter. Excluding those factors, Exchange Written Premium grew by $224.2 million (or 29%) and $879.6 million (or 44%) for the three and nine months ended September 30, 2025, respectively.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

The Adjusted EBITDA margin was 70% and 67% for the three and nine months ended September 30, 2025, down from 72% and 71% from the respective comparative periods in the prior year. These declines were primarily driven by increased expenses related to investments we are making in our Risk Exchange capabilities.

***MGA Operations***

As noted above, our segment results are presented prior to elimination and, as such, a portion of MGA Operations direct commission income revenue was generated from transactions between Accelerant-affiliated entities, which are eliminated upon consolidation. MGA Operations direct commission income from Accelerant Underwriting accounted for 58% and 64% of the segment's direct commission income for the three and nine months ended September 30, 2025, respectively, compared to 77% and 76% for the same periods in 2024.

MGA Operations revenue grew $37.9 million to $80.8 million for the three months ended September 30, 2025 and by $86.6 million to $190.2 million for the nine months ended September 30, 2025. These increases were primarily driven by growth in direct commission income (increases of $7.3 million and $54.4 million, respectively, from the three and nine months ended September 30, 2024). As of September 30, 2025, we had 45 total Members in MGA Operations consisting of 15 Owned Members and 30 Mission Members. Revenues are recognized in accordance with written premium when the performance obligations underlying the services have been satisfied.

Revenue for the nine months ended September 30, 2025 includes $30.3 million of investment realized gains and unrealized gains following observable price change related to an owned MGA held as an other investment that we account for under the measurement alternative. Refer to Note 4 to our interim condensed consolidated financial statements for additional information.

MGA Operations Adjusted EBITDA was $45.4 million and $89.8 million for the three and nine months ended September 30, 2025, respectively, representing increases of $27.7 million and $62.8 million, respectively, compared to the same periods in 2024.

For the three months ended September 30, 2025, the increase in Adjusted EBITDA was primarily driven by the $30.3 million increase in net realized and unrealized gains during the third quarter of 2025, primarily driven by the aforementioned investment gains, and an increase in direct commission income of $7.3 million, which included a $3.2 million increase from Mission Underwriters, as well as an increase from our Owned Members of $4.1 million primarily due to organic growth, partially offset by a $10.2 million increase in general and administrative expenses. For the nine months ended September 30, 2025, the increase in Adjusted EBITDA was primarily driven by an increase in direct commission income of $54.4 million, which included an $36.5 million increase from Mission Underwriters, as well as an increase from our Owned Members of $17.9 million primarily due to organic growth, and an increase in unrealized gains of $27.1 million, primarily driven by the aforementioned investment gains, partially offset by a $23.8 million increase in general and administrative expenses.

For both periods, the increases in general and administrative expenses were driven by the continued investment in Mission Underwriters which contributed $7.5 million and $16.5 million, respectively, of the year-over-year increases from the three and nine months ended September 30, 2024, primarily due to investments in newly acquired owned MGAs.

Adjusted EBITDA margin for the segment increased to 56% and 47%, respectively, for the three and nine months ended September 30, 2025, up from 41% and 26%, respectively, from the same periods in 2024. The improvements were driven by higher direct commission income and unrealized gains, partially offset by increased general and administrative expenses as the segment continues to scale its operations.

***Underwriting***

The Underwriting segment generated revenues of $117.6 million and $320.3 million for the three and nine months ended September 30, 2025, respectively, representing growth of 41% and 32%, respectively, compared to revenues of $83.7 million and $243.5 million for the three and nine months ended September 30, 2024, respectively.

For the three months ended September 30, 2025, net earned premium increased by $22.8 million to $82.1 million due to our gross earned premium growth during the three months ended September 30, 2025. Ceding commission income increased by $13.6 million over the comparative period as we continued to grow our premium base and the amount ceded to reinsurers, as well as improvement in net sliding scale commission adjustments resulting from the improved loss experience of covered insurance contracts in the US as compared to the same period in 2024.

For the nine months ended September 30, 2025, net earned premium increased by $60.2 million to $215.7 million due to our gross written premium growth over the preceding periods. Revenues also benefited from a $2.5 million increase in net investment income due to year-over-year growth in average investment portfolio size.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

The gross loss ratio on the gross premiums earned was 50.1% and 51.2% for the three and nine months ended September 30, 2025, respectively, compared to 51.8% and 52.8% for the three and nine months ended September 30, 2024. The corresponding net loss ratios (after impacts of our reinsurance programs) were 61.9% and 68.3% for the three and nine months ended September 30, 2025, compared to 66.9% and 71.8% for the same periods in 2024. Our net loss ratio differs from the gross loss ratio due to decisions that we make regarding the amount of excess of loss reinsurance secured (since this will reduce the amount of retained premiums we have). The decision to engage such reinsurance, which, in most cases, inures to the benefit of our Risk Capital Partners, supports our management of downside risk to large losses. While the cost of the excess of loss reinsurance that we incur is reflected in our earned premiums, any reimbursements for such excess of loss reinsurance in the form of the ceding commissions we receive from Risk Capital Partners are not reflected in either our gross or net loss ratio.

The components of our Underwriting segment gross and net loss ratios are set forth in the tables below for three months ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| ***(in millions)*** | **Gross** | **Ceded - Quota Share** | **Ceded - Excess of Loss & Other** | **Net** |
| Earned premium | $782.7 | $(675.0) | $(25.6) | $82.1 |
| Losses and loss adjustment expenses <sup>(1)</sup> | 392.2 | (339.9) | (1.5) | 50.8 |
| **Loss ratio** | **50.1%** | **50.4%** | **5.9%** | **61.9%** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| ***(in millions)*** | **Gross** | **Ceded - Quota Share** | **Ceded - Excess of Loss & Other** | **Net** |
| Earned premium | $599.5 | $(508.1) | $(32.1) | $59.3 |
| Losses and loss adjustment expenses | 310.6 | (267.4) | (3.5) | 39.7 |
| **Loss ratio** | **51.8%** | **52.6%** | **10.9%** | **66.9%** |

---

The components of our Underwriting segment gross and net loss ratios are set forth in the tables below for the nine months ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| ***(in millions)*** | **Gross** | **Ceded - Quota Share** | **Ceded - Excess of Loss & Other** | **Net** |
| Earned premium | $2284.8 | $(1980.9) | $(88.2) | $215.7 |
| Losses and loss adjustment expenses | 1170.4 | (1023.3) | 0.2 | 147.3 |
| **Loss ratio** | **51.2%** | **51.7%** | **(0.2)%** | **68.3%** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| ***(in millions)*** | **Gross** | **Ceded - Quota Share** | **Ceded - Excess of Loss & Other** | **Net** |
| Earned premium | $1564.3 | $(1341.8) | $(67.0) | $155.5 |
| Losses and loss adjustment expenses | 826.5 | (710.3) | (4.6) | 111.6 |
| **Loss ratio** | **52.8%** | **52.9%** | **6.9%** | **71.8%** |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

Adjusted EBITDA for the Underwriting segment was $17.6 million and $44.8 million for the three and nine months ended September 30, 2025, respectively, representing relative increases of $34.9 million and $60.5 million, respectively from the comparative periods in 2024 which had Adjusted EBITDA losses. These improvements were driven by the aforementioned increase in revenue and decreases in operating expenses due to improved operating leverage as the segment continues to reach operational maturity.

***Corporate and Other***

Corporate and Other includes the general and administrative expenses and investment results of our holding companies.

Adjusted EBITDA loss from Corporate and Other was $13.3 million and $40.7 million for the three and nine months ended September 30, 2025, respectively, representing increases of $11.2 million and $24.8 million as compared to the same periods in 2024. These increases were primarily driven by increased costs to support the growth of the business, as partially offset by aggregate increases in investment returns of $5.7 million and $9.1 million for the three and nine months ended September 30, 2025, respectively. The three and nine months ended September 30, 2025 includes a net unrealized gain of $8.4 million relating to an investment in a TPA.

***Consolidation and Elimination Adjustments***

As noted above, our business includes transactions that occur among our various segments. Our Accelerant-owned insurance companies within our Underwriting segment accounted for the majority of our Exchange Written Premium during the three and nine months ended September 30, 2025 and 2024 as we built out our business model and proved the value proposition for the connection of our Members and the Risk Exchange. We expect the amount of premium written with Risk Exchange Insurers to grow significantly over time. Similarly, Mission Members and Owned Members transact with our Risk Exchange in the sourcing of business. Our equity ownership interests in Mission Members and Owned Members allow us to participate in those commissions earned that otherwise would be paid to third parties or our Independent Members. The transactions among these entities must be eliminated in consolidation as they represent transactions among entities under common control. However, there are considerable benefits to these intercompany transactions, as we retain associated economics rather than incurring costs otherwise paid to third parties, thereby lowering our expense base.

The impacts to our financial statements can be observed in the consolidation and elimination adjustments column within our presentation of segments above. The following represents an explanation of the various components of activity for the three and nine months ended September 30, 2025 and 2024.

*Impacts to direct commission income for Exchange Services and MGA Operations*

Revenue generated from transactions between Accelerant-affiliated entities (including from Underwriting to Exchange Services and Exchange Services to MGA Operations) were $89.6 million and $288.1 million for the three and nine months ended September 30, 2025, respectively, compared to $87.8 million and $220.0 million for the same periods in 2024. These amounts were eliminated, reflected by a corresponding offsetting entry in the consolidation and elimination adjustments column above. We present the segment results on a standalone basis, as if they were transactions with third parties, to assess their individual performance as well as to derive insight on the results we expect in the future as more business is sourced from Risk Exchange Insurers.

*Impacts to ceding commission income and amortization of deferred acquisition costs*

The operating results of our Underwriting segment presented above include the full commissions paid to Exchange Services in the form of deferred acquisition costs. These costs are required to be capitalized and then amortized over the related policy term. Ceding commissions received from third-party reinsurers are first offset against the deferred acquisition costs for the business ceded, with any resulting excess ceding commissions amortized over the corresponding policy term as ceding commission income. These two factors result in the Underwriting segment incurring higher amortization of DAC expense and lower ceding commission income due to the presentation of the segment's operating results on a standalone basis. Commissions paid to affiliates are eliminated, resulting in lower consolidated deferred acquisition costs. These eliminations increased the amount of ceding commission income (adjustments to increase ceding commission income by $63.3 million and $186.8 million for the three and nine months ended September 30, 2025, respectively, compared to $46.7 million and $121.2 million for the same periods in 2024, while the amortization of deferred acquisition costs were decreased by $12.1 million and $29.5 million for the three and nine months ended September 30, 2025, compared to $7.0 million and $15.4 million for the same periods in 2024.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

*Impacts to general and administrative expenses*

There are costs eliminated in consolidation which consist of expenses attributable to Exchange Services and MGA Operations that form components of acquisition costs of insurance policies that would be capitalized in consolidation, which are offset by adjustments as components of the other consolidation and elimination adjustments. These eliminations were $10.3 million and $27.3 million for the three and nine months ended September 30, 2025, respectively, compared to $16.6 million and $41.4 million for the same periods in 2024.

**Liquidity and Capital Resources**

***General***

Liquidity is a measure of a company's ability to generate cash flows sufficient to meet short-term and long-term cash requirements of its business operations. Accelerant Holdings' insurance and reinsurance operations are subject to regulation and supervision in each of the jurisdictions where they are domiciled and licensed to conduct business. See "Regulation." Generally, regulatory authorities have broad supervisory and administrative powers over such matters as licenses, standards of solvency, premium rates, policy forms, investments, security deposits, methods of accounting, form and content of financial statements, reserves for unpaid loss and LAE, reinsurance, minimum capital and surplus requirements, dividends and other distributions to shareholders, periodic examinations, and annual and other report filings. In general, such regulation is for the protection of policyholders rather than shareholders. Accelerant Holdings supports its liquidity needs with available liquid cash resources and short duration, high quality fixed income portfolios.

***Sources and uses of funds***

Accelerant Holdings is a holding company with no substantial operations of its own and its assets consist primarily of its investments in subsidiaries. Its cash needs primarily consist of the payment of corporate expenses, interest payments on senior notes and strategic investment opportunities (i.e., into MGA Operations). We may receive cash through (1) issuance of mezzanine equity, permanent equity or debt securities, (2) loans from banks, (3) corporate service fees from our Exchange Services, MGA Operations and Underwriting segments, (4) payments from subsidiaries pursuant to our consolidated tax allocation agreements, and (5) dividends from subsidiaries within the Exchange Services, MGA Operations and Underwriting segments. We may use the proceeds from these sources to support business growth, invest in Member MGAs and Mission Underwriters, pay taxes, and for other business purposes.

The Exchange Services and MGA Operations segments generate cash from net commission income from the services provided to both affiliates and third parties.

Cash generated by our insurance and reinsurance operating subsidiaries is used primarily to settle loss and LAE, reinsurance premiums, acquisition costs, interest expense, taxes, and general and administrative expenses. The underwriting segment generates liquidity, as premiums are received in advance of the time that losses are paid.

We file a consolidated federal income tax return for our US subsidiaries, and under our corporate tax allocation agreement, each participant is charged or refunded taxes according to the amount that the participant would have paid or received had it filed on a separate return basis with the Internal Revenue Service.

As of September 30, 2025, we had $2.55 billion in investments, cash, cash equivalents and restricted cash, compared to $1.88 billion as of December 31, 2024. As of September 30, 2025 we had $547.2 million within current accounts and money-market accounts of non-regulated entities, primarily our agencies servicing the Risk Exchange and holding companies, included within the total cash and investments, compared to $266.7 million as of December 31, 2024.

**Financial Condition**

***Equity***

As of September 30, 2025 and December 31, 2024 total equity was $703.8 million and $427.0 million, respectively. The change as of September 30, 2025 compared to December 31, 2024 was primarily due to $376.0 million related to the issuance of Class A common shares and net income excluding the profits interest expenses, as partially offset by $175.3 million related to the redemption of Class C convertible preference shares. As referenced previously, the profits interest charge of $1.38 billion that created an overall net loss was fully offset by a corresponding capital contribution, and therefore had no impact to net equity.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Cash, Cash Equivalents and Restricted Cash***

As of September 30, 2025 and December 31, 2024, we had cash and cash equivalents balances of $1.68 billion and $1.27 billion, respectively. As of September 30, 2025, we had restricted cash and cash equivalents balances of $71.9 million. Cash and cash equivalents are comprised of amounts in interest-bearing deposit accounts with financial institutions insured by the FDIC up to $250 thousand per account. Restricted cash and cash equivalents are comprised of cash and money market funds that have been contributed toward trusts. Generally, our cash and cash equivalents in interest-bearing deposit accounts may exceed FDIC insurance limits exposing us to credit risk in the event of default by the financial institutions. We believe the risk of loss from such an event of default is minimal, however, we periodically review the financial stability of these institutions.

***Investment Portfolio***

Our invested assets consist of fixed maturity securities, short-term investments, equity method investments, equity securities, and other investments. As of September 30, 2025, 82% of our investments were comprised of $721.9 million of available for sale fixed maturity securities. Also included in our investments were $64.8 million of short-term investments available for sale, at fair value, $81.7 million of other investments, and $9.4 million of equity method investments.

Our investment portfolio has consistently maintained high credit quality and short duration investments that are positioned for capital preservation. We primarily invest in liquid, short- and medium-term securities, investment-grade fixed income, bond fund investment vehicles with low duration and volatility with the primary objectives of matching assets with liabilities and covering near-term obligations. We limit our exposure to alternative investments. As of September 30, 2025, our cash and fixed income and short-term investments portfolio represented 96% of our total portfolio. 89% of our fixed income and short-term investments carried an S&P fixed income rating of A or higher, the balance of which was rated BB or higher, and maintained a duration of 2.6 years.

The following table summarizes the components of our total investments and cash, cash equivalents and restricted cash as of September 30, 2025 and December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| ***(in millions)*** | **Fair value** | **% of total** | **Fair value** | **% of total** |
| Fixed maturity securities | 721.9 | 28% | 479.5 | 25% |
| Short-term investments | 64.8 | 3% | 64.8 | 3% |
| Equity method investments | 9.4 | —% | 18.2 | 1% |
| Other investments | 81.7 | 3% | 45.3 | 2% |
| Cash, cash equivalents and restricted cash | 1675.9 | 66% | 1273.0 | 69% |
| **Total investments and cash, cash equivalents and restricted cash** | $**2553.7** | **100%** | $**1880.8** | **100%** |

---

*Fixed maturity securities and Short-term investments*

At September 30, 2025 and December 31, 2024, the fair values of fixed maturity and short-term investments were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| ***(in millions)*** | **Fair value** | **% of total** | **Fair value** | **% of total** |
| Corporate | $279.7 | 35% | $174.0 | 32% |
| US government and agency | 153.6 | 20% | 128.2 | 24% |
| Non-US government and agency | 234.4 | 30% | 158.6 | 29% |
| Residential mortgage-backed | 62.9 | 8% | 43.0 | 8% |
| Commercial mortgage-backed | 20.4 | 3% | 18.4 | 3% |
| Other asset-backed securities | 35.7 | 4% | 22.1 | 4% |
| **Total fixed maturity and short-term investments** | $**786.7** | **100%** | $**544.3** | **100%** |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

The following table summarizes the credit quality of fixed maturity and short-term investments as of September 30, 2025 and December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| **Rating** | **Fair value** | **% of total** | **Fair value** | **% of total** |
| AAA | $182.6 | 23% | $110.1 | 20% |
| AA | 366.8 | 47% | 276.1 | 51% |
| A | 147.2 | 19% | 92.6 | 17% |
| BBB | 89.5 | 11% | 65.5 | 12% |
| BB | $0.6 | —% | $— | —% |
| **Total fixed maturity and short-term investments** | $**786.7** | **100%** | $**544.3** | **100%** |

---

The amortized cost and fair values of fixed maturity and short-term investments by contractual maturity were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| ***(in millions)*** | **Amortized cost** | **Fair value** | **% of total** | **Amortized cost** | **Fair value** | **% of total** |
| Due in one year or less | $127.0 | $127.2 | 16% | $105.6 | $104.6 | 19% |
| Due after one year through five years | 456.9 | 460.9 | 59% | 277.0 | 275.0 | 51% |
| Due after five years through ten years | 78.9 | 79.1 | 10% | 76.4 | 75.0 | 14% |
| Due after ten years | 0.5 | 0.5 | —% | 6.5 | 6.2 | 1% |
| Residential mortgage-backed | 62.8 | 62.9 | 8% | 44.4 | 43.0 | 8% |
| Commercial mortgage-backed | 20.1 | 20.4 | 2% | 18.6 | 18.4 | 3% |
| Other asset-backed securities | 35.5 | 35.7 | 5% | 22.1 | 22.1 | 4% |
| **Total** | $**781.7** | $**786.7** | **100%** | $**550.6** | $**544.3** | **100%** |

---

**Cash Flows**

Our most significant source of cash inflow is from premiums received from our insureds, which, for most policies, we receive at the beginning of the coverage period. Our most significant cash outflow is for claims that arise when a policyholder incurs an insured loss. Because the payment of claims occurs after the receipt of the premium, with the potential for a multi-year timeline, we invest the cash in various investment securities that earn interest and dividends. We also use cash to pay commissions to brokers, as well as to pay for ongoing operating expenses such as salaries, consulting services and taxes. As described under "Reinsurance" below, we use reinsurance to manage the risk that we take on our policies. We cede, or pay out, part of the premiums we receive to our reinsurers and collect cash back when losses subject to our reinsurance coverage are paid.

Our cash flows for the nine months ended September 30, 2025 and 2024 were:

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| ***(in millions)*** | **2025** | **2024** |
| Cash, cash equivalents and restricted cash provided by (used in): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating activities | $383.2 | $543.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investing activities | (238.3) | (231.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing activities | 209.5 | (3.4) |
| Effect of foreign currency rate change on cash, cash equivalents and restricted cash | 48.5 | 0.3 |
| **Net change in cash, cash equivalents, and restricted cash** | $**402.9** | $**309.6** |

---

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Operating Activities***

We believe that claim payments will be sufficiently supported by annual positive cash flows from operating activities. However, should operating cash flows be insufficient to fund claim payment obligations, we would use alternative internal funding sources from cash and cash equivalent balances, liquidation of portfolio investments and potential external sources, such as credit facilities. Our fixed portfolio is weighted towards conservative, high-quality securities. Management expects that, if necessary, the full value of cash, cash equivalents, short-term and fixed income investments could be available in two to three business days under normal market conditions.

Net cash proceeds from operating activities for the nine months ended September 30, 2025 and 2024 were $383.2 million and $543.9 million, respectively. The year-over-year decrease was primarily driven by timing differences in our insurance and reinsurance programs.

***Investing Activities***

Our portfolio is weighted towards conservative, high-quality securities as well as cash and cash equivalent investments, such as money market funds. We also hold investments in alternative securities that typically report on a consistent lag basis whereby their valuation may change in response to future financial performance of the investees.

For the nine months ended September 30, 2025, net cash used in investing activities was $238.3 million, which is primarily related to purchases of high-quality fixed maturity securities, partially offset by sales and maturities of fixed maturity securities.

For the nine months ended September 30, 2024, net cash used in investing activities was $231.2 million, which is primarily related to the repositioning of our investment portfolio through the divestment of our mutual funds into separately managed portfolios mainly investing in high-quality fixed maturity securities during the period, as well as net purchases of short-term investments.

***Financing Activities***

Net cash provided by financing activities for the nine months ended September 30, 2025 was $209.5 million and primarily related to the $392.0 million from the issuance of common shares, partially offset by $175.3 million related to the redemption of Class C preference shares and $7.2 million of dividends paid to non-controlling interests.

Net cash used in financing activities for the nine months ended September 30, 2024 was $3.4 million and primarily related to dividends paid to non-controlling interests holders and payments made on our outstanding debt obligations.

**Supplemental non-cash activity information** 

For the nine months ended September 30, 2025 and 2024, refer to the notes to the cash flow statement presented in our interim condensed consolidated financial statements included elsewhere in this Form 10-Q for information related to significant non-cash investing and financing activities.

**Reinsurance**

As part of our strategy to engage with Risk Capital Partners, we offer quota share reinsurance contracts to these partners. We also purchase excess of loss reinsurance contracts for the business that we retain to further limit our exposure to potential large losses. Our reinsurance is primarily contracted under quota-share reinsurance treaties and excess of loss treaties. In quota-share reinsurance, the reinsurer agrees to assume a specified percentage of the ceding company's losses arising out of a defined class of business in exchange for a corresponding percentage of premiums, net of a ceding commission. In excess of loss reinsurance, the reinsurer agrees to assume all or a portion of the ceding company's losses, in excess of a specified amount. In excess of loss reinsurance, the premium payable to the reinsurer is negotiated by the parties based on their assessment of the amount of risk being ceded to the reinsurer because the reinsurer does not share proportionately in the ceding company's losses.

We employ disciplined and principles-based reserving practices with effective controls and oversight. We actively manage risk through reinsurance, partnering primarily with reinsurers that maintain "A-" or better A.M. Best financial strength ratings, possess a history of strong credit quality or that fully collateralize their recoverables, all of which ensures high-quality recoverable assets and minimizes counterparty risk. We believe our high-quality balance sheet provides the foundation for consistently delivering financial performance and returns.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

Credit risk exists with reinsurance ceded to the extent that any reinsurer is unable to meet the obligation assumed under the reinsurance agreements. An allowance is established for amounts deemed uncollectible. We evaluate the financial condition of our reinsurers and monitor concentration of credit risk arising from our exposure to individual reinsurers. To further reduce credit exposure to reinsurance recoverables balances, we have received letters of credit from certain reinsurers that are not authorized as reinsurers under US state insurance regulations.

Of the total reinsurance recoverables on paid and unpaid losses and LAE outstanding as of September 30, 2025, 55% were with reinsurers having an A.M. Best rating of "A-" (excellent) or better, and we require reinsurance recoverables with reinsurers that have an A.M. Best rating below "A-" or are not rated by A.M. Best to be subject to collateral arrangements through a combination of letters of credit, funds withheld arrangements or trust agreements. We consider such collateral arrangements, credit ratings assigned to reinsurers by A.M. Best and other historical default rate information in estimating the credit valuation allowance for reinsurance recoverables. The credit valuation allowance was $0.6 million and $0.4 million as of September 30, 2025 and December 31, 2024, respectively.

We cede a significant portion of our insurance business to our unconsolidated collateralized reinsurance sidecar vehicle, Flywheel Re. Flywheel Re is a Cayman Islands special purpose reinsurance company that provides committed multi-year collateralized quota share capacity, capitalized by long-term institutional investors.

***Regulated deposits and restricted assets***

Certain companies in the Group are required to maintain assets on deposit with various regulatory authorities to support our insurance and reinsurance operations. Securities on deposit for regulatory and other purposes were $5.0 million and $4.9 million as of September 30, 2025 and December 31, 2024, respectively, which are included in the "Fixed maturity securities available for sale, at fair value" in the consolidated balance sheets.

In addition, we have pledged cash and cash equivalents of $71.9 million, short-term investments of $8.0 million and fixed maturity securities of $25.6 million as of September 30, 2025 in favor of certain ceding companies to collateralize obligations. As of December 31, 2024, we had pledged cash and cash equivalents of $47.3 million, short-term investments of $17.2 million and fixed maturity securities of $33.0 million in favor of certain ceding companies to collateralize obligations.

***Reserves for losses and loss adjustment expenses***

Reserves for losses and LAE represent our estimated indemnity cost and related adjustment expenses necessary to administer and settle claims. Our estimates are based upon individual case estimates for reported claims set by our claims specialists, adjusted with actuarial estimates for any further expected development on reported claims and for losses that have been incurred, but not yet reported. Actual losses and settlement expenses paid may deviate, perhaps substantially, from the reserve estimates reflected in our consolidated financial statements. Similarly, the timing for payment of our estimated losses is not fixed and is not determinable on an individual or aggregate basis due to the uncertainty inherent in the process of estimating such payments.

***Reinsurance recoverables***

Reinsurance recoverables on reserves for losses and LAE are reported separately as assets, instead of being netted with the related liabilities, since reinsurance does not discharge us of our liability to policyholders. The method for determining reinsurance recoverables for unpaid losses and LAE involves reviewing actuarial estimates of gross unpaid losses and LAE to determine our ability to cede unpaid losses and loss adjustment expenses under our existing reinsurance contracts.

***Debt***

We have a senior unsecured syndicated US dollar denominated loan facility with a September 2029 maturity date with an aggregate outstanding principal balance of $125 million. The credit agreement includes a $50 million revolving credit facility (all of which was unutilized and available as of September 30, 2025. Each borrowing under the revolving credit facility may have a maturity of one, three or six months, at the Company's election, but may not extend beyond the credit agreement's maturity date. Such borrowings may be repaid early.

The senior notes are senior unsecured obligations and include a delayed draw term loan ("DDTL") feature that allows us to withdraw predefined amounts. Incremental facilities up to an additional $75 million are available to draw upon request, subject to the agreement of the lenders.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

Partial quarterly repayments of the aggregate principal amount are required until the maturity date. Interest payments on the senior notes are due at the end of each period, being a certain month or quarter during which the applicable interest rate has been reset. The interest rate is subject to a sliding scale based on our consolidated senior debt to capitalization ratio and varies between a 3.4% and 4.0% spread in addition to the Secured Overnight Financing Rate ("SOFR"). Interest is calculated based on a 360-day year of twelve 30-day months. Interest expense for the three months ended September 30, 2025 and 2024 was $2.6 million and $3.1 million, respectively. Interest expense for the nine months ended September 30, 2025 and 2024 was $7.7 million and $9.1 million, respectively.

Subject to conditions of optional prepayment, we may voluntarily prepay the senior notes at any time and from time to time, prior to the maturity date without penalty. Any prepayment, in whole or in part, shall include any accrued and unpaid interest thereon to, but excluding, the prepayment date. Any amounts we prepay may not be reborrowed.

The senior notes contain certain restrictive and maintenance covenants customary for facilities of this type, including restrictions on minimum consolidated net worth, maximum leverage levels and a minimum interest coverage ratio. As of September 30, 2025, we were in compliance with all such covenants.

***Capital maintenance agreements***

We have established capital maintenance agreements with our insurance subsidiaries which obligates us to make capital contributions to our rated insurance and reinsurance subsidiaries to maintain surplus above our minimum regulatory and rating agency capital targets. These requirements are set by our Board of Directors. During the nine months ended September 30, 2025, we made capital contributions of $44.1 million to Accelerant Insurance UK Limited, $12.0 million to Accelerant Re. I.I. (Puerto Rico), $11.0 million to Accelerant National Insurance Company, $10.0 million to Accelerant Re (Cayman) Ltd, and $0.7 million to Accelerant Insurance Company of Canada.

**Ratings**

Ratings by independent agencies are an important factor in establishing the competitive position of insurance companies and reinsurance companies and are important to our ability attract Members and third-party capital providers. Rating organizations continually review the financial positions of insurers and reinsurers. These ratings reflect the rating agency's views regarding balance sheet strength, operating performance, business profile and enterprise risk management. It is not an evaluation directed toward the protection of investors or a recommendation to buy, sell or hold our shares. Our insurance and reinsurance operating subsidiaries are assigned financial strength ratings by A.M. Best as follows:

---

| | | |
|:---|:---|:---|
| | **Rating** | **Outlook** |
| Accelerant Insurance Europe SA | "A-" (Excellent) | Stable |
| Accelerant Specialty Insurance Company | "A-" (Excellent) | Stable |
| Accelerant National Insurance Company | "A-" (Excellent) | Stable |
| Accelerant Re (Cayman) Ltd. | "A-" (Excellent) | Stable |
| Accelerant Insurance UK Limited | "A-" (Excellent) | Stable |
| Accelerant Insurance Company of Canada | "A-" (Excellent) | Stable |
| Accelerant Re. I.I. (Puerto Rico) | "A-" (Excellent) | Stable |

---

These ratings reflect A.M. Best's opinion of the ability of Accelerant Holdings and respective subsidiaries to pay claims and are not evaluations directed to security holders. A.M. Best maintains a letter-scale rating system ranging from "A++" (Superior) to "F" (in liquidation). "A–" is the fourth highest of 16 financial strength ratings assigned by A.M. Best, as last updated in June 2025. These ratings are subject to periodic review and may be revised downward or revoked at the sole discretion of A.M. Best.

**Off-Balance Sheet Arrangements**

We do not have any off-balance sheet arrangements, as defined by applicable regulations of the SEC, which are reasonably likely to have a current or future material effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**Critical Accounting Policies and Estimates**

Our consolidated financial statements are prepared in conformity with US GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates on our historical experience and on various other assumptions that we believe are reasonable after weighing up all relevant information. Actual results may differ from those estimates.

The accounting policies listed below involve significant estimates, and therefore are critical in understanding our financial performance and operational results. For additional information, refer to Note 2 to our audited consolidated financial statements in the Prospectus.

***Unpaid Loss and Loss Adjustment Expenses***

We record loss reserves for our unpaid loss and LAE, which involves significant judgment and complex estimation processes. It represents management's best estimate of the unpaid portion of ultimate costs, of all reported and unreported loss incurred through the balance sheet date and is based upon the assumption that past developments are an appropriate indicator of future events among other factors. The reserves are based on individual claims, case reserves and other reserves estimates reported, as well as actuarial estimates of ultimate losses.

Inherent in the estimates of ultimate losses are expected trends in claim severity and frequency and other factors which could vary significantly as claims are settled. Ultimate losses may vary materially from the amounts provided in the consolidated financial statements. These estimates are reviewed regularly and as experience develops and new information becomes known, the reserves are adjusted as necessary. Such adjustments, if any, are reflected in the consolidated statements of operations in the period in which they become known and are accounted for as changes in estimates. The unpaid losses and LAE are presented on an undiscounted basis.

The process of establishing unpaid losses and LAE can be complex and is subject to considerable uncertainty, as it requires the use of informed estimates and judgments based on circumstances known at the date of accrual. These estimates and judgments are based on numerous factors and may be revised as additional experience and other data become available and are reviewed and as new or improved methodologies are developed. The adequacy of the reserves may be impacted by future trends in claims severity, frequency, payment patterns and other factors. These variables are affected by both external and internal events, including but not limited to, changes in the economic cycle, inflation, natural or human-made catastrophes and legislative changes.

The main risks and uncertainties are associated with limited historical data and new and evolving estimation processes. As such, we supplement our analysis using a combination of third-party data provided by Members and industry benchmark data as the basis for the selection of expected reporting patterns. We expect to continuously increase the use of our own data and experience as we accumulate such information over time. In addition, we incorporate our estimates of future trends in various factors such as loss frequency and severity in the evaluation process.

We review loss reserves in-depth every six months or more frequently depending on the facts and circumstances, with a high-level actual versus expected ("AvE") analysis done in between the in-depth reviews. During in-depth reviews, all estimates are reviewed and adjusted as our own experience develops and market conditions change. During the high level AvE analysis we make changes for any material developments over the period (e.g., large losses, catastrophic events or significant market changes).

Total IBNR reserves are determined by subtracting payments and case reserves implied from the ultimate loss and LAE estimates. Ultimate loss and LAE are estimated utilizing generally accepted actuarial loss reserving methods. Our reserving methods include the Chain Ladder, Bornheutter-Ferguson and Initial Expected Loss Ratio methods. Reportable catastrophe losses are analyzed and reserved separately using a frequency and severity approach. The underlying premise of the Chain Ladder method is that future claims are best estimated using past development pattern, whereas the Bornheutter-Ferguson method employs a combination of past claims development and prior estimates of ultimate losses based on expected loss ratio. The methods all involve aggregating paid and case-incurred loss data by underwriting year and development month, segmented into Members and products or lines of business as deemed appropriate and material. The ultimate loss selections for each year tend to be based upon the Chain Ladder results for the older years and the Bornheutter-Ferguson method for the most recent years.

Because we have limited data to assess our own claims experience given the recently formed nature of the business, we use industry and peer-group data, in addition to our own data, as a basis for selecting our expected paid and reporting patterns.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

Inflation rates in all major economic regions and the imposition (or threatened imposition) of tariffs add to the uncertainty of the future claim cost. Actuarial models base future emergence on historic experience, with adjustments for current trends, and the appropriateness of these assumptions has therefore involved more uncertainty in recent periods. We expect there will be impacts to the timing of loss emergence and ultimate loss ratios for certain underwritten coverages. The industry is experiencing new issues, including a backlog of civil court cases in most states, the extension of certain statutes of limitations and the impact on insureds from a significant reduction in economic activity. Our recorded reserves include consideration of these factors, but legislative, regulatory, or judicial actions could result in loss reserve deficiencies and reduce earnings in future periods.

The two categories of our loss reserves include case reserves and IBNR reserves. Our gross reserves for losses and LAE at September 30, 2025 and December 31, 2024 were $1.84 billion and $1.29 billion, 63% and 60% of which relates to IBNR, respectively. Our reserves for losses and loss adjustment expenses, net of reinsurance, at September 30, 2025 and December 31, 2024 were $288.5 million and $224.9 million, 54% and 52% of which relates to IBNR, respectively.

**The following table summarizes our reserves for unpaid losses and loss adjustment expenses, on a gross basis and net of reinsurance, as of September 30, 2025 and December 31, 2024:**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| ***(in millions)*** | **Gross** | **% of Total** | **Net** | **% of Total** | **Gross** | **% of Total** | **Net** | **% of Total** |
| Case Reserves | $678.2 | 37% | $132.3 | 46% | $514.4 | 40% | $107.5 | 48% |
| IBNR | 1163.2 | 63% | 156.2 | 54% | 780.0 | 60% | 117.4 | 52% |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total** | $**1841.4** | **100%** | $**288.5** | **100%** | $**1294.4** | **100%** | $**224.9** | **100%** |

---

Case reserves are established for the individual claims that have been reported to us. Based on the information available and the status of the claims, case reserves are established by TPAs, who have the authority of handling smaller claims (typically up to $250 thousand) or our claims teams, for large losses, through standard claim handling practices and professional judgment. As mentioned above, the estimates may be refined, and the ultimate value of claims liability may be adjusted either upward or downward as more information becomes available.

In case of catastrophes or other large losses, the additional IBNR in relation to those claims is estimated by the joint work of the claims, portfolio management, and actuarial teams, and those estimates are used in the final estimates provided to the finance team for recognition within our financial statements. Our internal threshold for catastrophe losses is $10 million of gross losses. We have had nine such events since inception: European flooding (July 2021), Storm Arwen (2021), Storm Eunice (February 2022), Hurricane Ian (September 2022), US winter storms (January 2024), Hurricane Helene (September 2024), California wildfires (January 2025), Storm Éowyn (January 2025) and Missouri Tornados (May 2025). In aggregate, these events led to approximately $12 million of net incurred losses. While we write insurance products in each of these potentially impacted areas, we also maintain significant reinsurance coverage such that our net exposure is limited. For example, the most recent Missouri Tornados resulted in $22 million of gross losses, which were reduced by $20 million of quota-share reinsurance benefits and thus only resulted in $2 million of net retained losses. In addition to our quota share cover, for the 2025 and prior treaty years, our US property catastrophe excess of loss retention for a modeled gross occurrence is expected to significantly reduce our net exposure to insignificant levels as part of our business model to limit our exposure to insurance risk.

In addition to the assumptions used in our data and reserves methodology, we used the following estimates to determine our unpaid loss and LAE: development patterns where we use Members' experience and/or applicable industry information; inflation assumptions for each class of business and territory; rate changes as provided by Members and underwriting changes as evidence leading to the rate changes; business mix changes for various Members; large loss load calculated from historic average performance or similar class of business; and selected loss ratio that is representative.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**The tables below represent the aggregated impact from potential deviations from our recorded reserve as of September 30, 2025 and December 31, 2024:**

Sensitivity factors are applied to our most recent underwriting year and we believe these potential changes will not have a material impact on our liquidity. An increase in the gross loss of 3% in the most recent underwriting year would equate to an increase in the net loss and LAE reserve of $11.5 million.

---

| | | | |
|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| ***Sensitivity<br>(in millions)*** | **Sensitivity for Ultimate Loss and LAE Sensitivity Factor** | **Net Loss and LAE Reserve** | **Increase/(Decrease) in Net Loss and LAE Reserve** |
| Increase | +3% | $300.0 | $11.5 |
| Increase | +2% | 296.2 | 7.7 |
| Increase | +1% | 292.4 | 3.9 |
| Actual (Base Case) | 0% | 288.5 |  |
| Decrease | -1% | 284.6 | (3.9) |
| Decrease | -2% | 280.8 | (7.7) |
| Decrease | -3% | 277.0 | (11.5) |

---

---

| | | | |
|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| ***Sensitivity<br>(in millions)*** | **Sensitivity for Ultimate Loss and LAE Sensitivity Factor** | **Net Loss and LAE Reserve** | **Increase/(Decrease) in Net Loss and LAE Reserve** |
| Increase | +3% | $230.9 | $6.0 |
| Increase | +2% | 228.9 | 4.0 |
| Increase | +1% | 226.9 | 2.0 |
| Actual (Base Case) | 0% | 224.9 |  |
| Decrease | -1% | 222.9 | (2.0) |
| Decrease | -2% | 220.9 | (4.0) |
| Decrease | -3% | 218.9 | (6.0) |

---

***Reinsurance Recoverable on Unpaid Losses***

In our Underwriting segment, we cede a large proportion of our GWP under various reinsurance contracts. These reinsurance agreements transfer portions of the underlying risk of the business that we underwrite and a share of premium to reinsurers, but they do not release or diminish our obligation to pay claims covered by the insurance policies. We are still primarily liable to the insured whether or not the reinsurer is able to meet its contractual obligations.

The quantum of ceded loss recoveries from our reinsurers are subject to uncertainty as our calculation of such amounts rely on similar estimates and methodologies as are used in estimating our gross loss reserves.

Additionally, there is a risk that one or more of our reinsurers may be unwilling or unable to pay their share of reinsurance recoverables. This risk is mitigated by placing our reinsurance with a diverse panel of reinsurers that are all either rated "A-" or better by A.M. Best or provide collateral to us to maximize the probability that reinsurance recoverables will be realized. We regularly monitor the financial condition of our reinsurers and we generally have special termination rights in our reinsurance treaties in the event of deterioration in the reinsurers' credit worthiness, generally if the A.M. Best rating falls below "A-" or there is a reduction in the capital and surplus of the reinsurer of more than 20% of their prior year end capital and surplus. Despite these arrangements, there is a risk that a reduction in one or more reinsurers' ability or willingness to pay our reinsurance recoverables could have a materially negative impact on our liquidity.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Impacts of Loss Ratio Estimates and Actual Loss Experience on Sliding Scale Commissions Impacting our Ceding Commission Income***

We cede a significant portion of our premiums written to reinsurance companies. The ceding commissions are offset against DAC related to the insurance contracts subject to such reinsurance. Any excess ceding commissions over the related DAC are subject to deferral over the insurance premiums earning period. Certain of our reinsurance arrangements are subject to sliding scale commission amounts pursuant to the agreements with various reinsurers based on the actual loss experience of covered insurance contracts.

The contractual ceding commission amounts are expressed as a percentage of the underlying premiums by type of insurance policy. Further, the amount of ceding commissions may vary based on the volume of ceded premium and the loss ratio. As that loss ratio changes from the original expected contractual amount, the amount of ceding commission inversely changes (such that adverse experience in the subject loss ratio will result in a reduction in ceding commissions and conversely, any favorable experience in the subject loss ratio will result in an increase in ceding commissions).

The change in ceding commissions will result in a change to the deferred ceding commission liability to the extent that the underlying premiums are unearned and, conversely, will result in a direct change to income to the extent that the underlying premium has been earned. As such, the sliding scale commissions act as a substantive participation in the underlying loss experience of the underlying insurance contracts.

Our typical reinsurance treaties' commissions vary based on the volume of ceded premium and the ratio of ceded loss to ceded premium. As that ratio decreases, the amount of commission increases. As of September 30, 2025, the average commission we receive is 50% of ceded premium at a 40% gross loss ratio and a minimum of 34% of ceded premium at gross loss ratios of 67% and above. The adjustment between the points is largely linear. We expect commissions of 43% of ceded premium at a gross loss ratio of 50%. There were no significant adverse adjustments to reinsurance commissions due to prior year claims experience during the nine months ended September 30, 2025.

Our process for calculating changes in ceding commissions from our reinsurers is linked to the results of our actuarial reserving process for loss and loss adjustment expense reserves, which is updated each reporting period. On a quarterly basis, our actuaries produce an actuarial central estimate of the gross and net loss reserves for all contracts bound as of the evaluation date. The calculations also include estimates of loss-sensitive contingent terms such as sliding scale ceding commissions. Calculations are done on a contract-by-contract basis and reflect the most recent premium and loss information available at the evaluation date.

***Valuation Allowance on Deferred Income Taxes***

Deferred tax assets and liabilities result from temporary differences between the amounts recorded in the consolidated financial statements and the tax basis of assets and liabilities used in the various jurisdictional tax returns. We recognize deferred tax assets to the extent we believe it is probable that future profits will be available to utilize these tax benefits. As of September 30, 2025, we had net deferred tax assets of $57.5 million.

A valuation allowance is set up for the portion of the asset that is more likely than not unrealizable, which reduces the total deferred tax asset to only the amount that we expect to realize. This allowance is assessed at each balance sheet date and is based on all available information including significant judgments related to the likely timing and level of forecasted taxable profits based on assumptions about future macroeconomic and Company-specific conditions and the associated future tax planning strategies. We subject the forecasts to stresses of key assumptions and evaluate the effect on tax attribute utilization. In performing our assessment of recoverability, we consider tax laws governing the utilization of net operating losses, capital losses and tax credit carryforwards in each applicable jurisdiction. The tax laws are subject to change, resulting in incremental uncertainty in our assessment of recoverability, along with the future tax planning strategies. If the actual taxable income in future periods differ from our forecast, it could impact our financial position in either a materially positive or negative way. As of September 30, 2025, our valuation allowance was $52.1 million. We intend to evaluate the realizability of our deferred tax asset quarterly through the assessment of the need for such a valuation allowance.

**Election Under the Jumpstart Our Business Startups Act of 2012**

We currently qualify as an "emerging growth company" as defined in the Jumpstart Our Business Act of 2012, or the JOBS Act. For so long as we remain an emerging growth company, we are permitted and intend to rely on exemptions from specified disclosure requirements that are applicable to other public companies that do not qualify as emerging growth companies. Accordingly, we are provided with the option to adopt new or revised accounting guidance either (i) within the same period as those otherwise applicable to non-emerging growth companies or (ii) within the same time period as private companies.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

We have elected to adopt new or revised accounting guidance within the same time period as private companies, unless we determine it is preferable to take advantage of early adoption provisions offered within the applicable guidance. We may take advantage of this provision for up to five years or such earlier time when we are no longer an emerging growth company and, as such, we expect to remain an emerging growth company at least through December 31, 2025. Therefore, our consolidated financial statements may not be comparable to those of companies that comply with new or revised accounting pronouncements as of public company effective dates.

**Item 3. Quantitative and Qualitative Disclosures about Market Risk**

Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument as the result of changes in credit spreads, interest rates, equity markets prices, foreign currency exchange rates, and other relevant market rates and prices.

***Credit Risk***

Credit risk is the potential loss resulting from adverse changes in an issuer's ability to repay its debt obligations. We have exposure to credit risk as a holder of fixed-maturity securities. We manage this credit risk through diversification in terms of instruments by issuer, geographic region and related industry. At September 30, 2025, approximately 88% of our fixed maturity investment portfolio was rated "A" or better and approximately 100% was classified as investment-grade.

***Interest Rate Risk***

Interest rate risk is the risk that we will incur economic losses due to adverse changes in interest rates. The primary market risk to the investment portfolio is interest rate risk associated with investments in fixed-maturity securities. Fluctuations in interest rates have a direct effect on the market valuation of these securities. When market interest rates rise, the fair value of our fixed-maturity securities decreases. Conversely, as interest rates fall, the fair value of our fixed-maturity securities increases. We manage this interest rate risk by investing in securities with varied maturity dates and by matching the duration of our investment portfolio to the duration of our loss and LAE reserves. Expressed in years, duration is the weighted average payment period of cash flows, where the weighting is based on the present value of the cash flows. We set duration targets for our fixed-maturity investment portfolios after consideration of the estimated duration of our liabilities and other factors. The effective weighted-average duration of the portfolio was 2.8 years as of September 30, 2025.

We had available for sale fixed maturity securities with a fair value of $721.9 million and $479.5 million at September 30, 2025 and December 31, 2024, respectively, that were subject to interest rate risk. The table below illustrates the sensitivity of the fair value of our fixed maturity securities to selected hypothetical changes in interest rates as of September 30, 2025 and December 31, 2024.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| ***(in millions)*** | **Fair Value** | **Estimated Change in Fair Value** | **Fair Value** | **Estimated Change in Fair Value** |
| 200 basis point increase | $680.8 | $(41.1) | $449.8 | $(29.7) |
| 100 basis point increase | 701.3 | (20.6) | 464.6 | (14.9) |
| No change | 721.9 |  | 479.5 |  |
| 100 basis point decrease | 742.5 | 20.6 | 494.4 | 14.9 |
| 200 basis point decrease | 763.0 | 41.1 | 509.2 | 29.7 |

---

Changes in interest rates will have an immediate effect on comprehensive income and shareholders' equity but will not ordinarily have an immediate effect on net income. Actual results may differ from the hypothetical change in market rates assumed in this disclosure. This sensitivity analysis does not reflect the results of any action that we may take to mitigate such hypothetical losses in fair value.

***Equity Risk***

Equity risk represents the potential economic losses due to adverse changes in equity security prices. Our equity securities consist of interests in highly rated, highly liquid, investment funds. We manage equity price risk of our equity portfolio primarily through asset allocation techniques, and fund selection within a given portfolio.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

***Foreign Currency Exchange Risk***

Foreign currency exchange-rate risk is the risk that we will incur losses on a US dollar basis due to adverse changes in foreign currency exchange rates. In the ordinary course of business, we hold non-US dollar denominated assets and liabilities, which are valued using period-end exchange rates. Non-US dollar denominated foreign revenues and expenses are valued using average exchange rates over the period. We have the following exposures to foreign currency risk.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Transaction Risk*: The functional currency for most of our subsidiaries is the US dollar. Within these entities, any fluctuations in foreign currency exchange rates relative to the US dollar has a direct impact on the valuation of our assets and liabilities denominated in other currencies. All changes in foreign exchange rates, except for non-US dollar fixed maturities and available for sale securities, are recognized in our consolidated statements of operations. Changes in foreign exchange rates relating to non-US dollar fixed maturities and available for sale securities are recorded in accumulated other comprehensive income in shareholders' equity. Our subsidiaries with non-US dollar functional currencies are also exposed to fluctuations in foreign currency exchange rates relative to their own functional currency.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Translation Risk*: We have net investments in certain European, British, and Canadian subsidiaries whose functional currencies are the Euro, British Pound and Canadian dollar, respectively. The foreign exchange gain or loss resulting from the translation of their financial statements from their respective functional currency into US dollars is recorded in the cumulative translation adjustment account, which is a component of accumulated other comprehensive income in shareholders' equity.

Our foreign currency policy is to broadly manage, where possible, our foreign currency risk by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Seeking to match our liabilities under (re)insurance policies that are payable in foreign currencies with assets that are denominated in such currencies, subject to regulatory constraints.

To the extent our foreign currency exposure is not matched, we may experience foreign exchange losses or gains, which would be reflected in our consolidated results of operations and financial condition. We continue to assess additional hedging strategies and instruments that could further reduce our exposure to foreign currency exchange-rate volatility.

The following table summarizes the estimated effects of a hypothetical 10% increase and decrease in the value of the US dollar against select foreign currencies would have had on the carrying value of our net assets as of September 30, 2025 and December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| ***(in millions)*** | **10% increase** | **10% decrease** | **10% increase** | **10% decrease** |
| British Pound to US Dollar | $(2.3) | $2.3 | $1.0 | $(1.0) |
| Euro to US Dollar | (5.5) | 5.5 | 5.7 | (5.7) |
| Canadian Dollar to US Dollar | 2.3 | (2.3) | 2.0 | (2.0) |

---

**Item 4. Controls and Procedures**

Disclosure controls and procedures are designed to ensure that information required to be disclosed in reports filed or submitted under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosures. In connection with the preparation of this Quarterly Report on Form 10-Q, an evaluation was carried out by Accelerant management, with the participation of Accelerant's Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of September 30, 2025. Based on this evaluation, Accelerant's Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2025.

There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f)) that have occurred during the quarter ended September 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

**PART II. OTHER INFORMATION**

**Item 1. Legal Proceedings**

Other than in the ordinary course of our business operations, we are not currently party to any civil or government investigation. We do not expect that the ultimate outcome of any of the currently ongoing legal proceedings, individually or collectively, would have a material adverse effect on our business, financial condition, results of operations, or prospects. However, the results of litigation and arbitration are inherently unpredictable, and the possibility exists that the ultimate resolution of matters to which we are or could become subject could result in a material adverse effect on our business, financial condition, results of operations or prospects.

**Item 1A. Risk Factors**

There have been no material changes to our risk factors that we believe are material to our business, results of operations and financial condition, from the risk factors previously disclosed in the section entitled "Risk Factors" in the Prospectus.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

On July 23, 2025, our registration statement on Form S-1 (File No. 333-288435) was declared effective by the SEC. Pursuant to such registration statement, we issued and sold 20,276,280 Class A common shares at a public offering price of $21.00 per share on July 25, 2025. We received net proceeds of $392.0 million, after deducting underwriting discounts and commissions and offering expenses. We used a portion of the net proceeds to fund the redemption of the Class C convertible preference shares for $175.3 million in cash (as all holders of the Class C convertible preference shares elected to redeem at the date of its IPO) and to fund a $25.0 million termination fee to an affiliate of Altamont Capital partners for a then-existing management services arrangement, and intend to use the remaining amount for general corporate purposes. In addition, certain shareholders sold 19,354,044 at the public offering price of $21.00 per share and received net proceeds of $384.1 million after deducting $22.4 million in underwriting discounts and commissions. We did not receive any proceeds from the sale of Class A common shares by the selling shareholders.

Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, BMO Capital Markets Corp. and RBC Capital Markets, LLC acted as joint book-running managers in the IPO.

For additional details on the IPO, refer to "Nature of business and basis of presentation—Initial Public Offering" in Note 1 of the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

**Item 3. Defaults Upon Senior Securities**

None.

**Item 4. Mine Safety Disclosures**

Not applicable.

**Item 5. Other Information**

During the three months ended September 30, 2025, none of the Company's directors or officers adopted, modified or terminated any "Rule 10b5-1 trading arrangement" or any "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408 of Regulation S-K.

------

<u>[**Table of Contents**](#ib1a6822efc494886a9b5551020e883af_7)</u>

 **Item 6. Exhibits**

---

| | |
|:---|:---|
| **Exhibits Index** | **Exhibits Index** |
| **Exhibit No.** | **Description** |
| 31.1\* | <u>[Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex311sox302certificationfo.htm)</u> |
| 31.2\* | <u>[Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex312sox302certificationfo.htm)</u> |
| 32.1\*\* | <u>[Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex321sox906certificationfo.htm)</u> |
| 32.2\*\* | <u>[Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex322sox906certificationfo.htm)</u> |
| 101.INS\* | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH\* | Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Documents. |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

\* Filed herewith. <br> \*\* Furnished herewith.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on November 12, 2025.

---

| | |
|:---|:---|
| **Accelerant Holdings** | **Accelerant Holdings** |
| By: | /s/ Jeff Radke |
| Name: | Jeff Radke |
| Title: | Chief Executive Officer (Principal Executive Officer)  |
| By: | /s/ Jay Green |
| Name: | Jay Green |
| Title: | Chief Financial Officer (Principal Financial Officer)  |

---

## Exhibit 31.1

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO**

**RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Jeff Radke, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 of Accelerant Holdings;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;(b) Paragraph omitted pursuant to Rule 13a-14;

&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: November 12, 2025 | By: | /s/ Jeff Radke |
|  |  | **Jeff Radke** |
|  |  | **Chief Executive Officer** |

---

## Exhibit 31.2

**CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO**

**RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Jay Green, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 of Accelerant Holdings;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;(b) Paragraph omitted pursuant to Rule 13a-14;

&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: November 12, 2025 | By: | /s/ Jay Green |
|  |  | **Jay Green** |
|  |  | **Chief Financial Officer** |

---

## Exhibit 32.1

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Accelerant Holdings (the "Company") on Form 10-Q for the period ending September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)&nbsp;&nbsp;&nbsp;&nbsp;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: November 12, 2025 | By: | /s/ Jeff Radke |
|  |  | **Jeff Radke** |
|  |  | **Chief Executive Officer** |

---

## Exhibit 32.2

**CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Accelerant Holdings (the "Company") on Form 10-Q for the period ending September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: November 12, 2025 | By: | /s/ Jay Green |
|  |  | **Jay Green** |
|  |  | **Chief Financial Officer** |

---

<br>